id	sid	tid	token	lemma	pos
iajs-3400	1	1	157	157	NUM
iajs-3400	1	2	this	this	DET
iajs-3400	1	3	work	work	NOUN
iajs-3400	1	4	is	be	AUX
iajs-3400	1	5	licensed	license	VERB
iajs-3400	1	6	under	under	ADP
iajs-3400	1	7	a	a	DET
iajs-3400	1	8	creative	creative	ADJ
iajs-3400	1	9	commons	common	NOUN
iajs-3400	1	10	attribution	attribution	NOUN
iajs-3400	1	11	4.0	4.0	NUM
iajs-3400	1	12	international	international	ADJ
iajs-3400	1	13	license	license	NOUN
iajs-3400	1	14	ihjpas	ihjpa	NOUN
iajs-3400	1	15	.	.	PUNCT
iajs-3400	2	1	37	37	NUM
iajs-3400	2	2	(	(	PUNCT
iajs-3400	2	3	2	2	NUM
iajs-3400	2	4	)	)	PUNCT
iajs-3400	2	5	2024	2024	NUM
iajs-3400	2	6	ibn	ibn	PROPN
iajs-3400	2	7	al	al	PROPN
iajs-3400	2	8	-	-	PUNCT
iajs-3400	2	9	haitham	haitham	PROPN
iajs-3400	2	10	journal	journal	PROPN
iajs-3400	2	11	for	for	ADP
iajs-3400	2	12	pure	pure	ADJ
iajs-3400	2	13	and	and	CCONJ
iajs-3400	2	14	applied	applied	ADJ
iajs-3400	2	15	sciences	sciences	PROPN
iajs-3400	2	16	journal	journal	PROPN
iajs-3400	2	17	homepage	homepage	NOUN
iajs-3400	2	18	:	:	PUNCT
iajs-3400	2	19	jih.uobaghdad.edu.iq	jih.uobaghdad.edu.iq	NOUN
iajs-3400	2	20	pissn	pissn	ADJ
iajs-3400	2	21	:	:	PUNCT
iajs-3400	2	22	1609	1609	NUM
iajs-3400	2	23	-	-	SYM
iajs-3400	2	24	4042	4042	NUM
iajs-3400	2	25	,	,	PUNCT
iajs-3400	2	26	eissn	eissn	NOUN
iajs-3400	2	27	:	:	PUNCT
iajs-3400	2	28	2521	2521	NUM
iajs-3400	2	29	-	-	SYM
iajs-3400	2	30	3407	3407	NUM
iajs-3400	2	31	evaluation	evaluation	NOUN
iajs-3400	2	32	of	of	ADP
iajs-3400	2	33	grhpr	grhpr	ADJ
iajs-3400	2	34	enzyme	enzyme	NOUN
iajs-3400	2	35	and	and	CCONJ
iajs-3400	2	36	some	some	DET
iajs-3400	2	37	biochemical	biochemical	ADJ
iajs-3400	2	38	variables	variable	NOUN
iajs-3400	2	39	in	in	ADP
iajs-3400	2	40	patients	patient	NOUN
iajs-3400	2	41	with	with	ADP
iajs-3400	2	42	calcium	calcium	NOUN
iajs-3400	2	43	oxalate	oxalate	NOUN
iajs-3400	2	44	kidney	kidney	NOUN
iajs-3400	2	45	stone	stone	NOUN
iajs-3400	2	46	disease	disease	NOUN
iajs-3400	2	47	duha	duha	PROPN
iajs-3400	2	48	abed	abe	VERB
iajs-3400	2	49	almuhssen	almuhssen	ADJ
iajs-3400	2	50	alzubaidy	alzubaidy	PROPN
iajs-3400	2	51	1	1	NUM
iajs-3400	2	52	*	*	ADJ
iajs-3400	2	53	and	and	CCONJ
iajs-3400	2	54	luma	luma	PROPN
iajs-3400	2	55	hassan	hassan	PROPN
iajs-3400	2	56	alwan	alwan	PROPN
iajs-3400	3	1	al	al	PROPN
iajs-3400	3	2	obaidy	obaidy	VERB
iajs-3400	3	3	2	2	NUM
iajs-3400	3	4	1,2	1,2	NUM
iajs-3400	3	5	department	department	NOUN
iajs-3400	3	6	of	of	ADP
iajs-3400	3	7	biology	biology	NOUN
iajs-3400	3	8	,	,	PUNCT
iajs-3400	3	9	college	college	NOUN
iajs-3400	3	10	of	of	ADP
iajs-3400	3	11	science	science	NOUN
iajs-3400	3	12	for	for	ADP
iajs-3400	3	13	women	woman	NOUN
iajs-3400	3	14	,	,	PUNCT
iajs-3400	3	15	university	university	NOUN
iajs-3400	3	16	of	of	ADP
iajs-3400	3	17	baghdad	baghdad	PROPN
iajs-3400	3	18	,	,	PUNCT
iajs-3400	3	19	baghdad	baghdad	PROPN
iajs-3400	3	20	,	,	PUNCT
iajs-3400	3	21	iraq	iraq	PROPN
iajs-3400	3	22	*	*	PUNCT
iajs-3400	3	23	corresponding	correspond	VERB
iajs-3400	3	24	author	author	NOUN
iajs-3400	3	25	.	.	PUNCT
iajs-3400	4	1	received	receive	VERB
iajs-3400	4	2	:	:	PUNCT
iajs-3400	4	3	16	16	NUM
iajs-3400	4	4	april	april	PROPN
iajs-3400	4	5	2023	2023	NUM
iajs-3400	4	6	accepted	accept	VERB
iajs-3400	4	7	:	:	PUNCT
iajs-3400	4	8	30	30	NUM
iajs-3400	4	9	may	may	PROPN
iajs-3400	4	10	2023	2023	NUM
iajs-3400	4	11	published	publish	VERB
iajs-3400	4	12	:	:	PUNCT
iajs-3400	4	13	20	20	NUM
iajs-3400	4	14	april	april	PROPN
iajs-3400	4	15	2024	2024	NUM
iajs-3400	4	16	doi.org/10.30526/37.2.3400	doi.org/10.30526/37.2.3400	PROPN
iajs-3400	4	17	abstract	abstract	ADJ
iajs-3400	4	18	kidney	kidney	NOUN
iajs-3400	4	19	stone	stone	NOUN
iajs-3400	4	20	disease	disease	NOUN
iajs-3400	4	21	is	be	AUX
iajs-3400	4	22	a	a	DET
iajs-3400	4	23	highly	highly	ADV
iajs-3400	4	24	significant	significant	ADJ
iajs-3400	4	25	clinical	clinical	ADJ
iajs-3400	4	26	issue	issue	NOUN
iajs-3400	4	27	that	that	PRON
iajs-3400	4	28	poses	pose	VERB
iajs-3400	4	29	a	a	DET
iajs-3400	4	30	serious	serious	ADJ
iajs-3400	4	31	threat	threat	NOUN
iajs-3400	4	32	to	to	ADP
iajs-3400	4	33	both	both	PRON
iajs-3400	4	34	global	global	ADJ
iajs-3400	4	35	health	health	NOUN
iajs-3400	4	36	and	and	CCONJ
iajs-3400	4	37	the	the	DET
iajs-3400	4	38	economy	economy	NOUN
iajs-3400	4	39	.	.	PUNCT
iajs-3400	5	1	for	for	ADP
iajs-3400	5	2	the	the	DET
iajs-3400	5	3	sustainability	sustainability	NOUN
iajs-3400	5	4	of	of	ADP
iajs-3400	5	5	good	good	ADJ
iajs-3400	5	6	health	health	NOUN
iajs-3400	5	7	and	and	CCONJ
iajs-3400	5	8	well	well	ADV
iajs-3400	5	9	-	-	PUNCT
iajs-3400	5	10	being	being	NOUN
iajs-3400	5	11	of	of	ADP
iajs-3400	5	12	kidney	kidney	NOUN
iajs-3400	5	13	stone	stone	NOUN
iajs-3400	5	14	patients	patient	NOUN
iajs-3400	5	15	,	,	PUNCT
iajs-3400	5	16	this	this	DET
iajs-3400	5	17	study	study	NOUN
iajs-3400	5	18	aimed	aim	VERB
iajs-3400	5	19	to	to	PART
iajs-3400	5	20	elucidate	elucidate	VERB
iajs-3400	5	21	the	the	DET
iajs-3400	5	22	role	role	NOUN
iajs-3400	5	23	of	of	ADP
iajs-3400	5	24	the	the	DET
iajs-3400	5	25	enzyme	enzyme	NOUN
iajs-3400	5	26	glyoxylate	glyoxylate	NOUN
iajs-3400	5	27	reductase	reductase	NOUN
iajs-3400	5	28	and	and	CCONJ
iajs-3400	5	29	hydroxypyruvate	hydroxypyruvate	ADJ
iajs-3400	5	30	reductase	reductase	NOUN
iajs-3400	5	31	(	(	PUNCT
iajs-3400	5	32	grhpr	grhpr	NOUN
iajs-3400	5	33	)	)	PUNCT
iajs-3400	5	34	in	in	ADP
iajs-3400	5	35	formation	formation	NOUN
iajs-3400	5	36	of	of	ADP
iajs-3400	5	37	the	the	DET
iajs-3400	5	38	kidney	kidney	NOUN
iajs-3400	5	39	stones	stone	NOUN
iajs-3400	5	40	and	and	CCONJ
iajs-3400	5	41	their	their	PRON
iajs-3400	5	42	development	development	NOUN
iajs-3400	5	43	.	.	PUNCT
iajs-3400	6	1	there	there	PRON
iajs-3400	6	2	are	be	VERB
iajs-3400	6	3	many	many	ADJ
iajs-3400	6	4	different	different	ADJ
iajs-3400	6	5	types	type	NOUN
iajs-3400	6	6	of	of	ADP
iajs-3400	6	7	kidney	kidney	NOUN
iajs-3400	6	8	stones	stone	NOUN
iajs-3400	6	9	,	,	PUNCT
iajs-3400	6	10	but	but	CCONJ
iajs-3400	6	11	calcium	calcium	NOUN
iajs-3400	6	12	oxalate	oxalate	NOUN
iajs-3400	6	13	kidney	kidney	NOUN
iajs-3400	6	14	stones	stone	NOUN
iajs-3400	6	15	are	be	AUX
iajs-3400	6	16	the	the	DET
iajs-3400	6	17	most	most	ADV
iajs-3400	6	18	prevalent	prevalent	ADJ
iajs-3400	6	19	in	in	ADP
iajs-3400	6	20	iraq	iraq	PROPN
iajs-3400	6	21	.	.	PUNCT
iajs-3400	7	1	in	in	ADP
iajs-3400	7	2	this	this	DET
iajs-3400	7	3	study	study	NOUN
iajs-3400	7	4	,	,	PUNCT
iajs-3400	7	5	50	50	NUM
iajs-3400	7	6	iraqi	iraqi	ADJ
iajs-3400	7	7	patients	patient	NOUN
iajs-3400	7	8	with	with	ADP
iajs-3400	7	9	calcium	calcium	NOUN
iajs-3400	7	10	oxalate	oxalate	NOUN
iajs-3400	7	11	stones	stone	NOUN
iajs-3400	7	12	(	(	PUNCT
iajs-3400	7	13	25	25	NUM
iajs-3400	7	14	males	male	NOUN
iajs-3400	7	15	and	and	CCONJ
iajs-3400	7	16	25	25	NUM
iajs-3400	7	17	females	female	NOUN
iajs-3400	7	18	)	)	PUNCT
iajs-3400	7	19	were	be	AUX
iajs-3400	7	20	compared	compare	VERB
iajs-3400	7	21	to	to	ADP
iajs-3400	7	22	30	30	NUM
iajs-3400	7	23	healthy	healthy	ADJ
iajs-3400	7	24	control	control	NOUN
iajs-3400	7	25	groups	group	NOUN
iajs-3400	7	26	(	(	PUNCT
iajs-3400	7	27	17	17	NUM
iajs-3400	7	28	males	male	NOUN
iajs-3400	7	29	and	and	CCONJ
iajs-3400	7	30	13	13	NUM
iajs-3400	7	31	females	female	NOUN
iajs-3400	7	32	)	)	PUNCT
iajs-3400	7	33	.	.	PUNCT
iajs-3400	8	1	the	the	DET
iajs-3400	8	2	biochemical	biochemical	ADJ
iajs-3400	8	3	tests	test	NOUN
iajs-3400	8	4	for	for	ADP
iajs-3400	8	5	kidney	kidney	NOUN
iajs-3400	8	6	function	function	NOUN
iajs-3400	8	7	,	,	PUNCT
iajs-3400	8	8	such	such	ADJ
iajs-3400	8	9	as	as	ADP
iajs-3400	8	10	serum	serum	NOUN
iajs-3400	8	11	urea	urea	NOUN
iajs-3400	8	12	,	,	PUNCT
iajs-3400	8	13	creatinine	creatinine	NOUN
iajs-3400	8	14	,	,	PUNCT
iajs-3400	8	15	and	and	CCONJ
iajs-3400	8	16	uric	uric	ADJ
iajs-3400	8	17	acid	acid	NOUN
iajs-3400	8	18	,	,	PUNCT
iajs-3400	8	19	were	be	AUX
iajs-3400	8	20	detected	detect	VERB
iajs-3400	8	21	in	in	ADP
iajs-3400	8	22	the	the	DET
iajs-3400	8	23	sera	sera	NOUN
iajs-3400	8	24	of	of	ADP
iajs-3400	8	25	both	both	DET
iajs-3400	8	26	study	study	NOUN
iajs-3400	8	27	groups	group	NOUN
iajs-3400	8	28	.	.	PUNCT
iajs-3400	9	1	in	in	ADP
iajs-3400	9	2	addition	addition	NOUN
iajs-3400	9	3	to	to	ADP
iajs-3400	9	4	fasting	fast	VERB
iajs-3400	9	5	blood	blood	NOUN
iajs-3400	9	6	sugar	sugar	NOUN
iajs-3400	9	7	(	(	PUNCT
iajs-3400	9	8	fbs	fbs	PROPN
iajs-3400	9	9	)	)	PUNCT
iajs-3400	9	10	,	,	PUNCT
iajs-3400	9	11	ca++	ca++	NOUN
iajs-3400	9	12	,	,	PUNCT
iajs-3400	9	13	na+	na+	NOUN
iajs-3400	9	14	,	,	PUNCT
iajs-3400	9	15	complete	complete	ADJ
iajs-3400	9	16	blood	blood	NOUN
iajs-3400	9	17	count	count	NOUN
iajs-3400	9	18	(	(	PUNCT
iajs-3400	9	19	cbc	cbc	PROPN
iajs-3400	9	20	)	)	PUNCT
iajs-3400	9	21	and	and	CCONJ
iajs-3400	9	22	blood	blood	NOUN
iajs-3400	9	23	group	group	NOUN
iajs-3400	9	24	tests	test	NOUN
iajs-3400	9	25	,	,	PUNCT
iajs-3400	9	26	urine	urine	NOUN
iajs-3400	9	27	was	be	AUX
iajs-3400	9	28	collected	collect	VERB
iajs-3400	9	29	for	for	ADP
iajs-3400	9	30	general	general	ADJ
iajs-3400	9	31	urine	urine	NOUN
iajs-3400	9	32	examination	examination	NOUN
iajs-3400	9	33	(	(	PUNCT
iajs-3400	9	34	gue	gue	NOUN
iajs-3400	9	35	)	)	PUNCT
iajs-3400	9	36	,	,	PUNCT
iajs-3400	9	37	to	to	PART
iajs-3400	9	38	visualize	visualize	VERB
iajs-3400	9	39	oxalate	oxalate	NOUN
iajs-3400	9	40	crystals	crystal	NOUN
iajs-3400	9	41	in	in	ADP
iajs-3400	9	42	the	the	DET
iajs-3400	9	43	patient	patient	NOUN
iajs-3400	9	44	’s	’s	PART
iajs-3400	9	45	urine	urine	NOUN
iajs-3400	9	46	.	.	PUNCT
iajs-3400	10	1	also	also	ADV
iajs-3400	10	2	,	,	PUNCT
iajs-3400	10	3	the	the	DET
iajs-3400	10	4	relationship	relationship	NOUN
iajs-3400	10	5	between	between	ADP
iajs-3400	10	6	the	the	DET
iajs-3400	10	7	concentration	concentration	NOUN
iajs-3400	10	8	of	of	ADP
iajs-3400	10	9	the	the	DET
iajs-3400	10	10	enzymes	enzyme	NOUN
iajs-3400	10	11	glyoxylate	glyoxylate	NOUN
iajs-3400	10	12	reductase	reductase	NOUN
iajs-3400	10	13	and	and	CCONJ
iajs-3400	10	14	hydroxypyruvate	hydroxypyruvate	ADJ
iajs-3400	10	15	reductase	reductase	NOUN
iajs-3400	10	16	(	(	PUNCT
iajs-3400	10	17	grhpr	grhpr	NOUN
iajs-3400	10	18	)	)	PUNCT
iajs-3400	10	19	and	and	CCONJ
iajs-3400	10	20	the	the	DET
iajs-3400	10	21	development	development	NOUN
iajs-3400	10	22	of	of	ADP
iajs-3400	10	23	calcium	calcium	NOUN
iajs-3400	10	24	oxalate	oxalate	NOUN
iajs-3400	10	25	kidney	kidney	NOUN
iajs-3400	10	26	stones	stone	NOUN
iajs-3400	10	27	in	in	ADP
iajs-3400	10	28	iraqi	iraqi	ADJ
iajs-3400	10	29	patients	patient	NOUN
iajs-3400	10	30	and	and	CCONJ
iajs-3400	10	31	the	the	DET
iajs-3400	10	32	control	control	NOUN
iajs-3400	10	33	group	group	NOUN
iajs-3400	10	34	was	be	AUX
iajs-3400	10	35	examined	examine	VERB
iajs-3400	10	36	.	.	PUNCT
iajs-3400	11	1	it	it	PRON
iajs-3400	11	2	was	be	AUX
iajs-3400	11	3	found	find	VERB
iajs-3400	11	4	that	that	SCONJ
iajs-3400	11	5	the	the	DET
iajs-3400	11	6	enzyme	enzyme	NOUN
iajs-3400	11	7	concentrations	concentration	NOUN
iajs-3400	11	8	in	in	ADP
iajs-3400	11	9	the	the	DET
iajs-3400	11	10	control	control	NOUN
iajs-3400	11	11	group	group	NOUN
iajs-3400	11	12	were	be	AUX
iajs-3400	11	13	(	(	PUNCT
iajs-3400	11	14	4.78	4.78	NUM
iajs-3400	11	15	±	±	NUM
iajs-3400	11	16	1.06	1.06	NUM
iajs-3400	11	17	mg	mg	PROPN
iajs-3400	11	18	/	/	SYM
iajs-3400	11	19	dl	dl	NOUN
iajs-3400	11	20	)	)	PUNCT
iajs-3400	11	21	significantly	significantly	ADV
iajs-3400	11	22	higher	high	ADJ
iajs-3400	11	23	than	than	ADP
iajs-3400	11	24	the	the	DET
iajs-3400	11	25	enzyme	enzyme	NOUN
iajs-3400	11	26	concentration	concentration	NOUN
iajs-3400	11	27	in	in	ADP
iajs-3400	11	28	the	the	DET
iajs-3400	11	29	patients	patient	NOUN
iajs-3400	11	30	group	group	NOUN
iajs-3400	11	31	(	(	PUNCT
iajs-3400	11	32	0.411	0.411	NUM
iajs-3400	11	33	±	±	NUM
iajs-3400	11	34	0.02	0.02	NUM
iajs-3400	11	35	mg	mg	PROPN
iajs-3400	11	36	/	/	SYM
iajs-3400	11	37	dl	dl	NOUN
iajs-3400	11	38	)	)	PUNCT
iajs-3400	11	39	.	.	PUNCT
iajs-3400	12	1	also	also	ADV
iajs-3400	12	2	,	,	PUNCT
iajs-3400	12	3	it	it	PRON
iajs-3400	12	4	was	be	AUX
iajs-3400	12	5	found	find	VERB
iajs-3400	12	6	,	,	PUNCT
iajs-3400	12	7	that	that	SCONJ
iajs-3400	12	8	the	the	DET
iajs-3400	12	9	uric	uric	ADJ
iajs-3400	12	10	acid	acid	NOUN
iajs-3400	12	11	concentrations	concentration	NOUN
iajs-3400	12	12	were	be	AUX
iajs-3400	12	13	within	within	ADP
iajs-3400	12	14	the	the	DET
iajs-3400	12	15	normal	normal	ADJ
iajs-3400	12	16	range	range	NOUN
iajs-3400	12	17	for	for	ADP
iajs-3400	12	18	both	both	DET
iajs-3400	12	19	groups	group	NOUN
iajs-3400	12	20	,	,	PUNCT
iajs-3400	12	21	but	but	CCONJ
iajs-3400	12	22	urea	urea	NOUN
iajs-3400	12	23	and	and	CCONJ
iajs-3400	12	24	creatinine	creatinine	NOUN
iajs-3400	12	25	were	be	AUX
iajs-3400	12	26	significantly	significantly	ADV
iajs-3400	12	27	higher	high	ADJ
iajs-3400	12	28	in	in	ADP
iajs-3400	12	29	kidney	kidney	NOUN
iajs-3400	12	30	stone	stone	NOUN
iajs-3400	12	31	patients	patient	NOUN
iajs-3400	12	32	,	,	PUNCT
iajs-3400	12	33	while	while	SCONJ
iajs-3400	12	34	they	they	PRON
iajs-3400	12	35	were	be	AUX
iajs-3400	12	36	at	at	ADP
iajs-3400	12	37	the	the	DET
iajs-3400	12	38	normal	normal	ADJ
iajs-3400	12	39	ranges	range	NOUN
iajs-3400	12	40	in	in	ADP
iajs-3400	12	41	the	the	DET
iajs-3400	12	42	control	control	NOUN
iajs-3400	12	43	group	group	NOUN
iajs-3400	12	44	.	.	PUNCT
iajs-3400	13	1	keywords	keyword	NOUN
iajs-3400	13	2	:	:	PUNCT
iajs-3400	13	3	kidney	kidney	NOUN
iajs-3400	13	4	stone	stone	NOUN
iajs-3400	13	5	,	,	PUNCT
iajs-3400	13	6	nephrolithiasis	nephrolithiasis	NOUN
iajs-3400	13	7	,	,	PUNCT
iajs-3400	13	8	calcium	calcium	NOUN
iajs-3400	13	9	oxalate	oxalate	NOUN
iajs-3400	13	10	,	,	PUNCT
iajs-3400	13	11	glyoxylate	glyoxylate	NOUN
iajs-3400	13	12	reductase	reductase	NOUN
iajs-3400	13	13	,	,	PUNCT
iajs-3400	13	14	hydroxypyruvate	hydroxypyruvate	NOUN
iajs-3400	13	15	reductase	reductase	NOUN
iajs-3400	13	16	.	.	PUNCT
iajs-3400	14	1	1	1	X
iajs-3400	14	2	.	.	X
iajs-3400	14	3	introduction	introduction	NOUN
iajs-3400	14	4	nephrolithiasis	nephrolithiasis	NOUN
iajs-3400	14	5	,	,	PUNCT
iajs-3400	14	6	often	often	ADV
iajs-3400	14	7	known	know	VERB
iajs-3400	14	8	as	as	ADP
iajs-3400	14	9	kidney	kidney	NOUN
iajs-3400	14	10	stones	stone	NOUN
iajs-3400	14	11	,	,	PUNCT
iajs-3400	14	12	is	be	AUX
iajs-3400	14	13	a	a	DET
iajs-3400	14	14	serious	serious	ADJ
iajs-3400	14	15	condition	condition	NOUN
iajs-3400	14	16	that	that	PRON
iajs-3400	14	17	is	be	AUX
iajs-3400	14	18	common	common	ADJ
iajs-3400	14	19	around	around	ADP
iajs-3400	14	20	the	the	DET
iajs-3400	14	21	world	world	NOUN
iajs-3400	15	1	[	[	X
iajs-3400	15	2	1	1	NUM
iajs-3400	15	3	]	]	PUNCT
iajs-3400	15	4	.	.	PUNCT
iajs-3400	16	1	it	it	PRON
iajs-3400	16	2	can	can	AUX
iajs-3400	16	3	affect	affect	VERB
iajs-3400	16	4	anyone	anyone	PRON
iajs-3400	16	5	of	of	ADP
iajs-3400	16	6	any	any	DET
iajs-3400	16	7	gender	gender	NOUN
iajs-3400	16	8	,	,	PUNCT
iajs-3400	16	9	age	age	NOUN
iajs-3400	16	10	,	,	PUNCT
iajs-3400	16	11	or	or	CCONJ
iajs-3400	16	12	race	race	NOUN
iajs-3400	16	13	[	[	X
iajs-3400	16	14	2	2	NUM
iajs-3400	16	15	]	]	PUNCT
iajs-3400	16	16	.	.	PUNCT
iajs-3400	17	1	humans	human	NOUN
iajs-3400	17	2	have	have	AUX
iajs-3400	17	3	experienced	experience	VERB
iajs-3400	17	4	urinary	urinary	ADJ
iajs-3400	17	5	stone	stone	NOUN
iajs-3400	17	6	illnesses	illness	NOUN
iajs-3400	17	7	since	since	SCONJ
iajs-3400	17	8	4000	4000	NUM
iajs-3400	17	9	bc	bc	PROPN
iajs-3400	17	10	[	[	X
iajs-3400	17	11	3	3	NUM
iajs-3400	17	12	]	]	PUNCT
iajs-3400	17	13	.	.	PUNCT
iajs-3400	18	1	it	it	PRON
iajs-3400	18	2	has	have	AUX
iajs-3400	18	3	surpassed	surpass	VERB
iajs-3400	18	4	14	14	NUM
iajs-3400	18	5	%	%	NOUN
iajs-3400	18	6	in	in	ADP
iajs-3400	18	7	the	the	DET
iajs-3400	18	8	general	general	ADJ
iajs-3400	18	9	population	population	NOUN
iajs-3400	19	1	[	[	X
iajs-3400	19	2	4	4	NUM
iajs-3400	19	3	]	]	PUNCT
iajs-3400	19	4	,	,	PUNCT
iajs-3400	19	5	since	since	SCONJ
iajs-3400	19	6	the	the	DET
iajs-3400	19	7	prevalence	prevalence	NOUN
iajs-3400	19	8	has	have	AUX
iajs-3400	19	9	increased	increase	VERB
iajs-3400	19	10	worldwide	worldwide	ADV
iajs-3400	19	11	,	,	PUNCT
iajs-3400	19	12	particularly	particularly	ADV
iajs-3400	19	13	in	in	ADP
iajs-3400	19	14	the	the	DET
iajs-3400	19	15	recent	recent	ADJ
iajs-3400	19	16	three	three	NUM
iajs-3400	19	17	decades	decade	NOUN
iajs-3400	19	18	[	[	X
iajs-3400	19	19	5	5	NUM
iajs-3400	19	20	]	]	PUNCT
iajs-3400	19	21	,	,	PUNCT
iajs-3400	19	22	and	and	CCONJ
iajs-3400	19	23	the	the	DET
iajs-3400	19	24	prevalence	prevalence	NOUN
iajs-3400	19	25	has	have	AUX
iajs-3400	19	26	varied	vary	VERB
iajs-3400	19	27	significantly	significantly	ADV
iajs-3400	19	28	between	between	ADP
iajs-3400	19	29	different	different	ADJ
iajs-3400	19	30	countries	country	NOUN
iajs-3400	20	1	[	[	X
iajs-3400	20	2	6	6	NUM
iajs-3400	20	3	]	]	PUNCT
iajs-3400	20	4	.	.	PUNCT
iajs-3400	21	1	it	it	PRON
iajs-3400	21	2	has	have	VERB
iajs-3400	21	3	a	a	DET
iajs-3400	21	4	high	high	ADJ
iajs-3400	21	5	financial	financial	ADJ
iajs-3400	21	6	cost	cost	NOUN
iajs-3400	21	7	,	,	PUNCT
iajs-3400	21	8	a	a	DET
iajs-3400	21	9	high	high	ADJ
iajs-3400	21	10	incidence	incidence	NOUN
iajs-3400	21	11	rate	rate	NOUN
iajs-3400	21	12	,	,	PUNCT
iajs-3400	21	13	and	and	CCONJ
iajs-3400	21	14	a	a	DET
iajs-3400	21	15	high	high	ADJ
iajs-3400	21	16	rate	rate	NOUN
iajs-3400	21	17	of	of	ADP
iajs-3400	21	18	recurrence	recurrence	NOUN
iajs-3400	21	19	that	that	PRON
iajs-3400	21	20	can	can	AUX
iajs-3400	21	21	affect	affect	VERB
iajs-3400	21	22	half	half	NOUN
iajs-3400	21	23	of	of	ADP
iajs-3400	21	24	the	the	DET
iajs-3400	21	25	patients	patient	NOUN
iajs-3400	21	26	in	in	ADP
iajs-3400	21	27	10	10	NUM
iajs-3400	21	28	years	year	NOUN
iajs-3400	21	29	and	and	CCONJ
iajs-3400	21	30	virtually	virtually	ADV
iajs-3400	21	31	all	all	DET
iajs-3400	21	32	patients	patient	NOUN
iajs-3400	21	33	in	in	ADP
iajs-3400	21	34	30	30	NUM
iajs-3400	21	35	years	year	NOUN
iajs-3400	22	1	[	[	X
iajs-3400	22	2	7	7	NUM
iajs-3400	22	3	]	]	PUNCT
iajs-3400	22	4	,	,	PUNCT
iajs-3400	22	5	the	the	DET
iajs-3400	22	6	recurrence	recurrence	NOUN
iajs-3400	22	7	rate	rate	NOUN
iajs-3400	22	8	varies	vary	VERB
iajs-3400	22	9	widely	widely	ADV
iajs-3400	22	10	amongst	amongst	ADP
iajs-3400	22	11	patients	patient	NOUN
iajs-3400	22	12	,	,	PUNCT
iajs-3400	22	13	some	some	DET
iajs-3400	22	14	https://jih.uobaghdad.edu.iq/index.php/j/index#1609-4042	https://jih.uobaghdad.edu.iq/index.php/j/index#1609-4042	NOUN
iajs-3400	22	15	https://jih.uobaghdad.edu.iq/index.php/j/index#2521-3407	https://jih.uobaghdad.edu.iq/index.php/j/index#2521-3407	VERB
iajs-3400	22	16	https://orcid.org/0009-0005-4017-3170	https://orcid.org/0009-0005-4017-3170	PRON
iajs-3400	22	17	mailto:doha.abdulmuhsin1202a@csw.uobaghdad.edu.iq	mailto:doha.abdulmuhsin1202a@csw.uobaghdad.edu.iq	PROPN
iajs-3400	22	18	https://orcid.org/0000-0002-7649-4516	https://orcid.org/0000-0002-7649-4516	ADJ
iajs-3400	22	19	mailto:lumaha_bio@csw.uobaghdad.edu.iq	mailto:lumaha_bio@csw.uobaghdad.edu.iq	PROPN
iajs-3400	22	20	https://orcid.org/0009-0005-4017-3170	https://orcid.org/0009-0005-4017-3170	PROPN
iajs-3400	22	21	mailto:doha.abdulmuhsin1202a@csw.uobaghdad.edu.iq	mailto:doha.abdulmuhsin1202a@csw.uobaghdad.edu.iq	PROPN
iajs-3400	22	22	https://orcid.org/0000-0002-7649-4516	https://orcid.org/0000-0002-7649-4516	ADJ
iajs-3400	22	23	mailto:lumaha_bio@csw.uobaghdad.edu.iq	mailto:lumaha_bio@csw.uobaghdad.edu.iq	PROPN
iajs-3400	22	24	https://orcid.org/0009-0005-4017-3170	https://orcid.org/0009-0005-4017-3170	PROPN
iajs-3400	22	25	mailto:doha.abdulmuhsin1202a@csw.uobaghdad.edu.iq	mailto:doha.abdulmuhsin1202a@csw.uobaghdad.edu.iq	PROPN
iajs-3400	22	26	https://orcid.org/0000-0002-7649-4516	https://orcid.org/0000-0002-7649-4516	ADJ
iajs-3400	22	27	mailto:lumaha_bio@csw.uobaghdad.edu.iq	mailto:lumaha_bio@csw.uobaghdad.edu.iq	PROPN
iajs-3400	22	28	https://orcid.org/0009-0005-4017-3170	https://orcid.org/0009-0005-4017-3170	PROPN
iajs-3400	22	29	mailto:doha.abdulmuhsin1202a@csw.uobaghdad.edu.iq	mailto:doha.abdulmuhsin1202a@csw.uobaghdad.edu.iq	PROPN
iajs-3400	22	30	https://orcid.org/0000-0002-7649-4516	https://orcid.org/0000-0002-7649-4516	ADJ
iajs-3400	22	31	mailto:lumaha_bio@csw.uobaghdad.edu.iq	mailto:lumaha_bio@csw.uobaghdad.edu.iq	PROPN
iajs-3400	22	32	https://orcid.org/0009-0005-4017-3170	https://orcid.org/0009-0005-4017-3170	PROPN
iajs-3400	22	33	mailto:doha.abdulmuhsin1202a@csw.uobaghdad.edu.iq	mailto:doha.abdulmuhsin1202a@csw.uobaghdad.edu.iq	PROPN
iajs-3400	22	34	https://orcid.org/0000-0002-7649-4516	https://orcid.org/0000-0002-7649-4516	ADJ
iajs-3400	22	35	mailto:lumaha_bio@csw.uobaghdad.edu.iq	mailto:lumaha_bio@csw.uobaghdad.edu.iq	PROPN
iajs-3400	22	36	https://orcid.org/0009-0005-4017-3170	https://orcid.org/0009-0005-4017-3170	PROPN
iajs-3400	22	37	mailto:doha.abdulmuhsin1202a@csw.uobaghdad.edu.iq	mailto:doha.abdulmuhsin1202a@csw.uobaghdad.edu.iq	PROPN
iajs-3400	22	38	https://orcid.org/0000-0002-7649-4516	https://orcid.org/0000-0002-7649-4516	ADJ
iajs-3400	22	39	mailto:lumaha_bio@csw.uobaghdad.edu.iq	mailto:lumaha_bio@csw.uobaghdad.edu.iq	PROPN
iajs-3400	22	40	https://orcid.org/0009-0005-4017-3170	https://orcid.org/0009-0005-4017-3170	PROPN
iajs-3400	22	41	mailto:doha.abdulmuhsin1202a@csw.uobaghdad.edu.iq	mailto:doha.abdulmuhsin1202a@csw.uobaghdad.edu.iq	PROPN
iajs-3400	23	1	https://orcid.org/0000-0002-7649-4516	https://orcid.org/0000-0002-7649-4516	ADJ
iajs-3400	23	2	mailto:lumaha_bio@csw.uobaghdad.edu.iq	mailto:lumaha_bio@csw.uobaghdad.edu.iq	PROPN
iajs-3400	23	3	https://orcid.org/0009-0005-4017-3170	https://orcid.org/0009-0005-4017-3170	PROPN
iajs-3400	23	4	mailto:doha.abdulmuhsin1202a@csw.uobaghdad.edu.iq	mailto:doha.abdulmuhsin1202a@csw.uobaghdad.edu.iq	PROPN
iajs-3400	23	5	https://orcid.org/0000-0002-7649-4516	https://orcid.org/0000-0002-7649-4516	ADJ
iajs-3400	23	6	mailto:lumaha_bio@csw.uobaghdad.edu.iq	mailto:lumaha_bio@csw.uobaghdad.edu.iq	PROPN
iajs-3400	23	7	ihjpas	ihjpa	NOUN
iajs-3400	23	8	.	.	PUNCT
iajs-3400	24	1	37	37	NUM
iajs-3400	24	2	(	(	PUNCT
iajs-3400	24	3	2	2	NUM
iajs-3400	24	4	)	)	PUNCT
iajs-3400	24	5	2024	2024	NUM
iajs-3400	24	6	158	158	NUM
iajs-3400	24	7	sufferers	sufferer	NOUN
iajs-3400	24	8	only	only	ADV
iajs-3400	24	9	once	once	ADV
iajs-3400	24	10	,	,	PUNCT
iajs-3400	24	11	whereas	whereas	SCONJ
iajs-3400	24	12	others	other	NOUN
iajs-3400	24	13	have	have	AUX
iajs-3400	24	14	repeated	repeat	VERB
iajs-3400	24	15	recurrences	recurrence	NOUN
iajs-3400	24	16	[	[	X
iajs-3400	24	17	8	8	NUM
iajs-3400	24	18	]	]	PUNCT
iajs-3400	24	19	thus	thus	ADV
iajs-3400	24	20	increasing	increase	VERB
iajs-3400	24	21	the	the	DET
iajs-3400	24	22	number	number	NOUN
iajs-3400	24	23	of	of	ADP
iajs-3400	24	24	individuals	individual	NOUN
iajs-3400	24	25	who	who	PRON
iajs-3400	24	26	need	need	VERB
iajs-3400	24	27	proper	proper	ADJ
iajs-3400	24	28	treatment	treatment	NOUN
iajs-3400	24	29	and	and	CCONJ
iajs-3400	24	30	recurrence	recurrence	NOUN
iajs-3400	24	31	prevention	prevention	NOUN
iajs-3400	24	32	[	[	X
iajs-3400	24	33	9	9	NUM
iajs-3400	24	34	]	]	PUNCT
iajs-3400	24	35	.	.	PUNCT
iajs-3400	25	1	there	there	PRON
iajs-3400	25	2	are	be	VERB
iajs-3400	25	3	many	many	ADJ
iajs-3400	25	4	types	type	NOUN
iajs-3400	25	5	of	of	ADP
iajs-3400	25	6	kidney	kidney	NOUN
iajs-3400	25	7	stones	stone	NOUN
iajs-3400	25	8	,	,	PUNCT
iajs-3400	25	9	including	include	VERB
iajs-3400	25	10	calcium	calcium	NOUN
iajs-3400	25	11	oxalate	oxalate	NOUN
iajs-3400	25	12	(	(	PUNCT
iajs-3400	25	13	caox	caox	PROPN
iajs-3400	25	14	)	)	PUNCT
iajs-3400	25	15	which	which	PRON
iajs-3400	25	16	is	be	AUX
iajs-3400	25	17	the	the	DET
iajs-3400	25	18	most	most	ADV
iajs-3400	25	19	common	common	ADJ
iajs-3400	25	20	type	type	NOUN
iajs-3400	25	21	around	around	ADP
iajs-3400	25	22	the	the	DET
iajs-3400	25	23	world	world	NOUN
iajs-3400	26	1	[	[	X
iajs-3400	26	2	10	10	NUM
iajs-3400	26	3	]	]	PUNCT
iajs-3400	26	4	,	,	PUNCT
iajs-3400	26	5	followed	follow	VERB
iajs-3400	26	6	by	by	ADP
iajs-3400	26	7	uric	uric	ADJ
iajs-3400	26	8	acid	acid	NOUN
iajs-3400	26	9	,	,	PUNCT
iajs-3400	26	10	calcium	calcium	NOUN
iajs-3400	26	11	phosphate	phosphate	NOUN
iajs-3400	26	12	(	(	PUNCT
iajs-3400	26	13	cap	cap	NOUN
iajs-3400	26	14	)	)	PUNCT
iajs-3400	26	15	,	,	PUNCT
iajs-3400	26	16	struvite	struvite	NOUN
iajs-3400	26	17	,	,	PUNCT
iajs-3400	26	18	apatite	apatite	NOUN
iajs-3400	26	19	,	,	PUNCT
iajs-3400	26	20	and	and	CCONJ
iajs-3400	26	21	cysteine	cysteine	NOUN
iajs-3400	26	22	[	[	X
iajs-3400	26	23	11	11	NUM
iajs-3400	26	24	]	]	PUNCT
iajs-3400	26	25	.	.	PUNCT
iajs-3400	27	1	kidney	kidney	NOUN
iajs-3400	27	2	stones	stone	NOUN
iajs-3400	27	3	,	,	PUNCT
iajs-3400	27	4	mostly	mostly	ADV
iajs-3400	27	5	caox	caox	ADJ
iajs-3400	27	6	,	,	PUNCT
iajs-3400	27	7	have	have	AUX
iajs-3400	27	8	increased	increase	VERB
iajs-3400	27	9	continuously	continuously	ADV
iajs-3400	27	10	in	in	ADP
iajs-3400	27	11	iraq	iraq	PROPN
iajs-3400	28	1	[	[	X
iajs-3400	28	2	12	12	NUM
iajs-3400	28	3	]	]	PUNCT
iajs-3400	28	4	.	.	PUNCT
iajs-3400	29	1	they	they	PRON
iajs-3400	29	2	have	have	AUX
iajs-3400	29	3	spread	spread	VERB
iajs-3400	29	4	greatly	greatly	ADV
iajs-3400	29	5	as	as	SCONJ
iajs-3400	29	6	they	they	PRON
iajs-3400	29	7	have	have	VERB
iajs-3400	29	8	many	many	ADJ
iajs-3400	29	9	etiologies	etiology	NOUN
iajs-3400	29	10	[	[	X
iajs-3400	29	11	13	13	NUM
iajs-3400	29	12	]	]	PUNCT
iajs-3400	29	13	,	,	PUNCT
iajs-3400	29	14	for	for	ADP
iajs-3400	29	15	example	example	NOUN
iajs-3400	29	16	,	,	PUNCT
iajs-3400	29	17	diabetes	diabete	VERB
iajs-3400	29	18	[	[	X
iajs-3400	29	19	14	14	NUM
iajs-3400	29	20	]	]	PUNCT
iajs-3400	29	21	,	,	PUNCT
iajs-3400	29	22	hypertension	hypertension	NOUN
iajs-3400	29	23	[	[	X
iajs-3400	29	24	15	15	NUM
iajs-3400	29	25	]	]	PUNCT
iajs-3400	29	26	,	,	PUNCT
iajs-3400	29	27	gout	gout	NOUN
iajs-3400	29	28	and	and	CCONJ
iajs-3400	29	29	metabolic	metabolic	NOUN
iajs-3400	29	30	syndrome	syndrome	NOUN
iajs-3400	30	1	[	[	X
iajs-3400	30	2	16	16	NUM
iajs-3400	30	3	]	]	PUNCT
iajs-3400	30	4	,	,	PUNCT
iajs-3400	30	5	obesity	obesity	NOUN
iajs-3400	30	6	,	,	PUNCT
iajs-3400	30	7	depending	depend	VERB
iajs-3400	30	8	on	on	ADP
iajs-3400	30	9	an	an	DET
iajs-3400	30	10	animal	animal	NOUN
iajs-3400	30	11	protein	protein	NOUN
iajs-3400	30	12	diet	diet	NOUN
iajs-3400	31	1	[	[	X
iajs-3400	31	2	17	17	NUM
iajs-3400	31	3	]	]	PUNCT
iajs-3400	31	4	,	,	PUNCT
iajs-3400	31	5	and	and	CCONJ
iajs-3400	31	6	eating	eat	VERB
iajs-3400	31	7	a	a	DET
iajs-3400	31	8	high	high	ADJ
iajs-3400	31	9	amount	amount	NOUN
iajs-3400	31	10	of	of	ADP
iajs-3400	31	11	food	food	NOUN
iajs-3400	31	12	containing	contain	VERB
iajs-3400	31	13	calcium	calcium	NOUN
iajs-3400	31	14	,	,	PUNCT
iajs-3400	31	15	potassium	potassium	NOUN
iajs-3400	31	16	,	,	PUNCT
iajs-3400	31	17	magnesium	magnesium	NOUN
iajs-3400	31	18	,	,	PUNCT
iajs-3400	31	19	and	and	CCONJ
iajs-3400	31	20	sodium	sodium	NOUN
iajs-3400	31	21	[	[	X
iajs-3400	31	22	18	18	NUM
iajs-3400	31	23	]	]	PUNCT
iajs-3400	31	24	.	.	PUNCT
iajs-3400	32	1	also	also	ADV
iajs-3400	32	2	,	,	PUNCT
iajs-3400	32	3	environmental	environmental	ADJ
iajs-3400	32	4	factors	factor	NOUN
iajs-3400	32	5	such	such	ADJ
iajs-3400	32	6	as	as	ADP
iajs-3400	32	7	high	high	ADJ
iajs-3400	32	8	temperatures	temperature	NOUN
iajs-3400	32	9	[	[	X
iajs-3400	32	10	19	19	NUM
iajs-3400	32	11	]	]	PUNCT
iajs-3400	32	12	and	and	CCONJ
iajs-3400	32	13	some	some	DET
iajs-3400	32	14	microorganisms	microorganism	NOUN
iajs-3400	32	15	that	that	PRON
iajs-3400	32	16	cause	cause	VERB
iajs-3400	32	17	kidney	kidney	NOUN
iajs-3400	32	18	stones	stone	NOUN
iajs-3400	32	19	,	,	PUNCT
iajs-3400	32	20	such	such	ADJ
iajs-3400	32	21	as	as	ADP
iajs-3400	32	22	pseudomonas	pseudomona	NOUN
iajs-3400	32	23	,	,	PUNCT
iajs-3400	32	24	klebsiella	klebsiella	NOUN
iajs-3400	33	1	[	[	X
iajs-3400	33	2	20–21	20–21	NOUN
iajs-3400	33	3	]	]	X
iajs-3400	33	4	,	,	PUNCT
iajs-3400	33	5	and	and	CCONJ
iajs-3400	33	6	toxoplasma	toxoplasma	PROPN
iajs-3400	33	7	,	,	PUNCT
iajs-3400	33	8	may	may	AUX
iajs-3400	33	9	alter	alter	VERB
iajs-3400	33	10	kidney	kidney	NOUN
iajs-3400	33	11	function	function	NOUN
iajs-3400	33	12	.	.	PUNCT
iajs-3400	34	1	[	[	X
iajs-3400	34	2	22	22	NUM
iajs-3400	34	3	]	]	PUNCT
iajs-3400	34	4	the	the	DET
iajs-3400	34	5	genetic	genetic	ADJ
iajs-3400	34	6	factor	factor	NOUN
iajs-3400	34	7	is	be	AUX
iajs-3400	34	8	very	very	ADV
iajs-3400	34	9	important	important	ADJ
iajs-3400	34	10	as	as	SCONJ
iajs-3400	34	11	it	it	PRON
iajs-3400	34	12	plays	play	VERB
iajs-3400	34	13	a	a	DET
iajs-3400	34	14	significant	significant	ADJ
iajs-3400	34	15	role	role	NOUN
iajs-3400	34	16	in	in	ADP
iajs-3400	34	17	kidney	kidney	NOUN
iajs-3400	34	18	stone	stone	NOUN
iajs-3400	34	19	formation	formation	NOUN
iajs-3400	35	1	[	[	X
iajs-3400	35	2	23	23	NUM
iajs-3400	35	3	]	]	PUNCT
iajs-3400	35	4	.	.	PUNCT
iajs-3400	36	1	for	for	ADP
iajs-3400	36	2	example	example	NOUN
iajs-3400	36	3	,	,	PUNCT
iajs-3400	36	4	the	the	DET
iajs-3400	36	5	three	three	NUM
iajs-3400	36	6	types	type	NOUN
iajs-3400	36	7	of	of	ADP
iajs-3400	36	8	primary	primary	ADJ
iajs-3400	36	9	hyperoxaluria	hyperoxaluria	NOUN
iajs-3400	36	10	,	,	PUNCT
iajs-3400	36	11	referred	refer	VERB
iajs-3400	36	12	to	to	ADP
iajs-3400	36	13	as	as	ADP
iajs-3400	36	14	ph1	ph1	PROPN
iajs-3400	36	15	,	,	PUNCT
iajs-3400	36	16	ph2	ph2	NOUN
iajs-3400	36	17	,	,	PUNCT
iajs-3400	36	18	and	and	CCONJ
iajs-3400	36	19	ph3	ph3	PROPN
iajs-3400	36	20	,	,	PUNCT
iajs-3400	36	21	were	be	AUX
iajs-3400	36	22	caused	cause	VERB
iajs-3400	36	23	by	by	ADP
iajs-3400	36	24	mutations	mutation	NOUN
iajs-3400	36	25	in	in	ADP
iajs-3400	36	26	the	the	DET
iajs-3400	36	27	agxt	agxt	NOUN
iajs-3400	36	28	,	,	PUNCT
iajs-3400	36	29	grhpr	grhpr	ADJ
iajs-3400	36	30	,	,	PUNCT
iajs-3400	36	31	and	and	CCONJ
iajs-3400	36	32	hoga1	hoga1	NOUN
iajs-3400	36	33	genes	gene	NOUN
iajs-3400	36	34	,	,	PUNCT
iajs-3400	36	35	respectively	respectively	ADV
iajs-3400	36	36	[	[	X
iajs-3400	36	37	24	24	NUM
iajs-3400	36	38	]	]	PUNCT
iajs-3400	36	39	.	.	PUNCT
iajs-3400	37	1	these	these	DET
iajs-3400	37	2	conditions	condition	NOUN
iajs-3400	37	3	are	be	AUX
iajs-3400	37	4	characterized	characterize	VERB
iajs-3400	37	5	by	by	ADP
iajs-3400	37	6	an	an	DET
iajs-3400	37	7	accumulation	accumulation	NOUN
iajs-3400	37	8	of	of	ADP
iajs-3400	37	9	oxalate	oxalate	NOUN
iajs-3400	37	10	salts	salt	NOUN
iajs-3400	37	11	in	in	ADP
iajs-3400	37	12	the	the	DET
iajs-3400	37	13	kidneys	kidney	NOUN
iajs-3400	37	14	,	,	PUNCT
iajs-3400	37	15	which	which	PRON
iajs-3400	37	16	eventually	eventually	ADV
iajs-3400	37	17	leads	lead	VERB
iajs-3400	37	18	to	to	ADP
iajs-3400	37	19	the	the	DET
iajs-3400	37	20	development	development	NOUN
iajs-3400	37	21	of	of	ADP
iajs-3400	37	22	calcium	calcium	NOUN
iajs-3400	37	23	oxalate	oxalate	NOUN
iajs-3400	37	24	stones	stone	NOUN
iajs-3400	37	25	.	.	PUNCT
iajs-3400	38	1	the	the	DET
iajs-3400	38	2	glyoxylate	glyoxylate	NOUN
iajs-3400	38	3	reductase	reductase	NOUN
iajs-3400	38	4	hydroxypyruvate	hydroxypyruvate	NOUN
iajs-3400	38	5	reductase	reductase	NOUN
iajs-3400	38	6	(	(	PUNCT
iajs-3400	38	7	grhpr	grhpr	NOUN
iajs-3400	38	8	)	)	PUNCT
iajs-3400	38	9	is	be	AUX
iajs-3400	38	10	an	an	DET
iajs-3400	38	11	enzyme	enzyme	NOUN
iajs-3400	38	12	encoded	encode	VERB
iajs-3400	38	13	by	by	ADP
iajs-3400	38	14	the	the	DET
iajs-3400	38	15	grhpr	grhpr	ADJ
iajs-3400	38	16	gene	gene	NOUN
iajs-3400	38	17	that	that	PRON
iajs-3400	38	18	may	may	AUX
iajs-3400	38	19	be	be	AUX
iajs-3400	38	20	related	relate	VERB
iajs-3400	38	21	to	to	ADP
iajs-3400	38	22	its	its	PRON
iajs-3400	38	23	deficiency	deficiency	NOUN
iajs-3400	38	24	,	,	PUNCT
iajs-3400	38	25	which	which	PRON
iajs-3400	38	26	is	be	AUX
iajs-3400	38	27	found	find	VERB
iajs-3400	38	28	in	in	ADP
iajs-3400	38	29	the	the	DET
iajs-3400	38	30	pericentromeric	pericentromeric	ADJ
iajs-3400	38	31	region	region	NOUN
iajs-3400	38	32	of	of	ADP
iajs-3400	38	33	chromosome	chromosome	NOUN
iajs-3400	38	34	9	9	NUM
iajs-3400	38	35	[	[	X
iajs-3400	38	36	25	25	NUM
iajs-3400	38	37	]	]	PUNCT
iajs-3400	38	38	.	.	PUNCT
iajs-3400	39	1	it	it	PRON
iajs-3400	39	2	has	have	VERB
iajs-3400	39	3	nine	nine	NUM
iajs-3400	39	4	exons	exon	NOUN
iajs-3400	39	5	and	and	CCONJ
iajs-3400	39	6	eight	eight	NUM
iajs-3400	39	7	introns	intron	NOUN
iajs-3400	39	8	,	,	PUNCT
iajs-3400	39	9	and	and	CCONJ
iajs-3400	39	10	it	it	PRON
iajs-3400	39	11	encodes	encode	VERB
iajs-3400	39	12	for	for	ADP
iajs-3400	39	13	328	328	NUM
iajs-3400	39	14	amino	amino	ADJ
iajs-3400	39	15	acids	acid	NOUN
iajs-3400	39	16	that	that	PRON
iajs-3400	39	17	are	be	AUX
iajs-3400	39	18	included	include	VERB
iajs-3400	39	19	in	in	ADP
iajs-3400	39	20	a	a	DET
iajs-3400	39	21	36	36	NUM
iajs-3400	39	22	kda	kda	NOUN
iajs-3400	39	23	protein	protein	NOUN
iajs-3400	39	24	[	[	X
iajs-3400	39	25	26	26	NUM
iajs-3400	39	26	]	]	PUNCT
iajs-3400	39	27	.	.	PUNCT
iajs-3400	40	1	the	the	DET
iajs-3400	40	2	enzyme	enzyme	NOUN
iajs-3400	40	3	performs	perform	VERB
iajs-3400	40	4	the	the	DET
iajs-3400	40	5	functions	function	NOUN
iajs-3400	40	6	of	of	ADP
iajs-3400	40	7	glyoxylate	glyoxylate	NOUN
iajs-3400	40	8	reductase	reductase	NOUN
iajs-3400	40	9	,	,	PUNCT
iajs-3400	40	10	hydroxypyruvate	hydroxypyruvate	NOUN
iajs-3400	40	11	reductase	reductase	NOUN
iajs-3400	40	12	,	,	PUNCT
iajs-3400	40	13	and	and	CCONJ
iajs-3400	40	14	d	d	X
iajs-3400	40	15	-	-	ADJ
iajs-3400	40	16	glycerate	glycerate	ADJ
iajs-3400	40	17	dehydrogenase	dehydrogenase	NOUN
iajs-3400	40	18	[	[	X
iajs-3400	40	19	27	27	NUM
iajs-3400	40	20	]	]	PUNCT
iajs-3400	40	21	.	.	PUNCT
iajs-3400	41	1	it	it	PRON
iajs-3400	41	2	uses	use	VERB
iajs-3400	41	3	the	the	DET
iajs-3400	41	4	coenzyme	coenzyme	PROPN
iajs-3400	41	5	nadph	nadph	PROPN
iajs-3400	41	6	to	to	PART
iajs-3400	41	7	catalyze	catalyze	VERB
iajs-3400	41	8	the	the	DET
iajs-3400	41	9	reduction	reduction	NOUN
iajs-3400	41	10	of	of	ADP
iajs-3400	41	11	glyoxylate	glyoxylate	NOUN
iajs-3400	41	12	and	and	CCONJ
iajs-3400	41	13	hydroxypyruvate	hydroxypyruvate	NOUN
iajs-3400	41	14	;	;	PUNCT
iajs-3400	41	15	glyoxylate	glyoxylate	NOUN
iajs-3400	41	16	is	be	AUX
iajs-3400	41	17	typically	typically	ADV
iajs-3400	41	18	eliminated	eliminate	VERB
iajs-3400	41	19	through	through	ADP
iajs-3400	41	20	the	the	DET
iajs-3400	41	21	conversion	conversion	NOUN
iajs-3400	41	22	to	to	PART
iajs-3400	41	23	glycolate	glycolate	VERB
iajs-3400	41	24	in	in	ADP
iajs-3400	41	25	the	the	DET
iajs-3400	41	26	liver	liver	NOUN
iajs-3400	41	27	cytosol	cytosol	NOUN
iajs-3400	41	28	and	and	CCONJ
iajs-3400	41	29	mitochondria	mitochondria	NOUN
iajs-3400	41	30	,	,	PUNCT
iajs-3400	41	31	and	and	CCONJ
iajs-3400	41	32	hydroxypyruvate	hydroxypyruvate	NOUN
iajs-3400	41	33	is	be	AUX
iajs-3400	41	34	normally	normally	ADV
iajs-3400	41	35	reduced	reduce	VERB
iajs-3400	41	36	to	to	ADP
iajs-3400	41	37	d	d	NOUN
iajs-3400	41	38	-	-	VERB
iajs-3400	41	39	glycerate	glycerate	ADJ
iajs-3400	41	40	.	.	PUNCT
iajs-3400	42	1	if	if	SCONJ
iajs-3400	42	2	this	this	DET
iajs-3400	42	3	enzyme	enzyme	NOUN
iajs-3400	42	4	is	be	AUX
iajs-3400	42	5	deficient	deficient	ADJ
iajs-3400	42	6	,	,	PUNCT
iajs-3400	42	7	it	it	PRON
iajs-3400	42	8	results	result	VERB
iajs-3400	42	9	in	in	ADP
iajs-3400	42	10	the	the	DET
iajs-3400	42	11	conversion	conversion	NOUN
iajs-3400	42	12	of	of	ADP
iajs-3400	42	13	glyoxylate	glyoxylate	NOUN
iajs-3400	42	14	to	to	PART
iajs-3400	42	15	oxalate	oxalate	NOUN
iajs-3400	42	16	by	by	ADP
iajs-3400	42	17	the	the	DET
iajs-3400	42	18	action	action	NOUN
iajs-3400	42	19	of	of	ADP
iajs-3400	42	20	l	l	NOUN
iajs-3400	42	21	-	-	PUNCT
iajs-3400	42	22	lactate	lactate	NOUN
iajs-3400	42	23	dehydrogenase	dehydrogenase	NOUN
iajs-3400	42	24	,	,	PUNCT
iajs-3400	42	25	resulting	result	VERB
iajs-3400	42	26	in	in	ADP
iajs-3400	42	27	the	the	DET
iajs-3400	42	28	accumulation	accumulation	NOUN
iajs-3400	42	29	of	of	ADP
iajs-3400	42	30	oxalate	oxalate	NOUN
iajs-3400	42	31	in	in	ADP
iajs-3400	42	32	the	the	DET
iajs-3400	42	33	kidney	kidney	NOUN
iajs-3400	42	34	,	,	PUNCT
iajs-3400	42	35	and	and	CCONJ
iajs-3400	42	36	in	in	ADP
iajs-3400	42	37	the	the	DET
iajs-3400	42	38	conversion	conversion	NOUN
iajs-3400	42	39	of	of	ADP
iajs-3400	42	40	hydroxypyruvate	hydroxypyruvate	NOUN
iajs-3400	42	41	to	to	ADP
iajs-3400	42	42	l	l	X
iajs-3400	42	43	-	-	VERB
iajs-3400	42	44	glycerate	glycerate	ADJ
iajs-3400	42	45	also	also	ADV
iajs-3400	42	46	by	by	ADP
iajs-3400	42	47	the	the	DET
iajs-3400	42	48	same	same	ADJ
iajs-3400	42	49	cytoplasmic	cytoplasmic	ADJ
iajs-3400	42	50	ld	ld	NOUN
iajs-3400	42	51	enzyme	enzyme	NOUN
iajs-3400	42	52	[	[	NOUN
iajs-3400	42	53	28	28	NUM
iajs-3400	42	54	]	]	PUNCT
iajs-3400	42	55	.	.	PUNCT
iajs-3400	43	1	despite	despite	SCONJ
iajs-3400	43	2	the	the	DET
iajs-3400	43	3	widespread	widespread	ADJ
iajs-3400	43	4	tissue	tissue	NOUN
iajs-3400	43	5	expression	expression	NOUN
iajs-3400	43	6	where	where	SCONJ
iajs-3400	43	7	this	this	DET
iajs-3400	43	8	enzyme	enzyme	NOUN
iajs-3400	43	9	is	be	AUX
iajs-3400	43	10	mostly	mostly	ADV
iajs-3400	43	11	found	find	VERB
iajs-3400	43	12	in	in	ADP
iajs-3400	43	13	the	the	DET
iajs-3400	43	14	liver	liver	NOUN
iajs-3400	43	15	,	,	PUNCT
iajs-3400	43	16	it	it	PRON
iajs-3400	43	17	can	can	AUX
iajs-3400	43	18	also	also	ADV
iajs-3400	43	19	be	be	AUX
iajs-3400	43	20	found	find	VERB
iajs-3400	43	21	in	in	ADP
iajs-3400	43	22	the	the	DET
iajs-3400	43	23	kidneys	kidney	NOUN
iajs-3400	43	24	,	,	PUNCT
iajs-3400	43	25	brain	brain	NOUN
iajs-3400	43	26	,	,	PUNCT
iajs-3400	43	27	cardiac	cardiac	ADJ
iajs-3400	43	28	,	,	PUNCT
iajs-3400	43	29	skin	skin	NOUN
iajs-3400	43	30	,	,	PUNCT
iajs-3400	43	31	and	and	CCONJ
iajs-3400	43	32	skeletal	skeletal	ADJ
iajs-3400	43	33	muscles	muscle	NOUN
iajs-3400	43	34	[	[	X
iajs-3400	43	35	29	29	NUM
iajs-3400	43	36	]	]	PUNCT
iajs-3400	43	37	.	.	PUNCT
iajs-3400	44	1	this	this	DET
iajs-3400	44	2	gene	gene	NOUN
iajs-3400	44	3	has	have	VERB
iajs-3400	44	4	multiple	multiple	ADJ
iajs-3400	44	5	reported	report	VERB
iajs-3400	44	6	polymorphisms	polymorphism	NOUN
iajs-3400	44	7	and	and	CCONJ
iajs-3400	44	8	mutations	mutation	NOUN
iajs-3400	44	9	that	that	PRON
iajs-3400	44	10	have	have	AUX
iajs-3400	44	11	been	be	AUX
iajs-3400	44	12	found	find	VERB
iajs-3400	44	13	in	in	ADP
iajs-3400	44	14	ph2	ph2	NOUN
iajs-3400	44	15	patients	patient	NOUN
iajs-3400	44	16	,	,	PUNCT
iajs-3400	44	17	which	which	PRON
iajs-3400	44	18	is	be	AUX
iajs-3400	44	19	evidence	evidence	NOUN
iajs-3400	44	20	that	that	SCONJ
iajs-3400	44	21	the	the	DET
iajs-3400	44	22	disease	disease	NOUN
iajs-3400	44	23	has	have	AUX
iajs-3400	44	24	a	a	DET
iajs-3400	44	25	genetic	genetic	ADJ
iajs-3400	44	26	basis	basis	NOUN
iajs-3400	44	27	.	.	PUNCT
iajs-3400	45	1	low	low	ADJ
iajs-3400	45	2	grhpr	grhpr	ADJ
iajs-3400	45	3	expression	expression	NOUN
iajs-3400	45	4	has	have	AUX
iajs-3400	45	5	been	be	AUX
iajs-3400	45	6	linked	link	VERB
iajs-3400	45	7	to	to	ADP
iajs-3400	45	8	a	a	DET
iajs-3400	45	9	high	high	ADJ
iajs-3400	45	10	degree	degree	NOUN
iajs-3400	45	11	of	of	ADP
iajs-3400	45	12	risk	risk	NOUN
iajs-3400	45	13	of	of	ADP
iajs-3400	45	14	hepatocellular	hepatocellular	ADJ
iajs-3400	45	15	carcinoma	carcinoma	NOUN
iajs-3400	45	16	(	(	PUNCT
iajs-3400	45	17	hcc	hcc	PROPN
iajs-3400	45	18	)	)	PUNCT
iajs-3400	45	19	,	,	PUNCT
iajs-3400	45	20	as	as	SCONJ
iajs-3400	45	21	it	it	PRON
iajs-3400	45	22	functions	function	VERB
iajs-3400	45	23	as	as	ADP
iajs-3400	45	24	a	a	DET
iajs-3400	45	25	tumor	tumor	NOUN
iajs-3400	45	26	suppressor	suppressor	NOUN
iajs-3400	45	27	gene	gene	NOUN
iajs-3400	45	28	[	[	X
iajs-3400	45	29	30	30	NUM
iajs-3400	45	30	]	]	PUNCT
iajs-3400	45	31	.	.	PUNCT
iajs-3400	46	1	it	it	PRON
iajs-3400	46	2	was	be	AUX
iajs-3400	46	3	recently	recently	ADV
iajs-3400	46	4	reported	report	VERB
iajs-3400	46	5	that	that	SCONJ
iajs-3400	46	6	it	it	PRON
iajs-3400	46	7	has	have	VERB
iajs-3400	46	8	a	a	DET
iajs-3400	46	9	low	low	ADJ
iajs-3400	46	10	expression	expression	NOUN
iajs-3400	46	11	level	level	NOUN
iajs-3400	46	12	in	in	ADP
iajs-3400	46	13	the	the	DET
iajs-3400	46	14	cancerous	cancerous	ADJ
iajs-3400	46	15	tissue	tissue	NOUN
iajs-3400	46	16	from	from	ADP
iajs-3400	46	17	it	it	PRON
iajs-3400	46	18	in	in	ADP
iajs-3400	46	19	the	the	DET
iajs-3400	46	20	neighboring	neighbor	VERB
iajs-3400	46	21	normal	normal	ADJ
iajs-3400	46	22	tissues	tissue	NOUN
iajs-3400	46	23	,	,	PUNCT
iajs-3400	46	24	and	and	CCONJ
iajs-3400	46	25	its	its	PRON
iajs-3400	46	26	expression	expression	NOUN
iajs-3400	46	27	was	be	AUX
iajs-3400	46	28	controlled	control	VERB
iajs-3400	46	29	by	by	ADP
iajs-3400	46	30	microrna	microrna	PROPN
iajs-3400	46	31	mir-138	mir-138	PROPN
iajs-3400	46	32	-	-	PUNCT
iajs-3400	46	33	5p	5p	PROPN
iajs-3400	47	1	[	[	X
iajs-3400	47	2	31	31	NUM
iajs-3400	47	3	]	]	PUNCT
iajs-3400	47	4	.	.	PUNCT
iajs-3400	48	1	also	also	ADV
iajs-3400	48	2	,	,	PUNCT
iajs-3400	48	3	because	because	SCONJ
iajs-3400	48	4	the	the	DET
iajs-3400	48	5	metabolic	metabolic	NOUN
iajs-3400	48	6	pathways	pathway	NOUN
iajs-3400	48	7	were	be	AUX
iajs-3400	48	8	impacted	impact	VERB
iajs-3400	48	9	,	,	PUNCT
iajs-3400	48	10	it	it	PRON
iajs-3400	48	11	was	be	AUX
iajs-3400	48	12	discovered	discover	VERB
iajs-3400	48	13	that	that	SCONJ
iajs-3400	48	14	the	the	DET
iajs-3400	48	15	cpg	cpg	NOUN
iajs-3400	48	16	regions	region	NOUN
iajs-3400	48	17	(	(	PUNCT
iajs-3400	48	18	cytosine	cytosine	NOUN
iajs-3400	48	19	nucleotides	nucleotide	NOUN
iajs-3400	48	20	followed	follow	VERB
iajs-3400	48	21	by	by	ADP
iajs-3400	48	22	guanine	guanine	NOUN
iajs-3400	48	23	nucleotides	nucleotide	NOUN
iajs-3400	48	24	)	)	PUNCT
iajs-3400	48	25	of	of	ADP
iajs-3400	48	26	the	the	DET
iajs-3400	48	27	grhpr	grhpr	ADJ
iajs-3400	48	28	gene	gene	NOUN
iajs-3400	48	29	could	could	AUX
iajs-3400	48	30	be	be	AUX
iajs-3400	48	31	methylated	methylate	VERB
iajs-3400	48	32	[	[	PUNCT
iajs-3400	48	33	32	32	NUM
iajs-3400	48	34	]	]	PUNCT
iajs-3400	48	35	.	.	PUNCT
iajs-3400	49	1	the	the	DET
iajs-3400	49	2	research	research	NOUN
iajs-3400	49	3	was	be	AUX
iajs-3400	49	4	intended	intend	VERB
iajs-3400	49	5	to	to	PART
iajs-3400	49	6	investigate	investigate	VERB
iajs-3400	49	7	the	the	DET
iajs-3400	49	8	connection	connection	NOUN
iajs-3400	49	9	between	between	ADP
iajs-3400	49	10	enzyme	enzyme	NOUN
iajs-3400	49	11	concentration	concentration	NOUN
iajs-3400	49	12	and	and	CCONJ
iajs-3400	49	13	stone	stone	NOUN
iajs-3400	49	14	development	development	NOUN
iajs-3400	49	15	in	in	ADP
iajs-3400	49	16	iraqi	iraqi	ADJ
iajs-3400	49	17	patients	patient	NOUN
iajs-3400	49	18	,	,	PUNCT
iajs-3400	49	19	since	since	SCONJ
iajs-3400	49	20	the	the	DET
iajs-3400	49	21	relationship	relationship	NOUN
iajs-3400	49	22	between	between	ADP
iajs-3400	49	23	this	this	DET
iajs-3400	49	24	enzyme	enzyme	NOUN
iajs-3400	49	25	and	and	CCONJ
iajs-3400	49	26	stone	stone	NOUN
iajs-3400	49	27	formation	formation	NOUN
iajs-3400	49	28	in	in	ADP
iajs-3400	49	29	iraqi	iraqi	ADJ
iajs-3400	49	30	society	society	NOUN
iajs-3400	49	31	has	have	AUX
iajs-3400	49	32	not	not	PART
iajs-3400	49	33	been	be	AUX
iajs-3400	49	34	investigated	investigate	VERB
iajs-3400	49	35	.	.	PUNCT
iajs-3400	50	1	2	2	X
iajs-3400	50	2	.	.	X
iajs-3400	50	3	materials	material	NOUN
iajs-3400	50	4	and	and	CCONJ
iajs-3400	50	5	methods	method	NOUN
iajs-3400	50	6	2.1	2.1	NUM
iajs-3400	50	7	.	.	PUNCT
iajs-3400	50	8	studied	study	VERB
iajs-3400	50	9	subjects	subject	NOUN
iajs-3400	50	10	peripheral	peripheral	ADJ
iajs-3400	50	11	whole	whole	ADJ
iajs-3400	50	12	blood	blood	NOUN
iajs-3400	50	13	samples	sample	NOUN
iajs-3400	50	14	were	be	AUX
iajs-3400	50	15	collected	collect	VERB
iajs-3400	50	16	from	from	ADP
iajs-3400	50	17	80	80	NUM
iajs-3400	50	18	individuals	individual	NOUN
iajs-3400	50	19	during	during	ADP
iajs-3400	50	20	the	the	DET
iajs-3400	50	21	period	period	NOUN
iajs-3400	50	22	from	from	ADP
iajs-3400	50	23	february	february	PROPN
iajs-3400	50	24	2022	2022	NUM
iajs-3400	50	25	to	to	ADP
iajs-3400	50	26	august	august	PROPN
iajs-3400	50	27	2022	2022	NUM
iajs-3400	50	28	.	.	PUNCT
iajs-3400	51	1	both	both	DET
iajs-3400	51	2	groups	group	NOUN
iajs-3400	51	3	’	'	PUNCT
iajs-3400	51	4	samples	sample	NOUN
iajs-3400	51	5	were	be	AUX
iajs-3400	51	6	collected	collect	VERB
iajs-3400	51	7	from	from	ADP
iajs-3400	51	8	al	al	PROPN
iajs-3400	51	9	karma	karma	PROPN
iajs-3400	51	10	teaching	teaching	NOUN
iajs-3400	51	11	ihjpas	ihjpas	PROPN
iajs-3400	51	12	.	.	PUNCT
iajs-3400	52	1	37	37	NUM
iajs-3400	52	2	(	(	PUNCT
iajs-3400	52	3	2	2	NUM
iajs-3400	52	4	)	)	PUNCT
iajs-3400	52	5	2024	2024	NUM
iajs-3400	52	6	159	159	NUM
iajs-3400	52	7	hospital	hospital	NOUN
iajs-3400	52	8	in	in	ADP
iajs-3400	52	9	baghdad	baghdad	PROPN
iajs-3400	52	10	governorate	governorate	PROPN
iajs-3400	52	11	.	.	PUNCT
iajs-3400	53	1	the	the	DET
iajs-3400	53	2	patients	patient	NOUN
iajs-3400	53	3	were	be	AUX
iajs-3400	53	4	diagnosed	diagnose	VERB
iajs-3400	53	5	(	(	PUNCT
iajs-3400	53	6	by	by	ADP
iajs-3400	53	7	the	the	DET
iajs-3400	53	8	specialists	specialist	NOUN
iajs-3400	53	9	)	)	PUNCT
iajs-3400	53	10	with	with	ADP
iajs-3400	53	11	oxalate	oxalate	PROPN
iajs-3400	53	12	kidney	kidney	NOUN
iajs-3400	53	13	stones	stone	NOUN
iajs-3400	53	14	according	accord	VERB
iajs-3400	53	15	to	to	ADP
iajs-3400	53	16	an	an	DET
iajs-3400	53	17	abdomen	abdomen	NOUN
iajs-3400	53	18	ultrasound	ultrasound	NOUN
iajs-3400	53	19	,	,	PUNCT
iajs-3400	53	20	kidney	kidney	NOUN
iajs-3400	53	21	stone	stone	NOUN
iajs-3400	53	22	analysis	analysis	NOUN
iajs-3400	53	23	,	,	PUNCT
iajs-3400	53	24	biochemical	biochemical	ADJ
iajs-3400	53	25	tests	test	NOUN
iajs-3400	53	26	,	,	PUNCT
iajs-3400	53	27	and	and	CCONJ
iajs-3400	53	28	the	the	DET
iajs-3400	53	29	presence	presence	NOUN
iajs-3400	53	30	of	of	ADP
iajs-3400	53	31	oxalate	oxalate	NOUN
iajs-3400	53	32	in	in	ADP
iajs-3400	53	33	the	the	DET
iajs-3400	53	34	urine	urine	NOUN
iajs-3400	53	35	.	.	PUNCT
iajs-3400	54	1	they	they	PRON
iajs-3400	54	2	visited	visit	VERB
iajs-3400	54	3	the	the	DET
iajs-3400	54	4	lithotripsy	lithotripsy	ADJ
iajs-3400	54	5	unit	unit	NOUN
iajs-3400	54	6	at	at	ADP
iajs-3400	54	7	al	al	PROPN
iajs-3400	54	8	karma	karma	PROPN
iajs-3400	54	9	teaching	teach	VERB
iajs-3400	54	10	hospital	hospital	NOUN
iajs-3400	54	11	for	for	ADP
iajs-3400	54	12	fragmenting	fragment	VERB
iajs-3400	54	13	and	and	CCONJ
iajs-3400	54	14	treating	treat	VERB
iajs-3400	54	15	kidney	kidney	NOUN
iajs-3400	54	16	stones	stone	NOUN
iajs-3400	54	17	.	.	PUNCT
iajs-3400	55	1	the	the	DET
iajs-3400	55	2	patients	patient	NOUN
iajs-3400	55	3	were	be	AUX
iajs-3400	55	4	50	50	NUM
iajs-3400	55	5	(	(	PUNCT
iajs-3400	55	6	25	25	NUM
iajs-3400	55	7	males	male	NOUN
iajs-3400	55	8	and	and	CCONJ
iajs-3400	55	9	25	25	NUM
iajs-3400	55	10	females	female	NOUN
iajs-3400	55	11	)	)	PUNCT
iajs-3400	55	12	;	;	PUNCT
iajs-3400	55	13	their	their	PRON
iajs-3400	55	14	ages	age	NOUN
iajs-3400	55	15	ranged	range	VERB
iajs-3400	55	16	from	from	ADP
iajs-3400	55	17	19	19	NUM
iajs-3400	55	18	to	to	PART
iajs-3400	55	19	60	60	NUM
iajs-3400	55	20	years	year	NOUN
iajs-3400	55	21	;	;	PUNCT
iajs-3400	55	22	the	the	DET
iajs-3400	55	23	control	control	NOUN
iajs-3400	55	24	group	group	NOUN
iajs-3400	55	25	included	include	VERB
iajs-3400	55	26	30	30	NUM
iajs-3400	55	27	individuals	individual	NOUN
iajs-3400	55	28	(	(	PUNCT
iajs-3400	55	29	17	17	NUM
iajs-3400	55	30	males	male	NOUN
iajs-3400	55	31	and	and	CCONJ
iajs-3400	55	32	13	13	NUM
iajs-3400	55	33	females	female	NOUN
iajs-3400	55	34	)	)	PUNCT
iajs-3400	55	35	,	,	PUNCT
iajs-3400	55	36	whose	whose	DET
iajs-3400	55	37	ages	age	NOUN
iajs-3400	55	38	ranged	range	VERB
iajs-3400	55	39	from	from	ADP
iajs-3400	55	40	15	15	NUM
iajs-3400	55	41	to	to	PART
iajs-3400	55	42	53	53	NUM
iajs-3400	55	43	years	year	NOUN
iajs-3400	55	44	.	.	PUNCT
iajs-3400	56	1	the	the	DET
iajs-3400	56	2	members	member	NOUN
iajs-3400	56	3	of	of	ADP
iajs-3400	56	4	the	the	DET
iajs-3400	56	5	two	two	NUM
iajs-3400	56	6	groups	group	NOUN
iajs-3400	56	7	were	be	AUX
iajs-3400	56	8	nonsmokers	nonsmoker	NOUN
iajs-3400	56	9	,	,	PUNCT
iajs-3400	56	10	did	do	AUX
iajs-3400	56	11	n’t	not	PART
iajs-3400	56	12	have	have	VERB
iajs-3400	56	13	hypertension	hypertension	NOUN
iajs-3400	56	14	,	,	PUNCT
iajs-3400	56	15	and	and	CCONJ
iajs-3400	56	16	did	do	AUX
iajs-3400	56	17	not	not	PART
iajs-3400	56	18	suffer	suffer	VERB
iajs-3400	56	19	from	from	ADP
iajs-3400	56	20	diabetes	diabetes	NOUN
iajs-3400	56	21	or	or	CCONJ
iajs-3400	56	22	obesity	obesity	NOUN
iajs-3400	56	23	.	.	PUNCT
iajs-3400	57	1	a	a	DET
iajs-3400	57	2	questionnaire	questionnaire	NOUN
iajs-3400	57	3	was	be	AUX
iajs-3400	57	4	prepared	prepare	VERB
iajs-3400	57	5	and	and	CCONJ
iajs-3400	57	6	filled	fill	VERB
iajs-3400	57	7	out	out	ADP
iajs-3400	57	8	by	by	ADP
iajs-3400	57	9	all	all	DET
iajs-3400	57	10	the	the	DET
iajs-3400	57	11	participants	participant	NOUN
iajs-3400	57	12	.	.	PUNCT
iajs-3400	58	1	the	the	DET
iajs-3400	58	2	oral	oral	ADJ
iajs-3400	58	3	agreement	agreement	NOUN
iajs-3400	58	4	was	be	AUX
iajs-3400	58	5	obtained	obtain	VERB
iajs-3400	58	6	from	from	ADP
iajs-3400	58	7	patients	patient	NOUN
iajs-3400	58	8	and	and	CCONJ
iajs-3400	58	9	controls	control	NOUN
iajs-3400	58	10	,	,	PUNCT
iajs-3400	58	11	and	and	CCONJ
iajs-3400	58	12	the	the	DET
iajs-3400	58	13	ethical	ethical	ADJ
iajs-3400	58	14	approval	approval	NOUN
iajs-3400	58	15	was	be	AUX
iajs-3400	58	16	registered	register	VERB
iajs-3400	58	17	with	with	ADP
iajs-3400	58	18	the	the	DET
iajs-3400	58	19	iraqi	iraqi	ADJ
iajs-3400	58	20	ministry	ministry	PROPN
iajs-3400	58	21	of	of	ADP
iajs-3400	58	22	health	health	NOUN
iajs-3400	58	23	.	.	PUNCT
iajs-3400	59	1	2.2.biochemical	2.2.biochemical	ADJ
iajs-3400	59	2	parameters	parameter	NOUN
iajs-3400	59	3	and	and	CCONJ
iajs-3400	59	4	laboratory	laboratory	NOUN
iajs-3400	59	5	investigations	investigation	NOUN
iajs-3400	59	6	the	the	DET
iajs-3400	59	7	laboratory	laboratory	NOUN
iajs-3400	59	8	investigation	investigation	NOUN
iajs-3400	59	9	was	be	AUX
iajs-3400	59	10	performed	perform	VERB
iajs-3400	59	11	in	in	ADP
iajs-3400	59	12	the	the	DET
iajs-3400	59	13	hospital	hospital	NOUN
iajs-3400	59	14	laboratories	laboratory	NOUN
iajs-3400	59	15	for	for	ADP
iajs-3400	59	16	both	both	DET
iajs-3400	59	17	groups	group	NOUN
iajs-3400	59	18	(	(	PUNCT
iajs-3400	59	19	patients	patient	NOUN
iajs-3400	59	20	and	and	CCONJ
iajs-3400	59	21	control	control	NOUN
iajs-3400	59	22	)	)	PUNCT
iajs-3400	59	23	;	;	PUNCT
iajs-3400	59	24	it	it	PRON
iajs-3400	59	25	included	include	VERB
iajs-3400	59	26	biochemical	biochemical	ADJ
iajs-3400	59	27	tests	test	NOUN
iajs-3400	59	28	for	for	ADP
iajs-3400	59	29	kidney	kidney	NOUN
iajs-3400	59	30	function	function	NOUN
iajs-3400	59	31	like	like	ADP
iajs-3400	59	32	serum	serum	NOUN
iajs-3400	59	33	uric	uric	ADJ
iajs-3400	59	34	acid	acid	NOUN
iajs-3400	59	35	,	,	PUNCT
iajs-3400	59	36	urea	urea	NOUN
iajs-3400	59	37	,	,	PUNCT
iajs-3400	59	38	and	and	CCONJ
iajs-3400	59	39	creatinine	creatinine	NOUN
iajs-3400	59	40	.	.	PUNCT
iajs-3400	60	1	in	in	ADP
iajs-3400	60	2	addition	addition	NOUN
iajs-3400	60	3	to	to	ADP
iajs-3400	60	4	fasting	fast	VERB
iajs-3400	60	5	blood	blood	NOUN
iajs-3400	60	6	sugar	sugar	NOUN
iajs-3400	60	7	(	(	PUNCT
iajs-3400	60	8	fbs	fbs	PROPN
iajs-3400	60	9	)	)	PUNCT
iajs-3400	60	10	,	,	PUNCT
iajs-3400	60	11	complete	complete	ADJ
iajs-3400	60	12	blood	blood	NOUN
iajs-3400	60	13	count	count	NOUN
iajs-3400	60	14	(	(	PUNCT
iajs-3400	60	15	cbc	cbc	PROPN
iajs-3400	60	16	)	)	PUNCT
iajs-3400	60	17	,	,	PUNCT
iajs-3400	60	18	and	and	CCONJ
iajs-3400	60	19	blood	blood	NOUN
iajs-3400	60	20	group	group	NOUN
iajs-3400	60	21	tests	test	NOUN
iajs-3400	60	22	,	,	PUNCT
iajs-3400	60	23	urine	urine	NOUN
iajs-3400	60	24	was	be	AUX
iajs-3400	60	25	collected	collect	VERB
iajs-3400	60	26	for	for	ADP
iajs-3400	60	27	general	general	ADJ
iajs-3400	60	28	urine	urine	NOUN
iajs-3400	60	29	examination	examination	NOUN
iajs-3400	60	30	(	(	PUNCT
iajs-3400	60	31	gue	gue	NOUN
iajs-3400	60	32	)	)	PUNCT
iajs-3400	60	33	,	,	PUNCT
iajs-3400	60	34	to	to	PART
iajs-3400	60	35	be	be	AUX
iajs-3400	60	36	examined	examine	VERB
iajs-3400	60	37	for	for	ADP
iajs-3400	60	38	urinary	urinary	ADJ
iajs-3400	60	39	tract	tract	NOUN
iajs-3400	60	40	infection	infection	NOUN
iajs-3400	60	41	and	and	CCONJ
iajs-3400	60	42	to	to	PART
iajs-3400	60	43	visualize	visualize	VERB
iajs-3400	60	44	oxalate	oxalate	NOUN
iajs-3400	60	45	crystals	crystal	NOUN
iajs-3400	60	46	in	in	ADP
iajs-3400	60	47	the	the	DET
iajs-3400	60	48	patient	patient	NOUN
iajs-3400	60	49	’s	’s	PART
iajs-3400	60	50	urine	urine	NOUN
iajs-3400	60	51	,	,	PUNCT
iajs-3400	60	52	in	in	ADP
iajs-3400	60	53	addition	addition	NOUN
iajs-3400	60	54	to	to	ADP
iajs-3400	60	55	measuring	measure	VERB
iajs-3400	60	56	grhpr	grhpr	ADJ
iajs-3400	60	57	enzyme	enzyme	NOUN
iajs-3400	60	58	concentration	concentration	NOUN
iajs-3400	60	59	in	in	ADP
iajs-3400	60	60	the	the	DET
iajs-3400	60	61	sera	sera	NOUN
iajs-3400	60	62	of	of	ADP
iajs-3400	60	63	both	both	DET
iajs-3400	60	64	groups	group	NOUN
iajs-3400	60	65	by	by	ADP
iajs-3400	60	66	enzyme	enzyme	NOUN
iajs-3400	60	67	linked	link	VERB
iajs-3400	61	1	immunosorbent	immunosorbent	ADJ
iajs-3400	61	2	assay	assay	PROPN
iajs-3400	61	3	(	(	PUNCT
iajs-3400	61	4	elisa	elisa	NOUN
iajs-3400	61	5	)	)	PUNCT
iajs-3400	61	6	the	the	DET
iajs-3400	61	7	technique	technique	NOUN
iajs-3400	61	8	was	be	AUX
iajs-3400	61	9	made	make	VERB
iajs-3400	61	10	using	use	VERB
iajs-3400	61	11	the	the	DET
iajs-3400	61	12	sandwich	sandwich	NOUN
iajs-3400	61	13	enzyme	enzyme	NOUN
iajs-3400	61	14	immunoassay	immunoassay	NOUN
iajs-3400	61	15	in	in	ADP
iajs-3400	61	16	the	the	DET
iajs-3400	61	17	serum	serum	NOUN
iajs-3400	61	18	of	of	ADP
iajs-3400	61	19	both	both	DET
iajs-3400	61	20	groups	group	NOUN
iajs-3400	61	21	according	accord	VERB
iajs-3400	61	22	to	to	ADP
iajs-3400	61	23	the	the	DET
iajs-3400	61	24	manufacturer	manufacturer	NOUN
iajs-3400	61	25	's	's	PART
iajs-3400	61	26	company	company	NOUN
iajs-3400	61	27	instructions	instruction	NOUN
iajs-3400	61	28	(	(	PUNCT
iajs-3400	61	29	yl	yl	NOUN
iajs-3400	61	30	biont	biont	ADJ
iajs-3400	61	31	)	)	PUNCT
iajs-3400	61	32	at	at	ADP
iajs-3400	61	33	al	al	PROPN
iajs-3400	61	34	shameem	shameem	VERB
iajs-3400	61	35	scientific	scientific	ADJ
iajs-3400	61	36	office	office	NOUN
iajs-3400	61	37	.	.	PUNCT
iajs-3400	62	1	2.3	2.3	NUM
iajs-3400	62	2	.	.	PUNCT
iajs-3400	63	1	statistical	statistical	ADJ
iajs-3400	63	2	analysis	analysis	NOUN
iajs-3400	63	3	the	the	DET
iajs-3400	63	4	statistical	statistical	ADJ
iajs-3400	63	5	analysis	analysis	NOUN
iajs-3400	63	6	systemsas	systemsa	NOUN
iajs-3400	63	7	(	(	PUNCT
iajs-3400	63	8	2018	2018	NUM
iajs-3400	63	9	)	)	PUNCT
iajs-3400	63	10	program	program	NOUN
iajs-3400	63	11	was	be	AUX
iajs-3400	63	12	used	use	VERB
iajs-3400	63	13	to	to	PART
iajs-3400	63	14	detect	detect	VERB
iajs-3400	63	15	the	the	DET
iajs-3400	63	16	effect	effect	NOUN
iajs-3400	63	17	of	of	ADP
iajs-3400	63	18	different	different	ADJ
iajs-3400	63	19	factors	factor	NOUN
iajs-3400	63	20	on	on	ADP
iajs-3400	63	21	study	study	NOUN
iajs-3400	63	22	parameters	parameter	NOUN
iajs-3400	63	23	.	.	PUNCT
iajs-3400	64	1	t	t	NOUN
iajs-3400	64	2	-	-	PUNCT
iajs-3400	64	3	test	test	NOUN
iajs-3400	64	4	and	and	CCONJ
iajs-3400	64	5	least	least	ADJ
iajs-3400	64	6	significant	significant	ADJ
iajs-3400	64	7	difference	difference	NOUN
iajs-3400	64	8	(	(	PUNCT
iajs-3400	64	9	lsd	lsd	NOUN
iajs-3400	64	10	)	)	PUNCT
iajs-3400	64	11	test	test	NOUN
iajs-3400	64	12	(	(	PUNCT
iajs-3400	64	13	analysis	analysis	NOUN
iajs-3400	64	14	of	of	ADP
iajs-3400	64	15	variation	variation	NOUN
iajs-3400	64	16	,	,	PUNCT
iajs-3400	64	17	anova	anova	PROPN
iajs-3400	64	18	)	)	PUNCT
iajs-3400	64	19	were	be	AUX
iajs-3400	64	20	used	use	VERB
iajs-3400	64	21	to	to	PART
iajs-3400	64	22	significantly	significantly	ADV
iajs-3400	64	23	compare	compare	VERB
iajs-3400	64	24	between	between	ADP
iajs-3400	64	25	means	mean	NOUN
iajs-3400	64	26	.	.	PUNCT
iajs-3400	65	1	a	a	DET
iajs-3400	65	2	chi	chi	ADJ
iajs-3400	65	3	-	-	PUNCT
iajs-3400	65	4	square	square	ADJ
iajs-3400	65	5	test	test	NOUN
iajs-3400	65	6	was	be	AUX
iajs-3400	65	7	used	use	VERB
iajs-3400	65	8	to	to	PART
iajs-3400	65	9	significantly	significantly	ADV
iajs-3400	65	10	compare	compare	VERB
iajs-3400	65	11	between	between	ADP
iajs-3400	65	12	percentages	percentage	NOUN
iajs-3400	65	13	(	(	PUNCT
iajs-3400	65	14	0.05	0.05	NUM
iajs-3400	65	15	and	and	CCONJ
iajs-3400	65	16	0.01	0.01	NUM
iajs-3400	65	17	probability	probability	NOUN
iajs-3400	65	18	)	)	PUNCT
iajs-3400	65	19	in	in	ADP
iajs-3400	65	20	this	this	DET
iajs-3400	65	21	study	study	NOUN
iajs-3400	65	22	.	.	PUNCT
iajs-3400	66	1	3	3	X
iajs-3400	66	2	.	.	X
iajs-3400	66	3	results	result	NOUN
iajs-3400	66	4	and	and	CCONJ
iajs-3400	66	5	discussion	discussion	VERB
iajs-3400	66	6	the	the	DET
iajs-3400	66	7	distribution	distribution	NOUN
iajs-3400	66	8	of	of	ADP
iajs-3400	66	9	samples	sample	NOUN
iajs-3400	66	10	according	accord	VERB
iajs-3400	66	11	to	to	ADP
iajs-3400	66	12	gender	gender	NOUN
iajs-3400	66	13	was	be	AUX
iajs-3400	66	14	studied	study	VERB
iajs-3400	66	15	in	in	ADP
iajs-3400	66	16	the	the	DET
iajs-3400	66	17	control	control	NOUN
iajs-3400	66	18	and	and	CCONJ
iajs-3400	66	19	patient	patient	ADJ
iajs-3400	66	20	groups	group	NOUN
iajs-3400	66	21	.	.	PUNCT
iajs-3400	67	1	the	the	DET
iajs-3400	67	2	patient	patient	ADJ
iajs-3400	67	3	group	group	NOUN
iajs-3400	67	4	registered	register	VERB
iajs-3400	67	5	in	in	ADP
iajs-3400	67	6	this	this	DET
iajs-3400	67	7	study	study	NOUN
iajs-3400	67	8	includes	include	VERB
iajs-3400	67	9	25	25	NUM
iajs-3400	67	10	(	(	PUNCT
iajs-3400	67	11	50	50	NUM
iajs-3400	67	12	%	%	NOUN
iajs-3400	67	13	)	)	PUNCT
iajs-3400	67	14	males	male	NOUN
iajs-3400	67	15	and	and	CCONJ
iajs-3400	67	16	25	25	NUM
iajs-3400	67	17	(	(	PUNCT
iajs-3400	67	18	50	50	NUM
iajs-3400	67	19	%	%	NOUN
iajs-3400	67	20	)	)	PUNCT
iajs-3400	67	21	females	female	NOUN
iajs-3400	67	22	,	,	PUNCT
iajs-3400	67	23	thus	thus	ADV
iajs-3400	67	24	the	the	DET
iajs-3400	67	25	results	result	NOUN
iajs-3400	67	26	were	be	AUX
iajs-3400	67	27	non	non	ADJ
iajs-3400	67	28	-	-	ADJ
iajs-3400	67	29	significant	significant	ADJ
iajs-3400	67	30	for	for	ADP
iajs-3400	67	31	this	this	DET
iajs-3400	67	32	group	group	NOUN
iajs-3400	67	33	.	.	PUNCT
iajs-3400	68	1	this	this	PRON
iajs-3400	68	2	may	may	AUX
iajs-3400	68	3	be	be	AUX
iajs-3400	68	4	due	due	ADJ
iajs-3400	68	5	to	to	ADP
iajs-3400	68	6	the	the	DET
iajs-3400	68	7	differences	difference	NOUN
iajs-3400	68	8	in	in	ADP
iajs-3400	68	9	sampling	sample	VERB
iajs-3400	68	10	methods	method	NOUN
iajs-3400	68	11	and	and	CCONJ
iajs-3400	68	12	may	may	AUX
iajs-3400	68	13	be	be	AUX
iajs-3400	68	14	due	due	ADJ
iajs-3400	68	15	to	to	ADP
iajs-3400	68	16	the	the	DET
iajs-3400	68	17	fact	fact	NOUN
iajs-3400	68	18	that	that	SCONJ
iajs-3400	68	19	males	male	NOUN
iajs-3400	68	20	present	present	VERB
iajs-3400	68	21	more	more	ADJ
iajs-3400	68	22	caox	caox	ADJ
iajs-3400	68	23	stones	stone	NOUN
iajs-3400	68	24	because	because	SCONJ
iajs-3400	68	25	of	of	ADP
iajs-3400	68	26	the	the	DET
iajs-3400	68	27	testosterone	testosterone	NOUN
iajs-3400	68	28	hormone	hormone	NOUN
iajs-3400	69	1	[	[	X
iajs-3400	69	2	33	33	NUM
iajs-3400	69	3	]	]	PUNCT
iajs-3400	69	4	,	,	PUNCT
iajs-3400	69	5	while	while	SCONJ
iajs-3400	69	6	the	the	DET
iajs-3400	69	7	estrogen	estrogen	NOUN
iajs-3400	69	8	hormone	hormone	NOUN
iajs-3400	69	9	in	in	ADP
iajs-3400	69	10	women	woman	NOUN
iajs-3400	69	11	prevents	prevent	VERB
iajs-3400	69	12	stone	stone	NOUN
iajs-3400	69	13	formation	formation	NOUN
iajs-3400	70	1	[	[	X
iajs-3400	70	2	34	34	NUM
iajs-3400	70	3	]	]	PUNCT
iajs-3400	70	4	.	.	PUNCT
iajs-3400	71	1	the	the	DET
iajs-3400	71	2	control	control	PROPN
iajs-3400	71	3	group	group	NOUN
iajs-3400	71	4	registered	register	VERB
iajs-3400	71	5	in	in	ADP
iajs-3400	71	6	this	this	DET
iajs-3400	71	7	study	study	NOUN
iajs-3400	71	8	was	be	AUX
iajs-3400	71	9	17	17	NUM
iajs-3400	71	10	(	(	PUNCT
iajs-3400	71	11	57	57	NUM
iajs-3400	71	12	%	%	NOUN
iajs-3400	71	13	male	male	NOUN
iajs-3400	71	14	)	)	PUNCT
iajs-3400	71	15	and	and	CCONJ
iajs-3400	71	16	13	13	NUM
iajs-3400	71	17	(	(	PUNCT
iajs-3400	71	18	43	43	NUM
iajs-3400	71	19	%	%	NOUN
iajs-3400	71	20	female	female	NOUN
iajs-3400	71	21	)	)	PUNCT
iajs-3400	71	22	;	;	PUNCT
iajs-3400	71	23	these	these	DET
iajs-3400	71	24	results	result	NOUN
iajs-3400	71	25	were	be	AUX
iajs-3400	71	26	also	also	ADV
iajs-3400	71	27	non	non	ADJ
iajs-3400	71	28	-	-	ADJ
iajs-3400	71	29	significant	significant	ADJ
iajs-3400	71	30	,	,	PUNCT
iajs-3400	71	31	as	as	SCONJ
iajs-3400	71	32	shown	show	VERB
iajs-3400	71	33	in	in	ADP
iajs-3400	71	34	table	table	NOUN
iajs-3400	71	35	1	1	NUM
iajs-3400	71	36	.	.	PUNCT
iajs-3400	71	37	table	table	NOUN
iajs-3400	71	38	1	1	NUM
iajs-3400	71	39	.	.	PUNCT
iajs-3400	72	1	the	the	DET
iajs-3400	72	2	distribution	distribution	NOUN
iajs-3400	72	3	of	of	ADP
iajs-3400	72	4	samples	sample	NOUN
iajs-3400	72	5	according	accord	VERB
iajs-3400	72	6	to	to	ADP
iajs-3400	72	7	gender	gender	NOUN
iajs-3400	72	8	group	group	NOUN
iajs-3400	72	9	no	no	DET
iajs-3400	72	10	male	male	NOUN
iajs-3400	72	11	no	no	INTJ
iajs-3400	72	12	.	.	PUNCT
iajs-3400	73	1	(	(	PUNCT
iajs-3400	73	2	%	%	INTJ
iajs-3400	73	3	)	)	PUNCT
iajs-3400	73	4	female	female	ADJ
iajs-3400	73	5	no	no	NOUN
iajs-3400	73	6	.	.	PUNCT
iajs-3400	74	1	(	(	PUNCT
iajs-3400	74	2	%	%	INTJ
iajs-3400	74	3	)	)	PUNCT
iajs-3400	74	4	p	p	ADJ
iajs-3400	74	5	-	-	PUNCT
iajs-3400	74	6	value	value	NOUN
iajs-3400	74	7	control	control	NOUN
iajs-3400	74	8	30	30	NUM
iajs-3400	74	9	17(57	17(57	NUM
iajs-3400	74	10	%	%	NOUN
iajs-3400	74	11	)	)	PUNCT
iajs-3400	74	12	13(43	13(43	NUM
iajs-3400	74	13	%	%	NOUN
iajs-3400	74	14	)	)	PUNCT
iajs-3400	74	15	0.071	0.071	NUM
iajs-3400	74	16	ns	ns	NUM
iajs-3400	74	17	patients	patient	NOUN
iajs-3400	74	18	50	50	NUM
iajs-3400	74	19	25(50	25(50	NUM
iajs-3400	74	20	%	%	NOUN
iajs-3400	74	21	)	)	PUNCT
iajs-3400	74	22	25(50	25(50	NUM
iajs-3400	74	23	%	%	NOUN
iajs-3400	74	24	)	)	PUNCT
iajs-3400	74	25	1.00	1.00	NUM
iajs-3400	74	26	ns	ns	NUM
iajs-3400	74	27	p	p	NOUN
iajs-3400	74	28	-	-	PUNCT
iajs-3400	74	29	value	value	NOUN
iajs-3400	74	30	-0.773	-0.773	X
iajs-3400	74	31	ns	ns	NUM
iajs-3400	74	32	0.427	0.427	NUM
iajs-3400	74	33	ns	ns	NUM
iajs-3400	74	34	--	--	PUNCT
iajs-3400	74	35	ns	ns	NUM
iajs-3400	74	36	:	:	PUNCT
iajs-3400	74	37	non	non	ADJ
iajs-3400	74	38	-	-	ADJ
iajs-3400	74	39	significant	significant	ADJ
iajs-3400	74	40	.	.	PUNCT
iajs-3400	75	1	the	the	DET
iajs-3400	75	2	differences	difference	NOUN
iajs-3400	75	3	in	in	ADP
iajs-3400	75	4	samples	sample	NOUN
iajs-3400	75	5	according	accord	VERB
iajs-3400	75	6	to	to	ADP
iajs-3400	75	7	age	age	NOUN
iajs-3400	75	8	in	in	ADP
iajs-3400	75	9	the	the	DET
iajs-3400	75	10	patients	patient	NOUN
iajs-3400	75	11	were	be	AUX
iajs-3400	75	12	significant	significant	ADJ
iajs-3400	75	13	,	,	PUNCT
iajs-3400	75	14	as	as	ADP
iajs-3400	75	15	10	10	NUM
iajs-3400	75	16	(	(	PUNCT
iajs-3400	75	17	20	20	NUM
iajs-3400	75	18	%	%	NOUN
iajs-3400	75	19	)	)	PUNCT
iajs-3400	75	20	patients	patient	NOUN
iajs-3400	75	21	were	be	AUX
iajs-3400	75	22	<	<	X
iajs-3400	75	23	30	30	NUM
iajs-3400	75	24	years	year	NOUN
iajs-3400	75	25	old	old	ADJ
iajs-3400	75	26	,	,	PUNCT
iajs-3400	75	27	20	20	NUM
iajs-3400	75	28	(	(	PUNCT
iajs-3400	75	29	40	40	NUM
iajs-3400	75	30	%	%	NOUN
iajs-3400	75	31	)	)	PUNCT
iajs-3400	76	1	patients	patient	NOUN
iajs-3400	76	2	were	be	AUX
iajs-3400	76	3	from	from	ADP
iajs-3400	76	4	30	30	NUM
iajs-3400	76	5	to	to	PART
iajs-3400	76	6	40	40	NUM
iajs-3400	76	7	years	year	NOUN
iajs-3400	76	8	old	old	ADJ
iajs-3400	76	9	,	,	PUNCT
iajs-3400	76	10	and	and	CCONJ
iajs-3400	76	11	20	20	NUM
iajs-3400	76	12	(	(	PUNCT
iajs-3400	76	13	40	40	NUM
iajs-3400	76	14	%	%	NOUN
iajs-3400	76	15	)	)	PUNCT
iajs-3400	76	16	patients	patient	NOUN
iajs-3400	76	17	were	be	AUX
iajs-3400	76	18	>	>	PUNCT
iajs-3400	76	19	40	40	NUM
iajs-3400	76	20	years	year	NOUN
iajs-3400	76	21	old	old	ADJ
iajs-3400	76	22	.	.	PUNCT
iajs-3400	77	1	the	the	DET
iajs-3400	77	2	distributions	distribution	NOUN
iajs-3400	77	3	of	of	ADP
iajs-3400	77	4	samples	sample	NOUN
iajs-3400	77	5	for	for	ADP
iajs-3400	77	6	the	the	DET
iajs-3400	77	7	control	control	NOUN
iajs-3400	77	8	were	be	AUX
iajs-3400	77	9	highly	highly	ADV
iajs-3400	77	10	significant	significant	ADJ
iajs-3400	77	11	,	,	PUNCT
iajs-3400	77	12	as	as	ADP
iajs-3400	77	13	16	16	NUM
iajs-3400	77	14	(	(	PUNCT
iajs-3400	77	15	53	53	NUM
iajs-3400	77	16	%	%	NOUN
iajs-3400	77	17	)	)	PUNCT
iajs-3400	77	18	ihjpas	ihjpas	PROPN
iajs-3400	77	19	.	.	PUNCT
iajs-3400	78	1	37	37	NUM
iajs-3400	78	2	(	(	PUNCT
iajs-3400	78	3	2	2	NUM
iajs-3400	78	4	)	)	PUNCT
iajs-3400	78	5	2024	2024	NUM
iajs-3400	78	6	160	160	NUM
iajs-3400	78	7	control	control	NOUN
iajs-3400	78	8	were	be	AUX
iajs-3400	78	9	<	<	X
iajs-3400	78	10	30	30	NUM
iajs-3400	78	11	years	year	NOUN
iajs-3400	78	12	,	,	PUNCT
iajs-3400	78	13	11	11	NUM
iajs-3400	78	14	(	(	PUNCT
iajs-3400	78	15	37	37	NUM
iajs-3400	78	16	%	%	NOUN
iajs-3400	78	17	control	control	NOUN
iajs-3400	78	18	)	)	PUNCT
iajs-3400	78	19	were	be	AUX
iajs-3400	78	20	from	from	ADP
iajs-3400	78	21	30	30	NUM
iajs-3400	78	22	to	to	PART
iajs-3400	78	23	40	40	NUM
iajs-3400	78	24	years	year	NOUN
iajs-3400	78	25	,	,	PUNCT
iajs-3400	78	26	and	and	CCONJ
iajs-3400	78	27	3	3	NUM
iajs-3400	78	28	control	control	NOUN
iajs-3400	78	29	were	be	AUX
iajs-3400	78	30	>	>	X
iajs-3400	78	31	40	40	NUM
iajs-3400	78	32	(	(	PUNCT
iajs-3400	78	33	10	10	NUM
iajs-3400	78	34	%	%	NOUN
iajs-3400	78	35	)	)	PUNCT
iajs-3400	78	36	years	year	NOUN
iajs-3400	78	37	.	.	PUNCT
iajs-3400	79	1	the	the	DET
iajs-3400	79	2	comparisons	comparison	NOUN
iajs-3400	79	3	of	of	ADP
iajs-3400	79	4	distributions	distribution	NOUN
iajs-3400	79	5	between	between	ADP
iajs-3400	79	6	control	control	NOUN
iajs-3400	79	7	and	and	CCONJ
iajs-3400	79	8	patients	patient	NOUN
iajs-3400	79	9	that	that	PRON
iajs-3400	79	10	are	be	AUX
iajs-3400	79	11	less	less	ADJ
iajs-3400	79	12	than	than	ADP
iajs-3400	79	13	30	30	NUM
iajs-3400	79	14	years	year	NOUN
iajs-3400	79	15	were	be	AUX
iajs-3400	79	16	significant	significant	ADJ
iajs-3400	79	17	;	;	PUNCT
iajs-3400	79	18	the	the	DET
iajs-3400	79	19	distribution	distribution	NOUN
iajs-3400	79	20	of	of	ADP
iajs-3400	79	21	samples	sample	NOUN
iajs-3400	79	22	for	for	ADP
iajs-3400	79	23	control	control	NOUN
iajs-3400	79	24	and	and	CCONJ
iajs-3400	79	25	patients	patient	NOUN
iajs-3400	79	26	that	that	PRON
iajs-3400	79	27	are	be	AUX
iajs-3400	79	28	between	between	ADP
iajs-3400	79	29	30	30	NUM
iajs-3400	79	30	and	and	CCONJ
iajs-3400	79	31	40	40	NUM
iajs-3400	79	32	years	year	NOUN
iajs-3400	79	33	was	be	AUX
iajs-3400	79	34	non	non	ADJ
iajs-3400	79	35	-	-	ADJ
iajs-3400	79	36	significant	significant	ADJ
iajs-3400	79	37	,	,	PUNCT
iajs-3400	79	38	while	while	SCONJ
iajs-3400	79	39	the	the	DET
iajs-3400	79	40	distribution	distribution	NOUN
iajs-3400	79	41	for	for	ADP
iajs-3400	79	42	those	those	PRON
iajs-3400	79	43	who	who	PRON
iajs-3400	79	44	are	be	AUX
iajs-3400	79	45	older	old	ADJ
iajs-3400	79	46	than	than	ADP
iajs-3400	79	47	40	40	NUM
iajs-3400	79	48	years	year	NOUN
iajs-3400	79	49	for	for	ADP
iajs-3400	79	50	both	both	DET
iajs-3400	79	51	groups	group	NOUN
iajs-3400	79	52	was	be	AUX
iajs-3400	79	53	highly	highly	ADV
iajs-3400	79	54	significant	significant	ADJ
iajs-3400	79	55	,	,	PUNCT
iajs-3400	79	56	as	as	SCONJ
iajs-3400	79	57	shown	show	VERB
iajs-3400	79	58	in	in	ADP
iajs-3400	79	59	table	table	NOUN
iajs-3400	79	60	2	2	NUM
iajs-3400	79	61	.	.	PUNCT
iajs-3400	80	1	therefore	therefore	ADV
iajs-3400	80	2	,	,	PUNCT
iajs-3400	80	3	people	people	NOUN
iajs-3400	80	4	over	over	ADP
iajs-3400	80	5	30	30	NUM
iajs-3400	80	6	years	year	NOUN
iajs-3400	80	7	old	old	ADJ
iajs-3400	80	8	make	make	VERB
iajs-3400	80	9	up	up	ADP
iajs-3400	80	10	more	more	ADJ
iajs-3400	80	11	than	than	ADP
iajs-3400	80	12	half	half	NOUN
iajs-3400	80	13	of	of	ADP
iajs-3400	80	14	the	the	DET
iajs-3400	80	15	patients	patient	NOUN
iajs-3400	80	16	in	in	ADP
iajs-3400	80	17	the	the	DET
iajs-3400	80	18	study	study	NOUN
iajs-3400	80	19	,	,	PUNCT
iajs-3400	80	20	and	and	CCONJ
iajs-3400	80	21	this	this	PRON
iajs-3400	80	22	agrees	agree	VERB
iajs-3400	80	23	with	with	ADP
iajs-3400	80	24	the	the	DET
iajs-3400	80	25	results	result	NOUN
iajs-3400	80	26	of	of	ADP
iajs-3400	80	27	[	[	X
iajs-3400	80	28	30	30	NUM
iajs-3400	80	29	]	]	PUNCT
iajs-3400	80	30	,	,	PUNCT
iajs-3400	80	31	but	but	CCONJ
iajs-3400	80	32	it	it	PRON
iajs-3400	80	33	does	do	AUX
iajs-3400	80	34	not	not	PART
iajs-3400	80	35	agree	agree	VERB
iajs-3400	80	36	with	with	ADP
iajs-3400	80	37	the	the	DET
iajs-3400	80	38	results	result	NOUN
iajs-3400	80	39	of	of	ADP
iajs-3400	80	40	the	the	DET
iajs-3400	80	41	iraqi	iraqi	ADJ
iajs-3400	80	42	study	study	NOUN
iajs-3400	80	43	of	of	ADP
iajs-3400	80	44	fadhil	fadhil	NOUN
iajs-3400	80	45	[	[	X
iajs-3400	80	46	35	35	NUM
iajs-3400	80	47	]	]	PUNCT
iajs-3400	80	48	that	that	PRON
iajs-3400	80	49	indicated	indicate	VERB
iajs-3400	80	50	a	a	DET
iajs-3400	80	51	high	high	ADJ
iajs-3400	80	52	incidence	incidence	NOUN
iajs-3400	80	53	of	of	ADP
iajs-3400	80	54	stones	stone	NOUN
iajs-3400	80	55	in	in	ADP
iajs-3400	80	56	elderly	elderly	ADJ
iajs-3400	80	57	patients	patient	NOUN
iajs-3400	80	58	between	between	ADP
iajs-3400	80	59	the	the	DET
iajs-3400	80	60	ages	age	NOUN
iajs-3400	80	61	of	of	ADP
iajs-3400	80	62	50	50	NUM
iajs-3400	80	63	and	and	CCONJ
iajs-3400	80	64	57	57	NUM
iajs-3400	80	65	years	year	NOUN
iajs-3400	80	66	old	old	ADJ
iajs-3400	80	67	.	.	PUNCT
iajs-3400	81	1	this	this	DET
iajs-3400	81	2	difference	difference	NOUN
iajs-3400	81	3	may	may	AUX
iajs-3400	81	4	be	be	AUX
iajs-3400	81	5	due	due	ADJ
iajs-3400	81	6	to	to	ADP
iajs-3400	81	7	the	the	DET
iajs-3400	81	8	difference	difference	NOUN
iajs-3400	81	9	in	in	ADP
iajs-3400	81	10	regions	region	NOUN
iajs-3400	81	11	and	and	CCONJ
iajs-3400	81	12	populations	population	NOUN
iajs-3400	81	13	in	in	ADP
iajs-3400	81	14	the	the	DET
iajs-3400	81	15	two	two	NUM
iajs-3400	81	16	studies	study	NOUN
iajs-3400	81	17	.	.	PUNCT
iajs-3400	82	1	table	table	NOUN
iajs-3400	82	2	2	2	NUM
iajs-3400	82	3	.	.	PUNCT
iajs-3400	83	1	the	the	DET
iajs-3400	83	2	distribution	distribution	NOUN
iajs-3400	83	3	of	of	ADP
iajs-3400	83	4	samples	sample	NOUN
iajs-3400	83	5	according	accord	VERB
iajs-3400	83	6	to	to	ADP
iajs-3400	83	7	age	age	NOUN
iajs-3400	83	8	group	group	NOUN
iajs-3400	83	9	no	no	DET
iajs-3400	83	10	<	<	NOUN
iajs-3400	83	11	30	30	NUM
iajs-3400	83	12	yr	yr	NOUN
iajs-3400	83	13	.	.	PROPN
iajs-3400	83	14	no.(%	no.(%	PROPN
iajs-3400	83	15	)	)	PUNCT
iajs-3400	83	16	30	30	NUM
iajs-3400	83	17	-	-	SYM
iajs-3400	83	18	40	40	NUM
iajs-3400	83	19	yr	yr	NOUN
iajs-3400	83	20	.	.	PROPN
iajs-3400	83	21	no.(%	no.(%	PROPN
iajs-3400	83	22	)	)	PUNCT
iajs-3400	84	1	>	>	PUNCT
iajs-3400	84	2	40	40	NUM
iajs-3400	84	3	yr	yr	NOUN
iajs-3400	84	4	.	.	PROPN
iajs-3400	84	5	no.(%	no.(%	PROPN
iajs-3400	84	6	)	)	PUNCT
iajs-3400	85	1	p	p	X
iajs-3400	85	2	-	-	PUNCT
iajs-3400	85	3	value	value	NOUN
iajs-3400	85	4	control	control	NOUN
iajs-3400	85	5	30	30	NUM
iajs-3400	85	6	16(53	16(53	NUM
iajs-3400	85	7	%	%	NOUN
iajs-3400	85	8	)	)	PUNCT
iajs-3400	85	9	11(37	11(37	NUM
iajs-3400	85	10	%	%	NOUN
iajs-3400	85	11	)	)	PUNCT
iajs-3400	85	12	3(10	3(10	NUM
iajs-3400	85	13	%	%	NOUN
iajs-3400	85	14	)	)	PUNCT
iajs-3400	86	1	0.0084	0.0084	NUM
iajs-3400	87	1	*	*	PUNCT
iajs-3400	87	2	*	*	PUNCT
iajs-3400	87	3	patients	patient	VERB
iajs-3400	87	4	50	50	NUM
iajs-3400	87	5	10(20	10(20	NUM
iajs-3400	87	6	%	%	NOUN
iajs-3400	87	7	)	)	PUNCT
iajs-3400	88	1	20(40	20(40	NUM
iajs-3400	88	2	%	%	NOUN
iajs-3400	88	3	)	)	PUNCT
iajs-3400	88	4	20(40	20(40	NUM
iajs-3400	88	5	%	%	NOUN
iajs-3400	88	6	)	)	PUNCT
iajs-3400	88	7	0.0255	0.0255	NUM
iajs-3400	88	8	*	*	PUNCT
iajs-3400	89	1	p	p	X
iajs-3400	89	2	-	-	PUNCT
iajs-3400	89	3	value	value	NOUN
iajs-3400	89	4	-0.0319	-0.0319	NOUN
iajs-3400	90	1	*	*	PUNCT
iajs-3400	90	2	0.385	0.385	NUM
iajs-3400	90	3	ns	ns	NUM
iajs-3400	90	4	0.0006	0.0006	NUM
iajs-3400	90	5	*	*	PUNCT
iajs-3400	90	6	*	*	PUNCT
iajs-3400	90	7	--	--	PUNCT
iajs-3400	90	8	*	*	PUNCT
iajs-3400	90	9	(	(	PUNCT
iajs-3400	90	10	p≤0.05	p≤0.05	NOUN
iajs-3400	90	11	)	)	PUNCT
iajs-3400	90	12	,	,	PUNCT
iajs-3400	90	13	*	*	PUNCT
iajs-3400	90	14	*	*	PUNCT
iajs-3400	90	15	(	(	PUNCT
iajs-3400	90	16	p≤0.01	p≤0.01	NOUN
iajs-3400	90	17	)	)	PUNCT
iajs-3400	90	18	.	.	PUNCT
iajs-3400	91	1	the	the	DET
iajs-3400	91	2	results	result	NOUN
iajs-3400	91	3	of	of	ADP
iajs-3400	91	4	the	the	DET
iajs-3400	91	5	sample	sample	NOUN
iajs-3400	91	6	distribution	distribution	NOUN
iajs-3400	91	7	regarding	regard	VERB
iajs-3400	91	8	the	the	DET
iajs-3400	91	9	blood	blood	NOUN
iajs-3400	91	10	groups	group	NOUN
iajs-3400	91	11	in	in	ADP
iajs-3400	91	12	the	the	DET
iajs-3400	91	13	control	control	NOUN
iajs-3400	91	14	group	group	NOUN
iajs-3400	91	15	were	be	AUX
iajs-3400	91	16	highly	highly	ADV
iajs-3400	91	17	significant	significant	ADJ
iajs-3400	91	18	,	,	PUNCT
iajs-3400	91	19	as	as	ADV
iajs-3400	91	20	well	well	ADV
iajs-3400	91	21	as	as	ADP
iajs-3400	91	22	in	in	ADP
iajs-3400	91	23	the	the	DET
iajs-3400	91	24	patient	patient	NOUN
iajs-3400	91	25	group	group	NOUN
iajs-3400	91	26	.	.	PUNCT
iajs-3400	92	1	the	the	DET
iajs-3400	92	2	o	o	PROPN
iajs-3400	92	3	blood	blood	NOUN
iajs-3400	92	4	type	type	NOUN
iajs-3400	92	5	was	be	AUX
iajs-3400	92	6	the	the	DET
iajs-3400	92	7	dominant	dominant	ADJ
iajs-3400	92	8	type	type	NOUN
iajs-3400	92	9	in	in	ADP
iajs-3400	92	10	this	this	DET
iajs-3400	92	11	study	study	NOUN
iajs-3400	92	12	,	,	PUNCT
iajs-3400	92	13	as	as	SCONJ
iajs-3400	92	14	18	18	NUM
iajs-3400	92	15	individuals	individual	NOUN
iajs-3400	92	16	,	,	PUNCT
iajs-3400	92	17	or	or	CCONJ
iajs-3400	92	18	60	60	NUM
iajs-3400	92	19	%	%	NOUN
iajs-3400	92	20	of	of	ADP
iajs-3400	92	21	the	the	DET
iajs-3400	92	22	controls	control	NOUN
iajs-3400	92	23	,	,	PUNCT
iajs-3400	92	24	had	have	VERB
iajs-3400	92	25	this	this	DET
iajs-3400	92	26	type	type	NOUN
iajs-3400	92	27	,	,	PUNCT
iajs-3400	92	28	and	and	CCONJ
iajs-3400	92	29	more	more	ADJ
iajs-3400	92	30	than	than	ADP
iajs-3400	92	31	half	half	NOUN
iajs-3400	92	32	of	of	ADP
iajs-3400	92	33	the	the	DET
iajs-3400	92	34	patients	patient	NOUN
iajs-3400	92	35	,	,	PUNCT
iajs-3400	92	36	or	or	CCONJ
iajs-3400	92	37	28	28	NUM
iajs-3400	92	38	individuals	individual	NOUN
iajs-3400	92	39	,	,	PUNCT
iajs-3400	92	40	or	or	CCONJ
iajs-3400	92	41	56	56	NUM
iajs-3400	92	42	%	%	NOUN
iajs-3400	92	43	,	,	PUNCT
iajs-3400	92	44	had	have	VERB
iajs-3400	92	45	this	this	DET
iajs-3400	92	46	type	type	NOUN
iajs-3400	92	47	.	.	PUNCT
iajs-3400	93	1	these	these	DET
iajs-3400	93	2	results	result	NOUN
iajs-3400	93	3	may	may	AUX
iajs-3400	93	4	be	be	AUX
iajs-3400	93	5	because	because	SCONJ
iajs-3400	93	6	the	the	DET
iajs-3400	93	7	o	o	NOUN
iajs-3400	93	8	blood	blood	NOUN
iajs-3400	93	9	type	type	NOUN
iajs-3400	93	10	is	be	AUX
iajs-3400	93	11	the	the	DET
iajs-3400	93	12	most	most	ADV
iajs-3400	93	13	common	common	ADJ
iajs-3400	93	14	in	in	ADP
iajs-3400	93	15	iraq	iraq	PROPN
iajs-3400	94	1	[	[	X
iajs-3400	94	2	36	36	NUM
iajs-3400	94	3	]	]	PUNCT
iajs-3400	94	4	.	.	PUNCT
iajs-3400	95	1	the	the	DET
iajs-3400	95	2	comparison	comparison	NOUN
iajs-3400	95	3	of	of	ADP
iajs-3400	95	4	sample	sample	NOUN
iajs-3400	95	5	distribution	distribution	NOUN
iajs-3400	95	6	between	between	ADP
iajs-3400	95	7	the	the	DET
iajs-3400	95	8	control	control	NOUN
iajs-3400	95	9	group	group	NOUN
iajs-3400	95	10	and	and	CCONJ
iajs-3400	95	11	the	the	DET
iajs-3400	95	12	patient	patient	ADJ
iajs-3400	95	13	group	group	NOUN
iajs-3400	95	14	in	in	ADP
iajs-3400	95	15	the	the	DET
iajs-3400	95	16	a	a	NOUN
iajs-3400	95	17	and	and	CCONJ
iajs-3400	95	18	o	o	NOUN
iajs-3400	95	19	blood	blood	NOUN
iajs-3400	95	20	groups	group	NOUN
iajs-3400	95	21	was	be	AUX
iajs-3400	95	22	non	non	ADJ
iajs-3400	95	23	-	-	ADJ
iajs-3400	95	24	significant	significant	ADJ
iajs-3400	95	25	,	,	PUNCT
iajs-3400	95	26	while	while	SCONJ
iajs-3400	95	27	it	it	PRON
iajs-3400	95	28	was	be	AUX
iajs-3400	95	29	significant	significant	ADJ
iajs-3400	95	30	for	for	ADP
iajs-3400	95	31	the	the	DET
iajs-3400	95	32	b	b	PROPN
iajs-3400	95	33	and	and	CCONJ
iajs-3400	95	34	ab	ab	PROPN
iajs-3400	95	35	blood	blood	NOUN
iajs-3400	95	36	groups	group	NOUN
iajs-3400	95	37	,	,	PUNCT
iajs-3400	95	38	as	as	SCONJ
iajs-3400	95	39	shown	show	VERB
iajs-3400	95	40	in	in	ADP
iajs-3400	95	41	table	table	NOUN
iajs-3400	95	42	3	3	NUM
iajs-3400	95	43	.	.	PUNCT
iajs-3400	95	44	table	table	NOUN
iajs-3400	95	45	3	3	NUM
iajs-3400	95	46	.	.	PUNCT
iajs-3400	96	1	the	the	DET
iajs-3400	96	2	distribution	distribution	NOUN
iajs-3400	96	3	of	of	ADP
iajs-3400	96	4	sample	sample	NOUN
iajs-3400	96	5	study	study	NOUN
iajs-3400	96	6	according	accord	VERB
iajs-3400	96	7	to	to	ADP
iajs-3400	96	8	blood	blood	NOUN
iajs-3400	96	9	group	group	NOUN
iajs-3400	96	10	in	in	ADP
iajs-3400	96	11	control	control	NOUN
iajs-3400	96	12	and	and	CCONJ
iajs-3400	96	13	patients	patient	NOUN
iajs-3400	96	14	group	group	NOUN
iajs-3400	96	15	no	no	INTJ
iajs-3400	96	16	a	a	DET
iajs-3400	96	17	no	no	NOUN
iajs-3400	96	18	.	.	PUNCT
iajs-3400	97	1	(	(	PUNCT
iajs-3400	97	2	%	%	INTJ
iajs-3400	97	3	)	)	PUNCT
iajs-3400	97	4	b	b	NOUN
iajs-3400	98	1	no	no	INTJ
iajs-3400	98	2	.	.	PUNCT
iajs-3400	99	1	(	(	PUNCT
iajs-3400	99	2	%	%	INTJ
iajs-3400	99	3	)	)	PUNCT
iajs-3400	100	1	ab	ab	PROPN
iajs-3400	100	2	no	no	INTJ
iajs-3400	100	3	.	.	PUNCT
iajs-3400	101	1	(	(	PUNCT
iajs-3400	101	2	%	%	INTJ
iajs-3400	101	3	)	)	PUNCT
iajs-3400	101	4	o	o	INTJ
iajs-3400	102	1	no	no	INTJ
iajs-3400	102	2	.	.	PUNCT
iajs-3400	103	1	(	(	PUNCT
iajs-3400	103	2	%	%	INTJ
iajs-3400	103	3	)	)	PUNCT
iajs-3400	103	4	p	p	ADJ
iajs-3400	103	5	-	-	PUNCT
iajs-3400	103	6	value	value	NOUN
iajs-3400	103	7	control	control	NOUN
iajs-3400	103	8	30	30	NUM
iajs-3400	103	9	9(30	9(30	NUM
iajs-3400	103	10	%	%	NOUN
iajs-3400	103	11	)	)	PUNCT
iajs-3400	103	12	2(7	2(7	NUM
iajs-3400	103	13	%	%	NOUN
iajs-3400	103	14	)	)	PUNCT
iajs-3400	103	15	1(3	1(3	NUM
iajs-3400	103	16	%	%	NOUN
iajs-3400	103	17	)	)	PUNCT
iajs-3400	104	1	18(60	18(60	NUM
iajs-3400	104	2	%	%	NOUN
iajs-3400	104	3	)	)	PUNCT
iajs-3400	104	4	0.0001	0.0001	NUM
iajs-3400	104	5	*	*	PUNCT
iajs-3400	104	6	*	*	NOUN
iajs-3400	104	7	patients	patient	VERB
iajs-3400	104	8	50	50	NUM
iajs-3400	104	9	7(14	7(14	NUM
iajs-3400	104	10	%	%	NOUN
iajs-3400	104	11	)	)	PUNCT
iajs-3400	104	12	11(22	11(22	NUM
iajs-3400	104	13	%	%	NOUN
iajs-3400	104	14	)	)	PUNCT
iajs-3400	104	15	4(16	4(16	NUM
iajs-3400	104	16	%	%	NOUN
iajs-3400	104	17	)	)	PUNCT
iajs-3400	104	18	28(56	28(56	NUM
iajs-3400	104	19	%	%	NOUN
iajs-3400	104	20	)	)	PUNCT
iajs-3400	105	1	0.0008	0.0008	NUM
iajs-3400	105	2	*	*	PUNCT
iajs-3400	105	3	*	*	PUNCT
iajs-3400	105	4	p	p	NOUN
iajs-3400	105	5	-	-	PUNCT
iajs-3400	105	6	value	value	NOUN
iajs-3400	105	7	-0.183	-0.183	NOUN
iajs-3400	105	8	ns	ns	NUM
iajs-3400	105	9	0.0379	0.0379	NUM
iajs-3400	105	10	*	*	PUNCT
iajs-3400	106	1	0.0498	0.0498	NUM
iajs-3400	106	2	*	*	PUNCT
iajs-3400	106	3	0.702	0.702	NUM
iajs-3400	106	4	ns	ns	NUM
iajs-3400	106	5	--	--	PUNCT
iajs-3400	106	6	*	*	PUNCT
iajs-3400	106	7	(	(	PUNCT
iajs-3400	106	8	p≤0.05	p≤0.05	NOUN
iajs-3400	106	9	)	)	PUNCT
iajs-3400	106	10	,	,	PUNCT
iajs-3400	106	11	*	*	PUNCT
iajs-3400	106	12	*	*	PUNCT
iajs-3400	106	13	(	(	PUNCT
iajs-3400	106	14	p≤0.01	p≤0.01	NOUN
iajs-3400	106	15	)	)	PUNCT
iajs-3400	106	16	.	.	PUNCT
iajs-3400	107	1	3.1	3.1	NUM
iajs-3400	107	2	.	.	PUNCT
iajs-3400	107	3	biochemical	biochemical	ADJ
iajs-3400	107	4	tests	test	NOUN
iajs-3400	107	5	3.1.1	3.1.1	NUM
iajs-3400	107	6	.	.	PUNCT
iajs-3400	108	1	general	general	ADJ
iajs-3400	108	2	urine	urine	NOUN
iajs-3400	108	3	examination	examination	NOUN
iajs-3400	108	4	in	in	ADP
iajs-3400	108	5	patients	patient	NOUN
iajs-3400	108	6	'	'	PART
iajs-3400	108	7	urine	urine	NOUN
iajs-3400	108	8	samples	sample	NOUN
iajs-3400	108	9	,	,	PUNCT
iajs-3400	108	10	the	the	DET
iajs-3400	108	11	presence	presence	NOUN
iajs-3400	108	12	of	of	ADP
iajs-3400	108	13	high	high	ADJ
iajs-3400	108	14	levels	level	NOUN
iajs-3400	108	15	of	of	ADP
iajs-3400	108	16	calcium	calcium	NOUN
iajs-3400	108	17	oxalate	oxalate	NOUN
iajs-3400	108	18	crystals	crystal	NOUN
iajs-3400	108	19	was	be	AUX
iajs-3400	108	20	observed	observe	VERB
iajs-3400	108	21	by	by	ADP
iajs-3400	108	22	a	a	DET
iajs-3400	108	23	compound	compound	NOUN
iajs-3400	108	24	microscope	microscope	NOUN
iajs-3400	108	25	,	,	PUNCT
iajs-3400	108	26	which	which	PRON
iajs-3400	108	27	may	may	AUX
iajs-3400	108	28	be	be	AUX
iajs-3400	108	29	caused	cause	VERB
iajs-3400	108	30	by	by	ADP
iajs-3400	108	31	animal	animal	NOUN
iajs-3400	108	32	proteins	protein	NOUN
iajs-3400	108	33	like	like	ADP
iajs-3400	108	34	meat	meat	NOUN
iajs-3400	108	35	,	,	PUNCT
iajs-3400	108	36	fish	fish	NOUN
iajs-3400	108	37	,	,	PUNCT
iajs-3400	108	38	and	and	CCONJ
iajs-3400	108	39	poultry	poultry	NOUN
iajs-3400	108	40	that	that	PRON
iajs-3400	108	41	have	have	VERB
iajs-3400	108	42	high	high	ADJ
iajs-3400	108	43	purines	purine	NOUN
iajs-3400	108	44	that	that	PRON
iajs-3400	108	45	are	be	AUX
iajs-3400	108	46	metabolized	metabolize	VERB
iajs-3400	108	47	to	to	ADP
iajs-3400	108	48	uric	uric	ADJ
iajs-3400	108	49	acid	acid	NOUN
iajs-3400	108	50	and	and	CCONJ
iajs-3400	108	51	oxalate	oxalate	NOUN
iajs-3400	108	52	,	,	PUNCT
iajs-3400	108	53	and	and	CCONJ
iajs-3400	108	54	it	it	PRON
iajs-3400	108	55	also	also	ADV
iajs-3400	108	56	reduces	reduce	VERB
iajs-3400	108	57	urine	urine	NOUN
iajs-3400	108	58	ph	ph	NOUN
iajs-3400	108	59	and	and	CCONJ
iajs-3400	108	60	helps	help	VERB
iajs-3400	108	61	the	the	DET
iajs-3400	108	62	growth	growth	NOUN
iajs-3400	108	63	of	of	ADP
iajs-3400	108	64	calcium	calcium	NOUN
iajs-3400	108	65	oxalate	oxalate	NOUN
iajs-3400	108	66	stones	stone	NOUN
iajs-3400	108	67	[	[	X
iajs-3400	108	68	37	37	NUM
iajs-3400	108	69	]	]	PUNCT
iajs-3400	108	70	,	,	PUNCT
iajs-3400	108	71	in	in	ADP
iajs-3400	108	72	addition	addition	NOUN
iajs-3400	108	73	to	to	ADP
iajs-3400	108	74	reduced	reduce	VERB
iajs-3400	108	75	fluid	fluid	NOUN
iajs-3400	108	76	intake	intake	NOUN
iajs-3400	108	77	,	,	PUNCT
iajs-3400	108	78	which	which	PRON
iajs-3400	108	79	lowers	lower	VERB
iajs-3400	108	80	the	the	DET
iajs-3400	108	81	rates	rate	NOUN
iajs-3400	108	82	of	of	ADP
iajs-3400	108	83	urine	urine	NOUN
iajs-3400	108	84	flow	flow	NOUN
iajs-3400	108	85	and	and	CCONJ
iajs-3400	108	86	leads	lead	VERB
iajs-3400	108	87	to	to	ADP
iajs-3400	108	88	oversaturation	oversaturation	NOUN
iajs-3400	108	89	and	and	CCONJ
iajs-3400	108	90	crystallization	crystallization	NOUN
iajs-3400	108	91	of	of	ADP
iajs-3400	108	92	salts	salt	NOUN
iajs-3400	108	93	in	in	ADP
iajs-3400	108	94	the	the	DET
iajs-3400	108	95	urine	urine	NOUN
iajs-3400	109	1	[	[	X
iajs-3400	109	2	38	38	NUM
iajs-3400	109	3	]	]	PUNCT
iajs-3400	109	4	,	,	PUNCT
iajs-3400	109	5	or	or	CCONJ
iajs-3400	109	6	it	it	PRON
iajs-3400	109	7	may	may	AUX
iajs-3400	109	8	be	be	AUX
iajs-3400	109	9	due	due	ADJ
iajs-3400	109	10	to	to	ADP
iajs-3400	109	11	coax	coax	ADJ
iajs-3400	109	12	stones	stone	NOUN
iajs-3400	109	13	caused	cause	VERB
iajs-3400	109	14	by	by	ADP
iajs-3400	109	15	the	the	DET
iajs-3400	109	16	grhpr	grhpr	ADJ
iajs-3400	109	17	enzyme	enzyme	NOUN
iajs-3400	109	18	absence	absence	NOUN
iajs-3400	109	19	that	that	PRON
iajs-3400	109	20	cause	cause	VERB
iajs-3400	109	21	calcium	calcium	NOUN
iajs-3400	109	22	oxalate	oxalate	NOUN
iajs-3400	109	23	kidney	kidney	NOUN
iajs-3400	109	24	stones	stone	NOUN
iajs-3400	109	25	leading	lead	VERB
iajs-3400	109	26	to	to	ADP
iajs-3400	109	27	crystal	crystal	NOUN
iajs-3400	109	28	formation	formation	NOUN
iajs-3400	109	29	in	in	ADP
iajs-3400	109	30	the	the	DET
iajs-3400	109	31	urine	urine	NOUN
iajs-3400	109	32	,	,	PUNCT
iajs-3400	109	33	as	as	SCONJ
iajs-3400	109	34	is	be	AUX
iajs-3400	109	35	shown	show	VERB
iajs-3400	109	36	in	in	ADP
iajs-3400	109	37	figure	figure	NOUN
iajs-3400	109	38	1	1	NUM
iajs-3400	109	39	.	.	PUNCT
iajs-3400	109	40	ihjpas	ihjpas	PROPN
iajs-3400	109	41	.	.	PUNCT
iajs-3400	110	1	37	37	NUM
iajs-3400	110	2	(	(	PUNCT
iajs-3400	110	3	2	2	NUM
iajs-3400	110	4	)	)	PUNCT
iajs-3400	110	5	2024	2024	NUM
iajs-3400	110	6	161	161	NUM
iajs-3400	110	7	figure	figure	NOUN
iajs-3400	110	8	1	1	NUM
iajs-3400	110	9	.	.	PUNCT
iajs-3400	110	10	calcium	calcium	NOUN
iajs-3400	110	11	oxalate	oxalate	NOUN
iajs-3400	110	12	under	under	ADP
iajs-3400	110	13	the	the	DET
iajs-3400	110	14	electron	electron	NOUN
iajs-3400	110	15	microscope	microscope	NOUN
iajs-3400	110	16	(	(	PUNCT
iajs-3400	110	17	40x	40x	NOUN
iajs-3400	110	18	)	)	PUNCT
iajs-3400	110	19	in	in	ADP
iajs-3400	110	20	urine	urine	NOUN
iajs-3400	110	21	samples	sample	NOUN
iajs-3400	110	22	.	.	PUNCT
iajs-3400	111	1	a	a	DET
iajs-3400	111	2	:	:	PUNCT
iajs-3400	111	3	calcium	calcium	NOUN
iajs-3400	111	4	oxalate	oxalate	NOUN
iajs-3400	111	5	monohydrate	monohydrate	NOUN
iajs-3400	111	6	crystals	crystal	NOUN
iajs-3400	111	7	,	,	PUNCT
iajs-3400	111	8	b	b	X
iajs-3400	111	9	:	:	PUNCT
iajs-3400	111	10	calcium	calcium	NOUN
iajs-3400	111	11	oxalate	oxalate	NOUN
iajs-3400	111	12	dihydrate	dihydrate	NOUN
iajs-3400	111	13	crystals	crystal	NOUN
iajs-3400	111	14	3.1.2	3.1.2	NOUN
iajs-3400	111	15	.	.	PUNCT
iajs-3400	112	1	kidney	kidney	NOUN
iajs-3400	112	2	functions	function	NOUN
iajs-3400	112	3	tests	test	VERB
iajs-3400	112	4	the	the	DET
iajs-3400	112	5	kidney	kidney	NOUN
iajs-3400	112	6	functions	function	NOUN
iajs-3400	112	7	were	be	AUX
iajs-3400	112	8	tested	test	VERB
iajs-3400	112	9	by	by	ADP
iajs-3400	112	10	measuring	measure	VERB
iajs-3400	112	11	uric	uric	ADJ
iajs-3400	112	12	acid	acid	NOUN
iajs-3400	112	13	,	,	PUNCT
iajs-3400	112	14	urea	urea	NOUN
iajs-3400	112	15	,	,	PUNCT
iajs-3400	112	16	and	and	CCONJ
iajs-3400	112	17	creatinine	creatinine	NOUN
iajs-3400	112	18	in	in	ADP
iajs-3400	112	19	the	the	DET
iajs-3400	112	20	sera	sera	NOUN
iajs-3400	112	21	of	of	ADP
iajs-3400	112	22	both	both	DET
iajs-3400	112	23	patients	patient	NOUN
iajs-3400	112	24	and	and	CCONJ
iajs-3400	112	25	control	control	NOUN
iajs-3400	112	26	groups	group	NOUN
iajs-3400	112	27	.	.	PUNCT
iajs-3400	113	1	urea	urea	PROPN
iajs-3400	113	2	is	be	AUX
iajs-3400	113	3	a	a	DET
iajs-3400	113	4	small	small	ADJ
iajs-3400	113	5	organic	organic	ADJ
iajs-3400	113	6	molecule	molecule	NOUN
iajs-3400	113	7	made	make	VERB
iajs-3400	113	8	up	up	ADP
iajs-3400	113	9	of	of	ADP
iajs-3400	113	10	a	a	DET
iajs-3400	113	11	pair	pair	NOUN
iajs-3400	113	12	of	of	ADP
iajs-3400	113	13	nitrogen	nitrogen	NOUN
iajs-3400	113	14	atoms	atom	NOUN
iajs-3400	113	15	(	(	PUNCT
iajs-3400	113	16	nh2	nh2	PROPN
iajs-3400	113	17	)	)	PUNCT
iajs-3400	113	18	.	.	PUNCT
iajs-3400	114	1	it	it	PRON
iajs-3400	114	2	is	be	AUX
iajs-3400	114	3	produced	produce	VERB
iajs-3400	114	4	in	in	ADP
iajs-3400	114	5	the	the	DET
iajs-3400	114	6	liver	liver	NOUN
iajs-3400	114	7	from	from	ADP
iajs-3400	114	8	protein	protein	NOUN
iajs-3400	114	9	and	and	CCONJ
iajs-3400	114	10	nitrogen	nitrogen	NOUN
iajs-3400	114	11	metabolism	metabolism	NOUN
iajs-3400	114	12	.	.	PUNCT
iajs-3400	115	1	creatinine	creatinine	NOUN
iajs-3400	115	2	is	be	AUX
iajs-3400	115	3	a	a	DET
iajs-3400	115	4	product	product	NOUN
iajs-3400	115	5	made	make	VERB
iajs-3400	115	6	up	up	ADP
iajs-3400	115	7	of	of	ADP
iajs-3400	115	8	creatinine	creatinine	NOUN
iajs-3400	115	9	phosphate	phosphate	NOUN
iajs-3400	115	10	breakdown	breakdown	NOUN
iajs-3400	115	11	from	from	ADP
iajs-3400	115	12	protein	protein	NOUN
iajs-3400	115	13	metabolism	metabolism	NOUN
iajs-3400	115	14	in	in	ADP
iajs-3400	115	15	the	the	DET
iajs-3400	115	16	muscle	muscle	NOUN
iajs-3400	115	17	[	[	X
iajs-3400	115	18	39	39	NUM
iajs-3400	115	19	]	]	PUNCT
iajs-3400	115	20	.	.	PUNCT
iajs-3400	116	1	it	it	PRON
iajs-3400	116	2	is	be	AUX
iajs-3400	116	3	the	the	DET
iajs-3400	116	4	most	most	ADV
iajs-3400	116	5	important	important	ADJ
iajs-3400	116	6	indication	indication	NOUN
iajs-3400	116	7	used	use	VERB
iajs-3400	116	8	for	for	ADP
iajs-3400	116	9	evaluating	evaluate	VERB
iajs-3400	116	10	glomerular	glomerular	ADJ
iajs-3400	116	11	filtration	filtration	NOUN
iajs-3400	116	12	rate	rate	NOUN
iajs-3400	116	13	(	(	PUNCT
iajs-3400	116	14	gfr	gfr	NOUN
iajs-3400	116	15	)	)	PUNCT
iajs-3400	116	16	as	as	SCONJ
iajs-3400	116	17	it	it	PRON
iajs-3400	116	18	is	be	AUX
iajs-3400	116	19	discarded	discard	VERB
iajs-3400	116	20	through	through	ADP
iajs-3400	116	21	glomerular	glomerular	ADJ
iajs-3400	116	22	filtration	filtration	NOUN
iajs-3400	116	23	[	[	X
iajs-3400	116	24	40	40	NUM
iajs-3400	116	25	]	]	PUNCT
iajs-3400	116	26	.	.	PUNCT
iajs-3400	117	1	the	the	DET
iajs-3400	117	2	results	result	NOUN
iajs-3400	117	3	of	of	ADP
iajs-3400	117	4	urea	urea	NOUN
iajs-3400	117	5	showed	show	VERB
iajs-3400	117	6	highly	highly	ADV
iajs-3400	117	7	significant	significant	ADJ
iajs-3400	117	8	differences	difference	NOUN
iajs-3400	117	9	between	between	ADP
iajs-3400	117	10	the	the	DET
iajs-3400	117	11	control	control	NOUN
iajs-3400	117	12	(	(	PUNCT
iajs-3400	117	13	15.95±0.19	15.95±0.19	NUM
iajs-3400	117	14	)	)	PUNCT
iajs-3400	117	15	and	and	CCONJ
iajs-3400	117	16	the	the	DET
iajs-3400	117	17	patient	patient	ADJ
iajs-3400	117	18	group	group	NOUN
iajs-3400	117	19	(	(	PUNCT
iajs-3400	117	20	31.44±2.17	31.44±2.17	PROPN
iajs-3400	117	21	)	)	PUNCT
iajs-3400	117	22	;	;	PUNCT
iajs-3400	117	23	the	the	DET
iajs-3400	117	24	normal	normal	ADJ
iajs-3400	117	25	ranges	range	NOUN
iajs-3400	117	26	are	be	AUX
iajs-3400	117	27	7–37	7–37	PROPN
iajs-3400	117	28	mg	mg	PROPN
iajs-3400	117	29	/	/	SYM
iajs-3400	117	30	dl	dl	PROPN
iajs-3400	117	31	.	.	PROPN
iajs-3400	117	32	creatinine	creatinine	PROPN
iajs-3400	117	33	is	be	AUX
iajs-3400	117	34	an	an	DET
iajs-3400	117	35	amino	amino	NOUN
iajs-3400	117	36	acid	acid	NOUN
iajs-3400	117	37	that	that	PRON
iajs-3400	117	38	is	be	AUX
iajs-3400	117	39	derived	derive	VERB
iajs-3400	117	40	from	from	ADP
iajs-3400	117	41	creatine	creatine	NOUN
iajs-3400	117	42	.	.	PUNCT
iajs-3400	118	1	it	it	PRON
iajs-3400	118	2	is	be	AUX
iajs-3400	118	3	usually	usually	ADV
iajs-3400	118	4	used	use	VERB
iajs-3400	118	5	to	to	PART
iajs-3400	118	6	evaluate	evaluate	VERB
iajs-3400	118	7	kidney	kidney	NOUN
iajs-3400	118	8	functions	function	NOUN
iajs-3400	118	9	[	[	X
iajs-3400	118	10	41	41	NUM
iajs-3400	118	11	]	]	PUNCT
iajs-3400	118	12	.	.	PUNCT
iajs-3400	119	1	the	the	DET
iajs-3400	119	2	results	result	NOUN
iajs-3400	119	3	of	of	ADP
iajs-3400	119	4	creatinine	creatinine	NOUN
iajs-3400	119	5	also	also	ADV
iajs-3400	119	6	showed	show	VERB
iajs-3400	119	7	highly	highly	ADV
iajs-3400	119	8	significant	significant	ADJ
iajs-3400	119	9	differences	difference	NOUN
iajs-3400	119	10	between	between	ADP
iajs-3400	119	11	the	the	DET
iajs-3400	119	12	control	control	NOUN
iajs-3400	119	13	(	(	PUNCT
iajs-3400	119	14	0.721±0.04	0.721±0.04	PROPN
iajs-3400	119	15	)	)	PUNCT
iajs-3400	119	16	and	and	CCONJ
iajs-3400	119	17	the	the	DET
iajs-3400	119	18	patient	patient	ADJ
iajs-3400	119	19	group	group	NOUN
iajs-3400	119	20	(	(	PUNCT
iajs-3400	119	21	1.29±0.11	1.29±0.11	NUM
iajs-3400	119	22	)	)	PUNCT
iajs-3400	119	23	as	as	SCONJ
iajs-3400	119	24	they	they	PRON
iajs-3400	119	25	were	be	AUX
iajs-3400	119	26	above	above	ADP
iajs-3400	119	27	the	the	DET
iajs-3400	119	28	normal	normal	ADJ
iajs-3400	119	29	range	range	NOUN
iajs-3400	119	30	;	;	PUNCT
iajs-3400	119	31	the	the	DET
iajs-3400	119	32	standard	standard	ADJ
iajs-3400	119	33	normal	normal	ADJ
iajs-3400	119	34	ranges	range	NOUN
iajs-3400	119	35	are	be	AUX
iajs-3400	119	36	(	(	PUNCT
iajs-3400	119	37	0.5	0.5	NUM
iajs-3400	119	38	-	-	SYM
iajs-3400	119	39	1.2	1.2	NUM
iajs-3400	119	40	mg	mg	PROPN
iajs-3400	119	41	/	/	SYM
iajs-3400	119	42	dl	dl	NOUN
iajs-3400	119	43	)	)	PUNCT
iajs-3400	119	44	.	.	PUNCT
iajs-3400	120	1	these	these	DET
iajs-3400	120	2	results	result	NOUN
iajs-3400	120	3	may	may	AUX
iajs-3400	120	4	indicate	indicate	VERB
iajs-3400	120	5	that	that	SCONJ
iajs-3400	120	6	the	the	DET
iajs-3400	120	7	patients	patient	NOUN
iajs-3400	120	8	have	have	VERB
iajs-3400	120	9	kidney	kidney	NOUN
iajs-3400	120	10	dysfunctions	dysfunction	NOUN
iajs-3400	120	11	;	;	PUNCT
iajs-3400	120	12	arindam	arindam	PROPN
iajs-3400	120	13	and	and	CCONJ
iajs-3400	120	14	his	his	PRON
iajs-3400	120	15	colleagues	colleague	NOUN
iajs-3400	120	16	found	find	VERB
iajs-3400	120	17	similar	similar	ADJ
iajs-3400	120	18	results	result	NOUN
iajs-3400	120	19	in	in	ADP
iajs-3400	120	20	their	their	PRON
iajs-3400	120	21	study	study	NOUN
iajs-3400	120	22	in	in	ADP
iajs-3400	120	23	patients	patient	NOUN
iajs-3400	120	24	with	with	ADP
iajs-3400	120	25	kidney	kidney	NOUN
iajs-3400	120	26	oxalate	oxalate	NOUN
iajs-3400	120	27	stones	stone	NOUN
iajs-3400	120	28	who	who	PRON
iajs-3400	120	29	have	have	VERB
iajs-3400	120	30	ph2	ph2	NOUN
iajs-3400	120	31	disease	disease	NOUN
iajs-3400	120	32	[	[	X
iajs-3400	120	33	42	42	NUM
iajs-3400	120	34	]	]	PUNCT
iajs-3400	120	35	.	.	PUNCT
iajs-3400	121	1	the	the	DET
iajs-3400	121	2	high	high	ADJ
iajs-3400	121	3	level	level	NOUN
iajs-3400	121	4	of	of	ADP
iajs-3400	121	5	urea	urea	NOUN
iajs-3400	121	6	and	and	CCONJ
iajs-3400	121	7	creatinine	creatinine	NOUN
iajs-3400	121	8	may	may	AUX
iajs-3400	121	9	be	be	AUX
iajs-3400	121	10	associated	associate	VERB
iajs-3400	121	11	with	with	ADP
iajs-3400	121	12	a	a	DET
iajs-3400	121	13	metabolic	metabolic	NOUN
iajs-3400	121	14	defect	defect	NOUN
iajs-3400	121	15	in	in	ADP
iajs-3400	121	16	the	the	DET
iajs-3400	121	17	kidneys	kidney	NOUN
iajs-3400	121	18	resulting	result	VERB
iajs-3400	121	19	from	from	ADP
iajs-3400	121	20	the	the	DET
iajs-3400	121	21	destruction	destruction	NOUN
iajs-3400	121	22	of	of	ADP
iajs-3400	121	23	some	some	DET
iajs-3400	121	24	glomerular	glomerular	ADJ
iajs-3400	121	25	filtration	filtration	NOUN
iajs-3400	121	26	units	unit	NOUN
iajs-3400	121	27	,	,	PUNCT
iajs-3400	121	28	in	in	ADP
iajs-3400	121	29	addition	addition	NOUN
iajs-3400	121	30	to	to	ADP
iajs-3400	121	31	a	a	DET
iajs-3400	121	32	decrease	decrease	NOUN
iajs-3400	121	33	in	in	ADP
iajs-3400	121	34	gfr	gfr	NOUN
iajs-3400	121	35	to	to	PART
iajs-3400	121	36	precipitate	precipitate	VERB
iajs-3400	121	37	calcium	calcium	NOUN
iajs-3400	121	38	oxalate	oxalate	NOUN
iajs-3400	121	39	crystals	crystal	NOUN
iajs-3400	121	40	,	,	PUNCT
iajs-3400	121	41	which	which	PRON
iajs-3400	121	42	leads	lead	VERB
iajs-3400	121	43	to	to	ADP
iajs-3400	121	44	obstruction	obstruction	NOUN
iajs-3400	121	45	of	of	ADP
iajs-3400	121	46	the	the	DET
iajs-3400	121	47	nephrons	nephron	NOUN
iajs-3400	121	48	and	and	CCONJ
iajs-3400	121	49	thus	thus	ADV
iajs-3400	121	50	increased	increase	VERB
iajs-3400	121	51	acidity	acidity	NOUN
iajs-3400	121	52	that	that	PRON
iajs-3400	121	53	makes	make	VERB
iajs-3400	121	54	the	the	DET
iajs-3400	121	55	urine	urine	NOUN
iajs-3400	121	56	supersaturated	supersaturate	VERB
iajs-3400	121	57	,	,	PUNCT
iajs-3400	121	58	and	and	CCONJ
iajs-3400	121	59	over	over	ADP
iajs-3400	121	60	time	time	NOUN
iajs-3400	121	61	,	,	PUNCT
iajs-3400	121	62	kidney	kidney	NOUN
iajs-3400	121	63	stones	stone	NOUN
iajs-3400	121	64	are	be	AUX
iajs-3400	121	65	formed	form	VERB
iajs-3400	121	66	[	[	X
iajs-3400	121	67	43	43	NUM
iajs-3400	121	68	]	]	PUNCT
iajs-3400	121	69	.	.	PUNCT
iajs-3400	122	1	thus	thus	ADV
iajs-3400	122	2	,	,	PUNCT
iajs-3400	122	3	the	the	DET
iajs-3400	122	4	kidneys	kidney	NOUN
iajs-3400	122	5	are	be	AUX
iajs-3400	122	6	unable	unable	ADJ
iajs-3400	122	7	to	to	PART
iajs-3400	122	8	purify	purify	VERB
iajs-3400	122	9	the	the	DET
iajs-3400	122	10	blood	blood	NOUN
iajs-3400	122	11	and	and	CCONJ
iajs-3400	122	12	excrete	excrete	NOUN
iajs-3400	122	13	waste	waste	NOUN
iajs-3400	122	14	,	,	PUNCT
iajs-3400	122	15	which	which	PRON
iajs-3400	122	16	leads	lead	VERB
iajs-3400	122	17	to	to	ADP
iajs-3400	122	18	the	the	DET
iajs-3400	122	19	accumulation	accumulation	NOUN
iajs-3400	122	20	of	of	ADP
iajs-3400	122	21	toxic	toxic	ADJ
iajs-3400	122	22	chemicals	chemical	NOUN
iajs-3400	122	23	and	and	CCONJ
iajs-3400	122	24	other	other	ADJ
iajs-3400	122	25	waste	waste	NOUN
iajs-3400	122	26	products	product	NOUN
iajs-3400	122	27	in	in	ADP
iajs-3400	122	28	the	the	DET
iajs-3400	122	29	blood	blood	NOUN
iajs-3400	122	30	,	,	PUNCT
iajs-3400	122	31	which	which	PRON
iajs-3400	122	32	leads	lead	VERB
iajs-3400	122	33	to	to	ADP
iajs-3400	122	34	kidney	kidney	NOUN
iajs-3400	122	35	dysfunction	dysfunction	NOUN
iajs-3400	122	36	[	[	X
iajs-3400	122	37	39	39	NUM
iajs-3400	122	38	]	]	PUNCT
iajs-3400	122	39	.	.	PUNCT
iajs-3400	123	1	the	the	DET
iajs-3400	123	2	difference	difference	NOUN
iajs-3400	123	3	in	in	ADP
iajs-3400	123	4	uric	uric	ADJ
iajs-3400	123	5	acid	acid	NOUN
iajs-3400	123	6	levels	level	NOUN
iajs-3400	123	7	between	between	ADP
iajs-3400	123	8	the	the	DET
iajs-3400	123	9	control	control	NOUN
iajs-3400	123	10	group	group	NOUN
iajs-3400	123	11	and	and	CCONJ
iajs-3400	123	12	the	the	DET
iajs-3400	123	13	patient	patient	NOUN
iajs-3400	123	14	group	group	NOUN
iajs-3400	123	15	was	be	AUX
iajs-3400	123	16	not	not	PART
iajs-3400	123	17	significant	significant	ADJ
iajs-3400	123	18	(	(	PUNCT
iajs-3400	123	19	4.45	4.45	NUM
iajs-3400	123	20	±0.19	±0.19	NUM
iajs-3400	123	21	)	)	PUNCT
iajs-3400	123	22	and	and	CCONJ
iajs-3400	123	23	(	(	PUNCT
iajs-3400	123	24	5.16	5.16	NUM
iajs-3400	123	25	±0.48	±0.48	NOUN
iajs-3400	123	26	)	)	PUNCT
iajs-3400	123	27	,	,	PUNCT
iajs-3400	123	28	respectively	respectively	ADV
iajs-3400	123	29	.	.	PUNCT
iajs-3400	124	1	the	the	DET
iajs-3400	124	2	normal	normal	ADJ
iajs-3400	124	3	range	range	NOUN
iajs-3400	124	4	is	be	AUX
iajs-3400	124	5	between	between	ADP
iajs-3400	124	6	2.4	2.4	NUM
iajs-3400	124	7	-	-	SYM
iajs-3400	124	8	6	6	NUM
iajs-3400	124	9	mg	mg	PROPN
iajs-3400	124	10	/	/	SYM
iajs-3400	124	11	dl	dl	PROPN
iajs-3400	124	12	,	,	PUNCT
iajs-3400	124	13	as	as	SCONJ
iajs-3400	124	14	shown	show	VERB
iajs-3400	124	15	in	in	ADP
iajs-3400	124	16	table	table	NOUN
iajs-3400	124	17	4	4	NUM
iajs-3400	124	18	.	.	PUNCT
iajs-3400	125	1	it	it	PRON
iajs-3400	125	2	may	may	AUX
iajs-3400	125	3	be	be	AUX
iajs-3400	125	4	due	due	ADJ
iajs-3400	125	5	to	to	ADP
iajs-3400	125	6	the	the	DET
iajs-3400	125	7	healthy	healthy	ADJ
iajs-3400	125	8	diet	diet	NOUN
iajs-3400	125	9	that	that	PRON
iajs-3400	125	10	contains	contain	VERB
iajs-3400	125	11	mostly	mostly	ADV
iajs-3400	125	12	vegetables	vegetable	NOUN
iajs-3400	125	13	,	,	PUNCT
iajs-3400	125	14	fruits	fruit	NOUN
iajs-3400	125	15	,	,	PUNCT
iajs-3400	125	16	and	and	CCONJ
iajs-3400	125	17	whole	whole	ADJ
iajs-3400	125	18	grains	grain	NOUN
iajs-3400	125	19	that	that	PRON
iajs-3400	125	20	the	the	DET
iajs-3400	125	21	patients	patient	NOUN
iajs-3400	125	22	avoid	avoid	VERB
iajs-3400	125	23	the	the	DET
iajs-3400	125	24	consumption	consumption	NOUN
iajs-3400	125	25	of	of	ADP
iajs-3400	125	26	high	high	ADJ
iajs-3400	125	27	-	-	PUNCT
iajs-3400	125	28	purine	purine	NOUN
iajs-3400	125	29	foods	food	NOUN
iajs-3400	125	30	like	like	ADP
iajs-3400	125	31	red	red	ADJ
iajs-3400	125	32	meat	meat	NOUN
iajs-3400	125	33	and	and	CCONJ
iajs-3400	125	34	alcoholic	alcoholic	ADJ
iajs-3400	125	35	beverages	beverage	NOUN
iajs-3400	125	36	.	.	PUNCT
iajs-3400	126	1	as	as	SCONJ
iajs-3400	126	2	shown	show	VERB
iajs-3400	126	3	in	in	ADP
iajs-3400	126	4	table	table	NOUN
iajs-3400	126	5	4	4	NUM
iajs-3400	126	6	.	.	PUNCT
iajs-3400	127	1	a	a	DET
iajs-3400	127	2	b	b	NOUN
iajs-3400	127	3	ihjpas	ihjpas	PROPN
iajs-3400	127	4	.	.	PUNCT
iajs-3400	128	1	37	37	NUM
iajs-3400	128	2	(	(	PUNCT
iajs-3400	128	3	2	2	NUM
iajs-3400	128	4	)	)	PUNCT
iajs-3400	128	5	2024	2024	NUM
iajs-3400	128	6	162	162	NUM
iajs-3400	128	7	table	table	NOUN
iajs-3400	128	8	4	4	NUM
iajs-3400	128	9	.	.	PUNCT
iajs-3400	128	10	comparison	comparison	NOUN
iajs-3400	128	11	between	between	ADP
iajs-3400	128	12	control	control	NOUN
iajs-3400	128	13	and	and	CCONJ
iajs-3400	128	14	patients	patient	NOUN
iajs-3400	128	15	’	'	PUNCT
iajs-3400	128	16	groups	group	NOUN
iajs-3400	128	17	in	in	ADP
iajs-3400	128	18	uric	uric	ADJ
iajs-3400	128	19	acid	acid	NOUN
iajs-3400	128	20	,	,	PUNCT
iajs-3400	128	21	urea	urea	NOUN
iajs-3400	128	22	and	and	CCONJ
iajs-3400	128	23	creatinine	creatinine	NOUN
iajs-3400	128	24	group	group	NOUN
iajs-3400	128	25	mean	mean	VERB
iajs-3400	128	26	±	±	PROPN
iajs-3400	128	27	se	se	PROPN
iajs-3400	128	28	uric	uric	PROPN
iajs-3400	128	29	acid	acid	PROPN
iajs-3400	128	30	(	(	PUNCT
iajs-3400	128	31	mg	mg	PROPN
iajs-3400	128	32	/	/	SYM
iajs-3400	128	33	dl	dl	PROPN
iajs-3400	128	34	)	)	PUNCT
iajs-3400	128	35	urea	urea	PROPN
iajs-3400	128	36	(	(	PUNCT
iajs-3400	128	37	mg	mg	PROPN
iajs-3400	128	38	/	/	SYM
iajs-3400	128	39	dl	dl	PROPN
iajs-3400	128	40	)	)	PUNCT
iajs-3400	128	41	creatinine	creatinine	NOUN
iajs-3400	128	42	(	(	PUNCT
iajs-3400	128	43	mg	mg	PROPN
iajs-3400	128	44	/	/	SYM
iajs-3400	128	45	dl	dl	PROPN
iajs-3400	128	46	)	)	PUNCT
iajs-3400	128	47	control	control	NOUN
iajs-3400	128	48	4.45	4.45	NUM
iajs-3400	128	49	±0.19	±0.19	SYM
iajs-3400	128	50	15.95	15.95	NUM
iajs-3400	128	51	±0.91	±0.91	NOUN
iajs-3400	128	52	0.721	0.721	NUM
iajs-3400	128	53	±0.04	±0.04	PROPN
iajs-3400	128	54	patients	patient	VERB
iajs-3400	128	55	5.16	5.16	NUM
iajs-3400	128	56	±0.48	±0.48	NOUN
iajs-3400	128	57	31.44	31.44	NUM
iajs-3400	128	58	±2.17	±2.17	PROPN
iajs-3400	128	59	1.29	1.29	NUM
iajs-3400	128	60	±0.11	±0.11	DET
iajs-3400	128	61	t	t	PROPN
iajs-3400	128	62	-	-	PUNCT
iajs-3400	128	63	test	test	NOUN
iajs-3400	128	64	1.289	1.289	NUM
iajs-3400	128	65	ns	ns	NUM
iajs-3400	128	66	5.782	5.782	NUM
iajs-3400	128	67	*	*	PUNCT
iajs-3400	128	68	*	*	NUM
iajs-3400	128	69	0.294	0.294	NUM
iajs-3400	128	70	*	*	PUNCT
iajs-3400	128	71	*	*	PUNCT
iajs-3400	128	72	p	p	X
iajs-3400	128	73	-	-	PUNCT
iajs-3400	128	74	value	value	NOUN
iajs-3400	128	75	0.278	0.278	NUM
iajs-3400	128	76	0.0001	0.0001	NUM
iajs-3400	128	77	0.0001	0.0001	NUM
iajs-3400	128	78	*	*	PUNCT
iajs-3400	128	79	*	*	PUNCT
iajs-3400	128	80	(	(	PUNCT
iajs-3400	128	81	p≤0.01	p≤0.01	NOUN
iajs-3400	128	82	)	)	PUNCT
iajs-3400	128	83	.	.	PUNCT
iajs-3400	129	1	3.1.3	3.1.3	X
iajs-3400	129	2	.	.	PUNCT
iajs-3400	129	3	fasting	fast	VERB
iajs-3400	129	4	blood	blood	NOUN
iajs-3400	129	5	sugar	sugar	NOUN
iajs-3400	129	6	test	test	NOUN
iajs-3400	129	7	fasting	fast	VERB
iajs-3400	129	8	blood	blood	NOUN
iajs-3400	129	9	sugar	sugar	NOUN
iajs-3400	129	10	was	be	AUX
iajs-3400	129	11	tested	test	VERB
iajs-3400	129	12	for	for	ADP
iajs-3400	129	13	both	both	DET
iajs-3400	129	14	patients	patient	NOUN
iajs-3400	129	15	and	and	CCONJ
iajs-3400	129	16	control	control	NOUN
iajs-3400	129	17	groups	group	NOUN
iajs-3400	129	18	because	because	SCONJ
iajs-3400	129	19	patients	patient	NOUN
iajs-3400	129	20	with	with	ADP
iajs-3400	129	21	diabetes	diabetes	NOUN
iajs-3400	129	22	have	have	VERB
iajs-3400	129	23	a	a	DET
iajs-3400	129	24	significantly	significantly	ADV
iajs-3400	129	25	increased	increase	VERB
iajs-3400	129	26	risk	risk	NOUN
iajs-3400	129	27	of	of	ADP
iajs-3400	129	28	developing	develop	VERB
iajs-3400	129	29	kidney	kidney	NOUN
iajs-3400	129	30	stone	stone	NOUN
iajs-3400	129	31	disease	disease	NOUN
iajs-3400	129	32	,	,	PUNCT
iajs-3400	129	33	and	and	CCONJ
iajs-3400	129	34	studies	study	NOUN
iajs-3400	129	35	show	show	VERB
iajs-3400	129	36	a	a	DET
iajs-3400	129	37	significantly	significantly	ADV
iajs-3400	129	38	increased	increase	VERB
iajs-3400	129	39	chance	chance	NOUN
iajs-3400	129	40	of	of	ADP
iajs-3400	129	41	developing	develop	VERB
iajs-3400	129	42	this	this	DET
iajs-3400	129	43	disease	disease	NOUN
iajs-3400	129	44	in	in	ADP
iajs-3400	129	45	patients	patient	NOUN
iajs-3400	129	46	with	with	ADP
iajs-3400	129	47	diabetes	diabetes	NOUN
iajs-3400	129	48	[	[	X
iajs-3400	129	49	44	44	NUM
iajs-3400	129	50	]	]	PUNCT
iajs-3400	129	51	.	.	PUNCT
iajs-3400	130	1	the	the	DET
iajs-3400	130	2	results	result	NOUN
iajs-3400	130	3	showed	show	VERB
iajs-3400	130	4	that	that	SCONJ
iajs-3400	130	5	both	both	DET
iajs-3400	130	6	groups	group	NOUN
iajs-3400	130	7	were	be	AUX
iajs-3400	130	8	in	in	ADP
iajs-3400	130	9	the	the	DET
iajs-3400	130	10	normal	normal	ADJ
iajs-3400	130	11	range	range	NOUN
iajs-3400	130	12	,	,	PUNCT
iajs-3400	130	13	indicating	indicate	VERB
iajs-3400	130	14	that	that	SCONJ
iajs-3400	130	15	they	they	PRON
iajs-3400	130	16	did	do	AUX
iajs-3400	130	17	n’t	not	PART
iajs-3400	130	18	have	have	VERB
iajs-3400	130	19	diabetes	diabetes	NOUN
iajs-3400	130	20	,	,	PUNCT
iajs-3400	130	21	as	as	SCONJ
iajs-3400	130	22	shown	show	VERB
iajs-3400	130	23	in	in	ADP
iajs-3400	130	24	table	table	NOUN
iajs-3400	130	25	5	5	NUM
iajs-3400	130	26	.	.	PUNCT
iajs-3400	130	27	table	table	NOUN
iajs-3400	130	28	5	5	NUM
iajs-3400	130	29	.	.	PUNCT
iajs-3400	131	1	the	the	DET
iajs-3400	131	2	comparison	comparison	NOUN
iajs-3400	131	3	between	between	ADP
iajs-3400	131	4	control	control	NOUN
iajs-3400	131	5	and	and	CCONJ
iajs-3400	131	6	patients	patient	NOUN
iajs-3400	131	7	in	in	ADP
iajs-3400	131	8	f.b.s	f.b.s	ADV
iajs-3400	131	9	group	group	NOUN
iajs-3400	131	10	control	control	NOUN
iajs-3400	131	11	patients	patient	NOUN
iajs-3400	131	12	t	t	NOUN
iajs-3400	131	13	-	-	PUNCT
iajs-3400	131	14	test	test	NOUN
iajs-3400	131	15	p	p	NOUN
iajs-3400	131	16	-	-	PUNCT
iajs-3400	131	17	value	value	NOUN
iajs-3400	131	18	mean	mean	NOUN
iajs-3400	131	19	±	±	NUM
iajs-3400	131	20	se	se	X
iajs-3400	131	21	of	of	ADP
iajs-3400	131	22	f.b.s	f.b.s	ADV
iajs-3400	131	23	(	(	PUNCT
iajs-3400	131	24	mg	mg	PROPN
iajs-3400	131	25	/	/	SYM
iajs-3400	131	26	dl	dl	PROPN
iajs-3400	131	27	)	)	PUNCT
iajs-3400	131	28	84.23	84.23	NUM
iajs-3400	131	29	±	±	NUM
iajs-3400	131	30	4.34	4.34	NUM
iajs-3400	131	31	87.12	87.12	NUM
iajs-3400	131	32	±	±	NUM
iajs-3400	131	33	4.09	4.09	NUM
iajs-3400	131	34	12.485	12.485	NUM
iajs-3400	131	35	ns	ns	NUM
iajs-3400	131	36	0.647	0.647	NUM
iajs-3400	131	37	ns	ns	ADJ
iajs-3400	131	38	:	:	PUNCT
iajs-3400	131	39	non	non	ADJ
iajs-3400	131	40	-	-	ADJ
iajs-3400	131	41	significant	significant	ADJ
iajs-3400	131	42	.	.	PUNCT
iajs-3400	132	1	3.2	3.2	NUM
iajs-3400	132	2	.	.	PUNCT
iajs-3400	133	1	the	the	DET
iajs-3400	133	2	relationship	relationship	NOUN
iajs-3400	133	3	between	between	ADP
iajs-3400	133	4	gender	gender	NOUN
iajs-3400	133	5	and	and	CCONJ
iajs-3400	133	6	the	the	DET
iajs-3400	133	7	patients	patient	NOUN
iajs-3400	133	8	’	’	PART
iajs-3400	133	9	parameters	parameter	NOUN
iajs-3400	133	10	the	the	DET
iajs-3400	133	11	comparison	comparison	NOUN
iajs-3400	133	12	between	between	ADP
iajs-3400	133	13	male	male	ADJ
iajs-3400	133	14	and	and	CCONJ
iajs-3400	133	15	female	female	ADJ
iajs-3400	133	16	samples	sample	NOUN
iajs-3400	133	17	for	for	ADP
iajs-3400	133	18	the	the	DET
iajs-3400	133	19	patients	patient	NOUN
iajs-3400	133	20	’	'	PUNCT
iajs-3400	133	21	group	group	NOUN
iajs-3400	133	22	in	in	ADP
iajs-3400	133	23	uric	uric	ADJ
iajs-3400	133	24	acid	acid	NOUN
iajs-3400	133	25	,	,	PUNCT
iajs-3400	133	26	urea	urea	NOUN
iajs-3400	133	27	,	,	PUNCT
iajs-3400	133	28	f.b.s	f.b.s	ADP
iajs-3400	133	29	.	.	PROPN
iajs-3400	133	30	,	,	PUNCT
iajs-3400	133	31	and	and	CCONJ
iajs-3400	133	32	grgpr	grgpr	NOUN
iajs-3400	133	33	concentrations	concentration	NOUN
iajs-3400	133	34	was	be	AUX
iajs-3400	133	35	non	non	ADJ
iajs-3400	133	36	-	-	ADJ
iajs-3400	133	37	significant	significant	ADJ
iajs-3400	133	38	,	,	PUNCT
iajs-3400	133	39	while	while	SCONJ
iajs-3400	133	40	in	in	ADP
iajs-3400	133	41	creatinine	creatinine	NOUN
iajs-3400	133	42	,	,	PUNCT
iajs-3400	133	43	it	it	PRON
iajs-3400	133	44	was	be	AUX
iajs-3400	133	45	significantly	significantly	ADV
iajs-3400	133	46	higher	high	ADJ
iajs-3400	133	47	in	in	ADP
iajs-3400	133	48	males	male	NOUN
iajs-3400	133	49	than	than	ADP
iajs-3400	133	50	females	female	NOUN
iajs-3400	133	51	,	,	PUNCT
iajs-3400	133	52	as	as	SCONJ
iajs-3400	133	53	shown	show	VERB
iajs-3400	133	54	in	in	ADP
iajs-3400	133	55	table	table	NOUN
iajs-3400	133	56	6	6	NUM
iajs-3400	133	57	.	.	PUNCT
iajs-3400	134	1	men	man	NOUN
iajs-3400	134	2	have	have	VERB
iajs-3400	134	3	a	a	DET
iajs-3400	134	4	higher	high	ADJ
iajs-3400	134	5	percentage	percentage	NOUN
iajs-3400	134	6	of	of	ADP
iajs-3400	134	7	creatinine	creatinine	NOUN
iajs-3400	134	8	in	in	ADP
iajs-3400	134	9	their	their	PRON
iajs-3400	134	10	blood	blood	NOUN
iajs-3400	134	11	,	,	PUNCT
iajs-3400	134	12	which	which	PRON
iajs-3400	134	13	may	may	AUX
iajs-3400	134	14	be	be	AUX
iajs-3400	134	15	due	due	ADJ
iajs-3400	134	16	to	to	ADP
iajs-3400	134	17	having	have	VERB
iajs-3400	134	18	stronger	strong	ADJ
iajs-3400	134	19	skeletal	skeletal	ADJ
iajs-3400	134	20	muscles	muscle	NOUN
iajs-3400	134	21	than	than	ADP
iajs-3400	134	22	women	woman	NOUN
iajs-3400	134	23	,	,	PUNCT
iajs-3400	134	24	or	or	CCONJ
iajs-3400	134	25	it	it	PRON
iajs-3400	134	26	may	may	AUX
iajs-3400	134	27	be	be	AUX
iajs-3400	134	28	due	due	ADJ
iajs-3400	134	29	to	to	ADP
iajs-3400	134	30	eating	eat	VERB
iajs-3400	134	31	more	more	ADJ
iajs-3400	134	32	meat	meat	NOUN
iajs-3400	134	33	and	and	CCONJ
iajs-3400	134	34	protein	protein	NOUN
iajs-3400	134	35	,	,	PUNCT
iajs-3400	134	36	which	which	PRON
iajs-3400	134	37	results	result	VERB
iajs-3400	134	38	in	in	ADP
iajs-3400	134	39	the	the	DET
iajs-3400	134	40	supersaturation	supersaturation	NOUN
iajs-3400	134	41	of	of	ADP
iajs-3400	134	42	uric	uric	ADJ
iajs-3400	134	43	acid	acid	NOUN
iajs-3400	134	44	and	and	CCONJ
iajs-3400	134	45	calcium	calcium	NOUN
iajs-3400	134	46	oxalate	oxalate	NOUN
iajs-3400	134	47	crystals	crystal	NOUN
iajs-3400	134	48	in	in	ADP
iajs-3400	134	49	the	the	DET
iajs-3400	134	50	urine	urine	NOUN
iajs-3400	135	1	[	[	X
iajs-3400	135	2	45	45	NUM
iajs-3400	135	3	]	]	PUNCT
iajs-3400	135	4	.	.	PUNCT
iajs-3400	136	1	table	table	NOUN
iajs-3400	136	2	6	6	NUM
iajs-3400	136	3	.	.	PUNCT
iajs-3400	137	1	the	the	DET
iajs-3400	137	2	relationship	relationship	NOUN
iajs-3400	137	3	between	between	ADP
iajs-3400	137	4	gender	gender	NOUN
iajs-3400	137	5	and	and	CCONJ
iajs-3400	137	6	parameters	parameter	NOUN
iajs-3400	137	7	study	study	NOUN
iajs-3400	137	8	of	of	ADP
iajs-3400	137	9	patients	patient	NOUN
iajs-3400	137	10	gender	gender	NOUN
iajs-3400	137	11	mean	mean	NOUN
iajs-3400	137	12	±	±	PROPN
iajs-3400	137	13	se	se	PROPN
iajs-3400	137	14	f.b.s	f.b.s	PROPN
iajs-3400	137	15	(	(	PUNCT
iajs-3400	137	16	mg	mg	PROPN
iajs-3400	137	17	/	/	SYM
iajs-3400	137	18	dl	dl	NOUN
iajs-3400	137	19	)	)	PUNCT
iajs-3400	137	20	uric	uric	ADJ
iajs-3400	137	21	acid	acid	NOUN
iajs-3400	137	22	(	(	PUNCT
iajs-3400	137	23	mg	mg	PROPN
iajs-3400	137	24	/	/	SYM
iajs-3400	137	25	dl	dl	PROPN
iajs-3400	137	26	)	)	PUNCT
iajs-3400	137	27	urea	urea	PROPN
iajs-3400	137	28	(	(	PUNCT
iajs-3400	137	29	mg	mg	PROPN
iajs-3400	137	30	/	/	SYM
iajs-3400	137	31	dl	dl	NOUN
iajs-3400	137	32	)	)	PUNCT
iajs-3400	137	33	creatinine	creatinine	NOUN
iajs-3400	137	34	(	(	PUNCT
iajs-3400	137	35	mg	mg	PROPN
iajs-3400	137	36	/	/	SYM
iajs-3400	137	37	dl	dl	PROPN
iajs-3400	137	38	)	)	PUNCT
iajs-3400	137	39	grhpr	grhpr	NOUN
iajs-3400	137	40	(	(	PUNCT
iajs-3400	137	41	mg	mg	PROPN
iajs-3400	137	42	/	/	SYM
iajs-3400	137	43	dl	dl	PROPN
iajs-3400	137	44	)	)	PUNCT
iajs-3400	137	45	male	male	NOUN
iajs-3400	137	46	84.08	84.08	NUM
iajs-3400	137	47	±6.25	±6.25	PROPN
iajs-3400	137	48	5.89	5.89	NUM
iajs-3400	137	49	±0.91	±0.91	NOUN
iajs-3400	137	50	34.94	34.94	NUM
iajs-3400	137	51	±4.04	±4.04	PROPN
iajs-3400	137	52	1.554	1.554	NUM
iajs-3400	137	53	±0.18	±0.18	NOUN
iajs-3400	137	54	0.426	0.426	NUM
iajs-3400	137	55	±0.03	±0.03	PROPN
iajs-3400	137	56	female	female	ADJ
iajs-3400	137	57	90.16	90.16	NUM
iajs-3400	137	58	±5.35	±5.35	NOUN
iajs-3400	137	59	4.43	4.43	NUM
iajs-3400	137	60	±0.31	±0.31	PROPN
iajs-3400	137	61	27.93	27.93	NUM
iajs-3400	137	62	±1.40	±1.40	PROPN
iajs-3400	137	63	1.027	1.027	NUM
iajs-3400	137	64	±0.11	±0.11	ADP
iajs-3400	137	65	0.396	0.396	NUM
iajs-3400	137	66	±0.01	±0.01	PROPN
iajs-3400	137	67	t	t	PROPN
iajs-3400	137	68	-	-	PUNCT
iajs-3400	137	69	test	test	NOUN
iajs-3400	137	70	13.72	13.72	NUM
iajs-3400	137	71	ns	ns	NUM
iajs-3400	137	72	1.955	1.955	NUM
iajs-3400	137	73	ns	ns	NUM
iajs-3400	137	74	8.758	8.758	NUM
iajs-3400	137	75	ns	ns	NUM
iajs-3400	137	76	0.409	0.409	NUM
iajs-3400	137	77	*	*	PUNCT
iajs-3400	137	78	0.063	0.063	NUM
iajs-3400	137	79	ns	ns	NUM
iajs-3400	137	80	p	p	NOUN
iajs-3400	137	81	-	-	PUNCT
iajs-3400	137	82	value	value	NOUN
iajs-3400	137	83	0.112	0.112	NUM
iajs-3400	137	84	0.084	0.084	NUM
iajs-3400	137	85	0.187	0.187	NUM
iajs-3400	137	86	0.050	0.050	NUM
iajs-3400	137	87	0.629	0.629	NUM
iajs-3400	137	88	*	*	PUNCT
iajs-3400	137	89	(	(	PUNCT
iajs-3400	137	90	p≤0.05	p≤0.05	NOUN
iajs-3400	137	91	)	)	PUNCT
iajs-3400	137	92	,	,	PUNCT
iajs-3400	137	93	ns	ns	NUM
iajs-3400	137	94	:	:	PUNCT
iajs-3400	137	95	non	non	ADJ
iajs-3400	137	96	-	-	ADJ
iajs-3400	137	97	significant	significant	ADJ
iajs-3400	137	98	.	.	PUNCT
iajs-3400	138	1	3.3	3.3	NUM
iajs-3400	138	2	.	.	PUNCT
iajs-3400	139	1	the	the	DET
iajs-3400	139	2	relationship	relationship	NOUN
iajs-3400	139	3	between	between	ADP
iajs-3400	139	4	age	age	NOUN
iajs-3400	139	5	groups	group	NOUN
iajs-3400	139	6	and	and	CCONJ
iajs-3400	139	7	the	the	DET
iajs-3400	139	8	patient	patient	NOUN
iajs-3400	139	9	’s	’s	PART
iajs-3400	139	10	parameters	parameter	NOUN
iajs-3400	139	11	the	the	DET
iajs-3400	139	12	relationship	relationship	NOUN
iajs-3400	139	13	between	between	ADP
iajs-3400	139	14	the	the	DET
iajs-3400	139	15	age	age	NOUN
iajs-3400	139	16	groups	group	NOUN
iajs-3400	139	17	of	of	ADP
iajs-3400	139	18	the	the	DET
iajs-3400	139	19	patients	patient	NOUN
iajs-3400	139	20	and	and	CCONJ
iajs-3400	139	21	uric	uric	ADJ
iajs-3400	139	22	acid	acid	NOUN
iajs-3400	139	23	,	,	PUNCT
iajs-3400	139	24	creatinine	creatinine	NOUN
iajs-3400	139	25	,	,	PUNCT
iajs-3400	139	26	and	and	CCONJ
iajs-3400	139	27	grhpr	grhpr	ADJ
iajs-3400	139	28	concentration	concentration	NOUN
iajs-3400	139	29	was	be	AUX
iajs-3400	139	30	non	non	ADJ
iajs-3400	139	31	-	-	ADJ
iajs-3400	139	32	significant	significant	ADJ
iajs-3400	139	33	,	,	PUNCT
iajs-3400	139	34	meaning	mean	VERB
iajs-3400	139	35	that	that	SCONJ
iajs-3400	139	36	there	there	PRON
iajs-3400	139	37	were	be	VERB
iajs-3400	139	38	no	no	DET
iajs-3400	139	39	differences	difference	NOUN
iajs-3400	139	40	in	in	ADP
iajs-3400	139	41	the	the	DET
iajs-3400	139	42	results	result	NOUN
iajs-3400	139	43	of	of	ADP
iajs-3400	139	44	the	the	DET
iajs-3400	139	45	tests	test	NOUN
iajs-3400	139	46	according	accord	VERB
iajs-3400	139	47	to	to	ADP
iajs-3400	139	48	age	age	NOUN
iajs-3400	139	49	.	.	PUNCT
iajs-3400	140	1	while	while	SCONJ
iajs-3400	140	2	it	it	PRON
iajs-3400	140	3	was	be	AUX
iajs-3400	140	4	significant	significant	ADJ
iajs-3400	140	5	for	for	ADP
iajs-3400	140	6	urea	urea	NOUN
iajs-3400	140	7	and	and	CCONJ
iajs-3400	140	8	f.b.s	f.b.s	ADJ
iajs-3400	140	9	.	.	PROPN
iajs-3400	140	10	tests	test	NOUN
iajs-3400	140	11	,	,	PUNCT
iajs-3400	140	12	the	the	DET
iajs-3400	140	13	f.b.s	f.b.s	PROPN
iajs-3400	140	14	.	.	PUNCT
iajs-3400	140	15	test	test	NOUN
iajs-3400	140	16	results	result	NOUN
iajs-3400	140	17	showed	show	VERB
iajs-3400	140	18	that	that	SCONJ
iajs-3400	140	19	there	there	PRON
iajs-3400	140	20	were	be	VERB
iajs-3400	140	21	no	no	DET
iajs-3400	140	22	significant	significant	ADJ
iajs-3400	140	23	differences	difference	NOUN
iajs-3400	140	24	between	between	ADP
iajs-3400	140	25	the	the	DET
iajs-3400	140	26	<	<	NOUN
iajs-3400	140	27	30	30	NUM
iajs-3400	140	28	years	year	NOUN
iajs-3400	140	29	and	and	CCONJ
iajs-3400	140	30	30	30	NUM
iajs-3400	140	31	-	-	SYM
iajs-3400	140	32	40	40	NUM
iajs-3400	140	33	years	year	NOUN
iajs-3400	140	34	’	'	PUNCT
iajs-3400	140	35	age	age	NOUN
iajs-3400	140	36	groups	group	NOUN
iajs-3400	140	37	,	,	PUNCT
iajs-3400	140	38	but	but	CCONJ
iajs-3400	140	39	there	there	PRON
iajs-3400	140	40	were	be	VERB
iajs-3400	140	41	significant	significant	ADJ
iajs-3400	140	42	differences	difference	NOUN
iajs-3400	140	43	between	between	ADP
iajs-3400	140	44	these	these	DET
iajs-3400	140	45	two	two	NUM
iajs-3400	140	46	groups	group	NOUN
iajs-3400	140	47	and	and	CCONJ
iajs-3400	140	48	the	the	DET
iajs-3400	140	49	>	>	SYM
iajs-3400	140	50	40	40	NUM
iajs-3400	140	51	years	year	NOUN
iajs-3400	140	52	’	'	PUNCT
iajs-3400	140	53	age	age	NOUN
iajs-3400	140	54	group	group	NOUN
iajs-3400	140	55	as	as	SCONJ
iajs-3400	140	56	diabetes	diabetes	NOUN
iajs-3400	140	57	increased	increase	VERB
iajs-3400	140	58	with	with	ADP
iajs-3400	140	59	age	age	NOUN
iajs-3400	140	60	[	[	X
iajs-3400	140	61	46	46	NUM
iajs-3400	140	62	]	]	PUNCT
iajs-3400	140	63	as	as	SCONJ
iajs-3400	140	64	shown	show	VERB
iajs-3400	140	65	in	in	ADP
iajs-3400	140	66	table	table	NOUN
iajs-3400	140	67	7	7	NUM
iajs-3400	141	1	.	.	PUNCT
iajs-3400	141	2	ihjpas	ihjpas	PROPN
iajs-3400	141	3	.	.	PUNCT
iajs-3400	142	1	37	37	NUM
iajs-3400	142	2	(	(	PUNCT
iajs-3400	142	3	2	2	NUM
iajs-3400	142	4	)	)	PUNCT
iajs-3400	142	5	2024	2024	NUM
iajs-3400	142	6	163	163	NUM
iajs-3400	142	7	table	table	NOUN
iajs-3400	142	8	7	7	NUM
iajs-3400	142	9	.	.	X
iajs-3400	142	10	relationship	relationship	NOUN
iajs-3400	142	11	between	between	ADP
iajs-3400	142	12	age	age	NOUN
iajs-3400	142	13	groups	group	NOUN
iajs-3400	142	14	and	and	CCONJ
iajs-3400	142	15	parameters	parameter	NOUN
iajs-3400	142	16	study	study	NOUN
iajs-3400	142	17	of	of	ADP
iajs-3400	142	18	patients	patient	NOUN
iajs-3400	142	19	age	age	NOUN
iajs-3400	142	20	groups	group	NOUN
iajs-3400	142	21	(	(	PUNCT
iajs-3400	142	22	year	year	NOUN
iajs-3400	142	23	)	)	PUNCT
iajs-3400	142	24	mean	mean	VERB
iajs-3400	142	25	±	±	X
iajs-3400	142	26	se	se	X
iajs-3400	142	27	f.b.s	f.b.s	PROPN
iajs-3400	142	28	(	(	PUNCT
iajs-3400	142	29	mg	mg	PROPN
iajs-3400	142	30	/	/	SYM
iajs-3400	142	31	dl	dl	NOUN
iajs-3400	142	32	)	)	PUNCT
iajs-3400	142	33	uric	uric	ADJ
iajs-3400	142	34	acid	acid	NOUN
iajs-3400	142	35	(	(	PUNCT
iajs-3400	142	36	mg	mg	PROPN
iajs-3400	142	37	/	/	SYM
iajs-3400	142	38	dl	dl	NOUN
iajs-3400	142	39	)	)	PUNCT
iajs-3400	142	40	urea	urea	NOUN
iajs-3400	142	41	(	(	PUNCT
iajs-3400	142	42	mg	mg	PROPN
iajs-3400	142	43	/	/	SYM
iajs-3400	142	44	dl	dl	NOUN
iajs-3400	142	45	)	)	PUNCT
iajs-3400	142	46	creatinine	creatinine	NOUN
iajs-3400	142	47	(	(	PUNCT
iajs-3400	142	48	mg	mg	PROPN
iajs-3400	142	49	/	/	SYM
iajs-3400	142	50	dl	dl	NOUN
iajs-3400	142	51	)	)	PUNCT
iajs-3400	142	52	grhpr	grhpr	NOUN
iajs-3400	142	53	(	(	PUNCT
iajs-3400	142	54	mg	mg	PROPN
iajs-3400	142	55	/	/	SYM
iajs-3400	142	56	dl	dl	NOUN
iajs-3400	142	57	)	)	PUNCT
iajs-3400	142	58	<	<	X
iajs-3400	142	59	30	30	NUM
iajs-3400	142	60	yr	yr	NOUN
iajs-3400	142	61	.	.	NOUN
iajs-3400	143	1	79.10	79.10	NUM
iajs-3400	143	2	±5.56	±5.56	PROPN
iajs-3400	143	3	b	b	PROPN
iajs-3400	143	4	4.29	4.29	NUM
iajs-3400	143	5	±0.47	±0.47	NOUN
iajs-3400	143	6	38.54	38.54	NUM
iajs-3400	143	7	±10.02	±10.02	ADP
iajs-3400	143	8	a	a	DET
iajs-3400	143	9	1.388	1.388	NUM
iajs-3400	143	10	±0.27	±0.27	PROPN
iajs-3400	143	11	0.411	0.411	NUM
iajs-3400	143	12	±0.02	±0.02	PROPN
iajs-3400	143	13	30	30	NUM
iajs-3400	143	14	-	-	SYM
iajs-3400	143	15	40	40	NUM
iajs-3400	143	16	yr	yr	NOUN
iajs-3400	143	17	.	.	PROPN
iajs-3400	143	18	78.60	78.60	NUM
iajs-3400	143	19	±2.68	±2.68	PROPN
iajs-3400	143	20	b	b	PROPN
iajs-3400	143	21	5.89	5.89	NUM
iajs-3400	143	22	±1.14	±1.14	PROPN
iajs-3400	143	23	28.73	28.73	NUM
iajs-3400	143	24	±1.62	±1.62	NOUN
iajs-3400	143	25	b	b	NUM
iajs-3400	143	26	1.149	1.149	NUM
iajs-3400	143	27	±0.18	±0.18	PROPN
iajs-3400	143	28	0.388	0.388	NUM
iajs-3400	143	29	±0.02	±0.02	PROPN
iajs-3400	143	30	>	>	X
iajs-3400	143	31	40	40	NUM
iajs-3400	143	32	yr	yr	NOUN
iajs-3400	143	33	.	.	PROPN
iajs-3400	143	34	99.65	99.65	NUM
iajs-3400	143	35	±8.93	±8.93	PROPN
iajs-3400	143	36	a	a	DET
iajs-3400	143	37	4.86	4.86	NUM
iajs-3400	143	38	±0.34	±0.34	PROPN
iajs-3400	143	39	30.59	30.59	NUM
iajs-3400	143	40	±1.55	±1.55	PROPN
iajs-3400	143	41	ab	ab	PROPN
iajs-3400	143	42	1.385	1.385	NUM
iajs-3400	143	43	±0.16	±0.16	PROPN
iajs-3400	143	44	0.433	0.433	NUM
iajs-3400	143	45	±0.03	±0.03	PROPN
iajs-3400	143	46	lsd	lsd	NOUN
iajs-3400	143	47	value	value	NOUN
iajs-3400	143	48	18.87	18.87	NUM
iajs-3400	143	49	*	*	SYM
iajs-3400	143	50	2.494	2.494	NUM
iajs-3400	143	51	ns	ns	NUM
iajs-3400	143	52	9.081	9.081	NUM
iajs-3400	143	53	*	*	SYM
iajs-3400	143	54	0.533	0.533	NUM
iajs-3400	143	55	ns	ns	NUM
iajs-3400	143	56	0.086	0.086	NUM
iajs-3400	143	57	ns	ns	NUM
iajs-3400	143	58	p	p	NOUN
iajs-3400	143	59	-	-	PUNCT
iajs-3400	143	60	value	value	NOUN
iajs-3400	143	61	0.0435	0.0435	NUM
iajs-3400	143	62	0.440	0.440	NUM
iajs-3400	143	63	0.0495	0.0495	NUM
iajs-3400	143	64	0.534	0.534	NUM
iajs-3400	143	65	0.475	0.475	NUM
iajs-3400	143	66	the	the	DET
iajs-3400	143	67	means	mean	NOUN
iajs-3400	143	68	having	have	VERB
iajs-3400	143	69	different	different	ADJ
iajs-3400	143	70	letters	letter	NOUN
iajs-3400	143	71	in	in	ADP
iajs-3400	143	72	the	the	DET
iajs-3400	143	73	same	same	ADJ
iajs-3400	143	74	column	column	NOUN
iajs-3400	143	75	differed	differ	VERB
iajs-3400	143	76	significantly	significantly	ADV
iajs-3400	143	77	.	.	PUNCT
iajs-3400	144	1	*	*	PUNCT
iajs-3400	144	2	(	(	PUNCT
iajs-3400	144	3	p≤0.05	p≤0.05	NOUN
iajs-3400	144	4	)	)	PUNCT
iajs-3400	144	5	.	.	PUNCT
iajs-3400	145	1	3.4	3.4	NUM
iajs-3400	145	2	.	.	PUNCT
iajs-3400	146	1	the	the	DET
iajs-3400	146	2	relationship	relationship	NOUN
iajs-3400	146	3	between	between	ADP
iajs-3400	146	4	blood	blood	NOUN
iajs-3400	146	5	group	group	NOUN
iajs-3400	146	6	and	and	CCONJ
iajs-3400	146	7	the	the	DET
iajs-3400	146	8	patients	patient	NOUN
iajs-3400	146	9	’	’	PART
iajs-3400	146	10	parameters	parameter	NOUN
iajs-3400	146	11	the	the	DET
iajs-3400	146	12	relationship	relationship	NOUN
iajs-3400	146	13	between	between	ADP
iajs-3400	146	14	the	the	DET
iajs-3400	146	15	blood	blood	NOUN
iajs-3400	146	16	groups	group	NOUN
iajs-3400	146	17	for	for	ADP
iajs-3400	146	18	the	the	DET
iajs-3400	146	19	patients	patient	NOUN
iajs-3400	146	20	in	in	ADP
iajs-3400	146	21	uric	uric	ADJ
iajs-3400	146	22	acid	acid	NOUN
iajs-3400	146	23	,	,	PUNCT
iajs-3400	146	24	urea	urea	NOUN
iajs-3400	146	25	,	,	PUNCT
iajs-3400	146	26	creatinine	creatinine	NOUN
iajs-3400	146	27	,	,	PUNCT
iajs-3400	146	28	fbs	fbs	PROPN
iajs-3400	146	29	,	,	PUNCT
iajs-3400	146	30	and	and	CCONJ
iajs-3400	146	31	grgpr	grgpr	NOUN
iajs-3400	146	32	concentrations	concentration	NOUN
iajs-3400	146	33	was	be	AUX
iajs-3400	146	34	non	non	ADJ
iajs-3400	146	35	-	-	ADJ
iajs-3400	146	36	significant	significant	ADJ
iajs-3400	146	37	because	because	SCONJ
iajs-3400	146	38	these	these	DET
iajs-3400	146	39	parameters	parameter	NOUN
iajs-3400	146	40	were	be	AUX
iajs-3400	146	41	not	not	PART
iajs-3400	146	42	affected	affect	VERB
iajs-3400	146	43	by	by	ADP
iajs-3400	146	44	the	the	DET
iajs-3400	146	45	blood	blood	NOUN
iajs-3400	146	46	group	group	NOUN
iajs-3400	146	47	,	,	PUNCT
iajs-3400	146	48	as	as	SCONJ
iajs-3400	146	49	shown	show	VERB
iajs-3400	146	50	in	in	ADP
iajs-3400	146	51	table	table	NOUN
iajs-3400	146	52	8	8	NUM
iajs-3400	146	53	.	.	PUNCT
iajs-3400	146	54	table	table	NOUN
iajs-3400	146	55	8	8	NUM
iajs-3400	146	56	.	.	PUNCT
iajs-3400	147	1	the	the	DET
iajs-3400	147	2	relationship	relationship	NOUN
iajs-3400	147	3	between	between	ADP
iajs-3400	147	4	blood	blood	NOUN
iajs-3400	147	5	groups	group	NOUN
iajs-3400	147	6	and	and	CCONJ
iajs-3400	147	7	parameters	parameter	NOUN
iajs-3400	147	8	study	study	NOUN
iajs-3400	147	9	of	of	ADP
iajs-3400	147	10	patients	patient	NOUN
iajs-3400	147	11	blood	blood	NOUN
iajs-3400	147	12	groups	group	NOUN
iajs-3400	147	13	mean	mean	VERB
iajs-3400	147	14	±	±	X
iajs-3400	147	15	se	se	X
iajs-3400	147	16	f.b.s	f.b.s	PROPN
iajs-3400	147	17	(	(	PUNCT
iajs-3400	147	18	mg	mg	PROPN
iajs-3400	147	19	/	/	SYM
iajs-3400	147	20	dl	dl	NOUN
iajs-3400	147	21	)	)	PUNCT
iajs-3400	147	22	uric	uric	ADJ
iajs-3400	147	23	acid	acid	NOUN
iajs-3400	147	24	(	(	PUNCT
iajs-3400	147	25	mg	mg	PROPN
iajs-3400	147	26	/	/	SYM
iajs-3400	147	27	dl	dl	NOUN
iajs-3400	147	28	)	)	PUNCT
iajs-3400	147	29	urea	urea	NOUN
iajs-3400	147	30	(	(	PUNCT
iajs-3400	147	31	mg	mg	PROPN
iajs-3400	147	32	/	/	SYM
iajs-3400	147	33	dl	dl	NOUN
iajs-3400	147	34	)	)	PUNCT
iajs-3400	147	35	creatinine	creatinine	NOUN
iajs-3400	147	36	(	(	PUNCT
iajs-3400	147	37	mg	mg	PROPN
iajs-3400	147	38	/	/	SYM
iajs-3400	147	39	dl	dl	NOUN
iajs-3400	147	40	)	)	PUNCT
iajs-3400	147	41	grhpr	grhpr	NOUN
iajs-3400	147	42	(	(	PUNCT
iajs-3400	147	43	mg	mg	PROPN
iajs-3400	147	44	/	/	SYM
iajs-3400	147	45	dl	dl	NOUN
iajs-3400	147	46	)	)	PUNCT
iajs-3400	147	47	a	a	DET
iajs-3400	147	48	96.28	96.28	NUM
iajs-3400	147	49	±20.14	±20.14	PROPN
iajs-3400	147	50	4.66	4.66	NUM
iajs-3400	147	51	±0.35	±0.35	PROPN
iajs-3400	147	52	26.29	26.29	NUM
iajs-3400	147	53	±3.07	±3.07	PROPN
iajs-3400	147	54	2.017	2.017	NUM
iajs-3400	147	55	±0.48	±0.48	NOUN
iajs-3400	147	56	0.448	0.448	NUM
iajs-3400	147	57	±0.07	±0.07	PROPN
iajs-3400	147	58	b	b	NOUN
iajs-3400	147	59	82.63	82.63	NUM
iajs-3400	147	60	±3.52	±3.52	NOUN
iajs-3400	147	61	5.19	5.19	NUM
iajs-3400	147	62	±0.43	±0.43	NOUN
iajs-3400	147	63	37.18	37.18	NUM
iajs-3400	147	64	±8.92	±8.92	PROPN
iajs-3400	147	65	1.138	1.138	NUM
iajs-3400	147	66	±0.25	±0.25	PROPN
iajs-3400	147	67	0346	0346	NUM
iajs-3400	147	68	±0.01	±0.01	NOUN
iajs-3400	147	69	ab	ab	NOUN
iajs-3400	147	70	99.00	99.00	NUM
iajs-3400	147	71	±18.76	±18.76	PROPN
iajs-3400	147	72	4.00	4.00	NUM
iajs-3400	147	73	±0.74	±0.74	PROPN
iajs-3400	147	74	25.43	25.43	NUM
iajs-3400	147	75	±4.04	±4.04	PROPN
iajs-3400	147	76	1.175	1.175	NUM
iajs-3400	147	77	±0.48	±0.48	NOUN
iajs-3400	147	78	0.386	0.386	NUM
iajs-3400	147	79	±0.02	±0.02	NOUN
iajs-3400	147	80	o	o	NOUN
iajs-3400	147	81	84.89	84.89	NUM
iajs-3400	147	82	±4.73	±4.73	PROPN
iajs-3400	147	83	5.43	5.43	NUM
iajs-3400	147	84	±0.84	±0.84	PROPN
iajs-3400	147	85	31.33	31.33	NUM
iajs-3400	147	86	±1.44	±1.44	ADP
iajs-3400	147	87	1.19	1.19	NUM
iajs-3400	147	88	±0.09	±0.09	ADJ
iajs-3400	147	89	0.431	0.431	NUM
iajs-3400	147	90	±0.02	±0.02	NOUN
iajs-3400	147	91	lsd	lsd	NOUN
iajs-3400	147	92	value	value	NOUN
iajs-3400	147	93	ns	ns	NUM
iajs-3400	147	94	ns	ns	NUM
iajs-3400	147	95	ns	ns	NUM
iajs-3400	147	96	ns	ns	NUM
iajs-3400	147	97	ns	ns	NUM
iajs-3400	147	98	p	p	NOUN
iajs-3400	147	99	-	-	PUNCT
iajs-3400	147	100	value	value	NOUN
iajs-3400	147	101	0.601	0.601	NUM
iajs-3400	147	102	0.760	0.760	NUM
iajs-3400	147	103	0.528	0.528	NUM
iajs-3400	147	104	0.113	0.113	NUM
iajs-3400	147	105	0.245	0.245	NUM
iajs-3400	147	106	ns	ns	ADJ
iajs-3400	147	107	:	:	PUNCT
iajs-3400	147	108	non	non	ADJ
iajs-3400	147	109	-	-	ADJ
iajs-3400	147	110	significant	significant	ADJ
iajs-3400	147	111	.	.	PUNCT
iajs-3400	148	1	3.5	3.5	NUM
iajs-3400	148	2	.	.	PUNCT
iajs-3400	149	1	enzyme	enzyme	NOUN
iajs-3400	149	2	linked	link	VERB
iajs-3400	149	3	immunosorbent	immunosorbent	ADJ
iajs-3400	149	4	assay	assay	NOUN
iajs-3400	149	5	for	for	ADP
iajs-3400	149	6	grhpr	grhpr	ADJ
iajs-3400	149	7	the	the	DET
iajs-3400	149	8	concentration	concentration	NOUN
iajs-3400	149	9	of	of	ADP
iajs-3400	149	10	grhpr	grhpr	NOUN
iajs-3400	149	11	was	be	AUX
iajs-3400	149	12	tested	test	VERB
iajs-3400	149	13	for	for	ADP
iajs-3400	149	14	both	both	DET
iajs-3400	149	15	patients	patient	NOUN
iajs-3400	149	16	and	and	CCONJ
iajs-3400	149	17	control	control	NOUN
iajs-3400	149	18	groups	group	NOUN
iajs-3400	149	19	.	.	PUNCT
iajs-3400	150	1	the	the	DET
iajs-3400	150	2	comparison	comparison	NOUN
iajs-3400	150	3	between	between	ADP
iajs-3400	150	4	the	the	DET
iajs-3400	150	5	two	two	NUM
iajs-3400	150	6	groups	group	NOUN
iajs-3400	150	7	was	be	AUX
iajs-3400	150	8	highly	highly	ADV
iajs-3400	150	9	significant	significant	ADJ
iajs-3400	150	10	,	,	PUNCT
iajs-3400	150	11	as	as	SCONJ
iajs-3400	150	12	shown	show	VERB
iajs-3400	150	13	in	in	ADP
iajs-3400	150	14	table	table	NOUN
iajs-3400	150	15	9	9	NUM
iajs-3400	150	16	.	.	PUNCT
iajs-3400	150	17	table	table	NOUN
iajs-3400	150	18	9	9	NUM
iajs-3400	150	19	.	.	PUNCT
iajs-3400	150	20	comparison	comparison	NOUN
iajs-3400	150	21	between	between	ADP
iajs-3400	150	22	control	control	NOUN
iajs-3400	150	23	and	and	CCONJ
iajs-3400	150	24	patients	patient	NOUN
iajs-3400	150	25	in	in	ADP
iajs-3400	150	26	glyoxylate	glyoxylate	NOUN
iajs-3400	150	27	and	and	CCONJ
iajs-3400	150	28	hydroxypyruvate	hydroxypyruvate	ADJ
iajs-3400	150	29	reductase	reductase	NOUN
iajs-3400	150	30	grhpr	grhpr	ADJ
iajs-3400	150	31	enzyme	enzyme	NOUN
iajs-3400	150	32	group	group	NOUN
iajs-3400	150	33	control	control	NOUN
iajs-3400	150	34	patients	patient	NOUN
iajs-3400	150	35	t	t	NOUN
iajs-3400	150	36	-	-	PUNCT
iajs-3400	150	37	test	test	NOUN
iajs-3400	150	38	p	p	NOUN
iajs-3400	150	39	-	-	PUNCT
iajs-3400	150	40	value	value	NOUN
iajs-3400	150	41	mean	mean	NOUN
iajs-3400	150	42	±	±	NUM
iajs-3400	150	43	se	se	X
iajs-3400	150	44	of	of	ADP
iajs-3400	150	45	grhpr	grhpr	ADJ
iajs-3400	150	46	enzyme	enzyme	NOUN
iajs-3400	150	47	(	(	PUNCT
iajs-3400	150	48	mg	mg	PROPN
iajs-3400	150	49	/	/	SYM
iajs-3400	150	50	dl	dl	NOUN
iajs-3400	150	51	)	)	PUNCT
iajs-3400	150	52	4.78	4.78	NUM
iajs-3400	150	53	±	±	NUM
iajs-3400	150	54	1.06	1.06	NUM
iajs-3400	150	55	4.78	4.78	NUM
iajs-3400	150	56	±	±	NUM
iajs-3400	150	57	1.06	1.06	NUM
iajs-3400	150	58	1.639	1.639	NUM
iajs-3400	150	59	*	*	PUNCT
iajs-3400	150	60	*	*	PUNCT
iajs-3400	151	1	0.0001	0.0001	NUM
iajs-3400	151	2	*	*	PUNCT
iajs-3400	151	3	*	*	PUNCT
iajs-3400	151	4	(	(	PUNCT
iajs-3400	151	5	p≤0.01	p≤0.01	NOUN
iajs-3400	151	6	)	)	PUNCT
iajs-3400	151	7	.	.	PUNCT
iajs-3400	152	1	the	the	DET
iajs-3400	152	2	results	result	NOUN
iajs-3400	152	3	showed	show	VERB
iajs-3400	152	4	that	that	SCONJ
iajs-3400	152	5	the	the	DET
iajs-3400	152	6	concentration	concentration	NOUN
iajs-3400	152	7	mean	mean	VERB
iajs-3400	152	8	±	±	NUM
iajs-3400	152	9	se	se	X
iajs-3400	152	10	of	of	ADP
iajs-3400	152	11	the	the	DET
iajs-3400	152	12	controls	control	NOUN
iajs-3400	152	13	was	be	AUX
iajs-3400	152	14	(	(	PUNCT
iajs-3400	152	15	4.78	4.78	NUM
iajs-3400	152	16	±	±	NUM
iajs-3400	152	17	1.06	1.06	NUM
iajs-3400	152	18	)	)	PUNCT
iajs-3400	152	19	while	while	SCONJ
iajs-3400	152	20	the	the	DET
iajs-3400	152	21	concentration	concentration	NOUN
iajs-3400	152	22	of	of	ADP
iajs-3400	152	23	the	the	DET
iajs-3400	152	24	patient	patient	NOUN
iajs-3400	152	25	’s	’s	PART
iajs-3400	152	26	group	group	NOUN
iajs-3400	152	27	was	be	AUX
iajs-3400	152	28	(	(	PUNCT
iajs-3400	152	29	0.411	0.411	NUM
iajs-3400	152	30	±	±	NUM
iajs-3400	152	31	0.02	0.02	NUM
iajs-3400	152	32	)	)	PUNCT
iajs-3400	152	33	.	.	PUNCT
iajs-3400	153	1	for	for	ADP
iajs-3400	153	2	that	that	DET
iajs-3400	153	3	reason	reason	NOUN
iajs-3400	153	4	,	,	PUNCT
iajs-3400	153	5	the	the	DET
iajs-3400	153	6	comparison	comparison	NOUN
iajs-3400	153	7	between	between	ADP
iajs-3400	153	8	the	the	DET
iajs-3400	153	9	two	two	NUM
iajs-3400	153	10	groups	group	NOUN
iajs-3400	153	11	was	be	AUX
iajs-3400	153	12	highly	highly	ADV
iajs-3400	153	13	significant	significant	ADJ
iajs-3400	153	14	,	,	PUNCT
iajs-3400	153	15	thus	thus	ADV
iajs-3400	153	16	the	the	DET
iajs-3400	153	17	patients	patient	NOUN
iajs-3400	153	18	lack	lack	VERB
iajs-3400	153	19	the	the	DET
iajs-3400	153	20	activity	activity	NOUN
iajs-3400	153	21	of	of	ADP
iajs-3400	153	22	this	this	DET
iajs-3400	153	23	enzyme	enzyme	NOUN
iajs-3400	153	24	,	,	PUNCT
iajs-3400	153	25	which	which	PRON
iajs-3400	153	26	agrees	agree	VERB
iajs-3400	153	27	with	with	ADP
iajs-3400	153	28	the	the	DET
iajs-3400	153	29	results	result	NOUN
iajs-3400	153	30	of	of	ADP
iajs-3400	153	31	[	[	X
iajs-3400	153	32	47	47	NUM
iajs-3400	153	33	]	]	PUNCT
iajs-3400	153	34	.	.	PUNCT
iajs-3400	154	1	the	the	DET
iajs-3400	154	2	enzyme	enzyme	NOUN
iajs-3400	154	3	function	function	NOUN
iajs-3400	154	4	is	be	AUX
iajs-3400	154	5	to	to	PART
iajs-3400	154	6	maintain	maintain	VERB
iajs-3400	154	7	the	the	DET
iajs-3400	154	8	concentration	concentration	NOUN
iajs-3400	154	9	levels	level	NOUN
iajs-3400	154	10	of	of	ADP
iajs-3400	154	11	glyoxylate	glyoxylate	NOUN
iajs-3400	154	12	and	and	CCONJ
iajs-3400	154	13	hydroxypyruvate	hydroxypyruvate	NOUN
iajs-3400	154	14	very	very	ADV
iajs-3400	154	15	low	low	ADJ
iajs-3400	154	16	to	to	PART
iajs-3400	154	17	prevent	prevent	VERB
iajs-3400	154	18	oxalate	oxalate	NOUN
iajs-3400	154	19	formation	formation	NOUN
iajs-3400	155	1	[	[	X
iajs-3400	155	2	42	42	NUM
iajs-3400	155	3	]	]	PUNCT
iajs-3400	155	4	.	.	PUNCT
iajs-3400	156	1	it	it	PRON
iajs-3400	156	2	also	also	ADV
iajs-3400	156	3	converts	convert	VERB
iajs-3400	156	4	glyoxylate	glyoxylate	NOUN
iajs-3400	156	5	to	to	PART
iajs-3400	156	6	glycolate	glycolate	VERB
iajs-3400	156	7	,	,	PUNCT
iajs-3400	156	8	and	and	CCONJ
iajs-3400	156	9	in	in	ADP
iajs-3400	156	10	the	the	DET
iajs-3400	156	11	case	case	NOUN
iajs-3400	156	12	of	of	ADP
iajs-3400	156	13	enzyme	enzyme	NOUN
iajs-3400	156	14	deficiency	deficiency	NOUN
iajs-3400	156	15	,	,	PUNCT
iajs-3400	156	16	glyoxylate	glyoxylate	NOUN
iajs-3400	156	17	is	be	AUX
iajs-3400	156	18	oxidized	oxidize	VERB
iajs-3400	156	19	to	to	PART
iajs-3400	156	20	oxalate	oxalate	NOUN
iajs-3400	156	21	by	by	ADP
iajs-3400	156	22	ldh	ldh	PROPN
iajs-3400	157	1	[	[	X
iajs-3400	157	2	48	48	NUM
iajs-3400	157	3	]	]	PUNCT
iajs-3400	157	4	.	.	PUNCT
iajs-3400	158	1	oxalate	oxalate	PROPN
iajs-3400	158	2	combines	combine	VERB
iajs-3400	158	3	with	with	ADP
iajs-3400	158	4	calcium	calcium	NOUN
iajs-3400	158	5	salts	salt	NOUN
iajs-3400	158	6	that	that	PRON
iajs-3400	158	7	are	be	AUX
iajs-3400	158	8	greatly	greatly	ADV
iajs-3400	158	9	insoluble	insoluble	ADJ
iajs-3400	158	10	and	and	CCONJ
iajs-3400	158	11	precipitate	precipitate	NOUN
iajs-3400	158	12	in	in	ADP
iajs-3400	158	13	the	the	DET
iajs-3400	158	14	form	form	NOUN
iajs-3400	158	15	of	of	ADP
iajs-3400	158	16	calcium	calcium	NOUN
iajs-3400	158	17	oxalate	oxalate	NOUN
iajs-3400	158	18	crystals	crystal	NOUN
iajs-3400	158	19	in	in	ADP
iajs-3400	158	20	normal	normal	ADJ
iajs-3400	158	21	ph	ph	ADJ
iajs-3400	158	22	conditions	condition	NOUN
iajs-3400	158	23	,	,	PUNCT
iajs-3400	158	24	and	and	CCONJ
iajs-3400	158	25	eventually	eventually	ADV
iajs-3400	158	26	forming	form	VERB
iajs-3400	158	27	calcium	calcium	NOUN
iajs-3400	158	28	oxalate	oxalate	NOUN
iajs-3400	158	29	stones	stone	NOUN
iajs-3400	158	30	.	.	PUNCT
iajs-3400	159	1	ihjpas	ihjpas	PROPN
iajs-3400	159	2	.	.	PUNCT
iajs-3400	160	1	37	37	NUM
iajs-3400	160	2	(	(	PUNCT
iajs-3400	160	3	2	2	NUM
iajs-3400	160	4	)	)	PUNCT
iajs-3400	160	5	2024	2024	NUM
iajs-3400	160	6	164	164	NUM
iajs-3400	160	7	4	4	NUM
iajs-3400	160	8	.	.	PUNCT
iajs-3400	160	9	conclusion	conclusion	NOUN
iajs-3400	160	10	through	through	ADP
iajs-3400	160	11	this	this	DET
iajs-3400	160	12	study	study	NOUN
iajs-3400	160	13	,	,	PUNCT
iajs-3400	160	14	it	it	PRON
iajs-3400	160	15	was	be	AUX
iajs-3400	160	16	found	find	VERB
iajs-3400	160	17	that	that	SCONJ
iajs-3400	160	18	creatinine	creatinine	NOUN
iajs-3400	160	19	and	and	CCONJ
iajs-3400	160	20	urea	urea	NOUN
iajs-3400	160	21	were	be	AUX
iajs-3400	160	22	high	high	ADJ
iajs-3400	160	23	in	in	ADP
iajs-3400	160	24	the	the	DET
iajs-3400	160	25	patients	patient	NOUN
iajs-3400	160	26	with	with	ADP
iajs-3400	160	27	kidney	kidney	NOUN
iajs-3400	160	28	stones	stone	NOUN
iajs-3400	160	29	of	of	ADP
iajs-3400	160	30	the	the	DET
iajs-3400	160	31	type	type	NOUN
iajs-3400	160	32	of	of	ADP
iajs-3400	160	33	calcium	calcium	NOUN
iajs-3400	160	34	oxalate	oxalate	NOUN
iajs-3400	160	35	compared	compare	VERB
iajs-3400	160	36	to	to	ADP
iajs-3400	160	37	the	the	DET
iajs-3400	160	38	controls	control	NOUN
iajs-3400	160	39	,	,	PUNCT
iajs-3400	160	40	indicating	indicate	VERB
iajs-3400	160	41	that	that	SCONJ
iajs-3400	160	42	they	they	PRON
iajs-3400	160	43	had	have	VERB
iajs-3400	160	44	kidney	kidney	NOUN
iajs-3400	160	45	dysfunction	dysfunction	NOUN
iajs-3400	160	46	.	.	PUNCT
iajs-3400	161	1	the	the	DET
iajs-3400	161	2	concentration	concentration	NOUN
iajs-3400	161	3	of	of	ADP
iajs-3400	161	4	the	the	DET
iajs-3400	161	5	glyoxylate	glyoxylate	NOUN
iajs-3400	161	6	reductase	reductase	NOUN
iajs-3400	161	7	hydroxypyruvate	hydroxypyruvate	NOUN
iajs-3400	161	8	reductase	reductase	NOUN
iajs-3400	161	9	enzyme	enzyme	NOUN
iajs-3400	161	10	that	that	PRON
iajs-3400	161	11	is	be	AUX
iajs-3400	161	12	responsible	responsible	ADJ
iajs-3400	161	13	for	for	ADP
iajs-3400	161	14	the	the	DET
iajs-3400	161	15	conversion	conversion	NOUN
iajs-3400	161	16	of	of	ADP
iajs-3400	161	17	the	the	DET
iajs-3400	161	18	glyoxylate	glyoxylate	NOUN
iajs-3400	161	19	to	to	PART
iajs-3400	161	20	glycolate	glycolate	VERB
iajs-3400	161	21	was	be	AUX
iajs-3400	161	22	also	also	ADV
iajs-3400	161	23	low	low	ADJ
iajs-3400	161	24	in	in	ADP
iajs-3400	161	25	the	the	DET
iajs-3400	161	26	patients	patient	NOUN
iajs-3400	161	27	,	,	PUNCT
iajs-3400	161	28	which	which	PRON
iajs-3400	161	29	may	may	AUX
iajs-3400	161	30	indicate	indicate	VERB
iajs-3400	161	31	that	that	SCONJ
iajs-3400	161	32	calcium	calcium	NOUN
iajs-3400	161	33	oxalate	oxalate	NOUN
iajs-3400	161	34	stones	stone	NOUN
iajs-3400	161	35	were	be	AUX
iajs-3400	161	36	formed	form	VERB
iajs-3400	161	37	as	as	ADP
iajs-3400	161	38	a	a	DET
iajs-3400	161	39	result	result	NOUN
iajs-3400	161	40	of	of	ADP
iajs-3400	161	41	this	this	DET
iajs-3400	161	42	deficiency	deficiency	NOUN
iajs-3400	161	43	,	,	PUNCT
iajs-3400	161	44	which	which	PRON
iajs-3400	161	45	leads	lead	VERB
iajs-3400	161	46	to	to	ADP
iajs-3400	161	47	the	the	DET
iajs-3400	161	48	accumulation	accumulation	NOUN
iajs-3400	161	49	of	of	ADP
iajs-3400	161	50	oxalates	oxalate	NOUN
iajs-3400	161	51	and	and	CCONJ
iajs-3400	161	52	crystals	crystal	NOUN
iajs-3400	161	53	and	and	CCONJ
iajs-3400	161	54	thus	thus	ADV
iajs-3400	161	55	the	the	DET
iajs-3400	161	56	formation	formation	NOUN
iajs-3400	161	57	of	of	ADP
iajs-3400	161	58	kidney	kidney	NOUN
iajs-3400	161	59	stones	stone	NOUN
iajs-3400	161	60	in	in	ADP
iajs-3400	161	61	the	the	DET
iajs-3400	161	62	kidneys	kidney	NOUN
iajs-3400	161	63	.	.	PUNCT
iajs-3400	162	1	acknowledgment	acknowledgment	NOUN
iajs-3400	162	2	the	the	DET
iajs-3400	162	3	authors	author	NOUN
iajs-3400	162	4	thank	thank	VERB
iajs-3400	162	5	the	the	DET
iajs-3400	162	6	staff	staff	NOUN
iajs-3400	162	7	of	of	ADP
iajs-3400	162	8	the	the	DET
iajs-3400	162	9	lithotripsy	lithotripsy	ADJ
iajs-3400	162	10	unit	unit	NOUN
iajs-3400	162	11	at	at	ADP
iajs-3400	162	12	al	al	PROPN
iajs-3400	162	13	karma	karma	PROPN
iajs-3400	162	14	teaching	teach	VERB
iajs-3400	162	15	hospital	hospital	NOUN
iajs-3400	162	16	for	for	ADP
iajs-3400	162	17	their	their	PRON
iajs-3400	162	18	cooperation	cooperation	NOUN
iajs-3400	162	19	and	and	CCONJ
iajs-3400	162	20	help	help	VERB
iajs-3400	162	21	in	in	ADP
iajs-3400	162	22	providing	provide	VERB
iajs-3400	162	23	the	the	DET
iajs-3400	162	24	blood	blood	NOUN
iajs-3400	162	25	samples	sample	NOUN
iajs-3400	162	26	as	as	ADV
iajs-3400	162	27	well	well	ADV
iajs-3400	162	28	as	as	ADP
iajs-3400	162	29	the	the	DET
iajs-3400	162	30	patient	patient	NOUN
iajs-3400	162	31	’s	’s	PART
iajs-3400	162	32	data	datum	NOUN
iajs-3400	162	33	.	.	PUNCT
iajs-3400	163	1	conflict	conflict	NOUN
iajs-3400	163	2	of	of	ADP
iajs-3400	163	3	interest	interest	NOUN
iajs-3400	163	4	the	the	DET
iajs-3400	163	5	authors	author	NOUN
iajs-3400	163	6	declare	declare	VERB
iajs-3400	163	7	that	that	SCONJ
iajs-3400	163	8	they	they	PRON
iajs-3400	163	9	have	have	VERB
iajs-3400	163	10	no	no	DET
iajs-3400	163	11	conflicts	conflict	NOUN
iajs-3400	163	12	of	of	ADP
iajs-3400	163	13	interest	interest	NOUN
iajs-3400	163	14	.	.	PUNCT
iajs-3400	164	1	funding	fund	VERB
iajs-3400	164	2	financial	financial	ADJ
iajs-3400	164	3	support	support	NOUN
iajs-3400	164	4	in	in	ADP
iajs-3400	164	5	preparation	preparation	NOUN
iajs-3400	164	6	for	for	ADP
iajs-3400	164	7	the	the	DET
iajs-3400	164	8	publication	publication	NOUN
iajs-3400	164	9	is	be	AUX
iajs-3400	164	10	funded	fund	VERB
iajs-3400	164	11	by	by	ADP
iajs-3400	164	12	the	the	DET
iajs-3400	164	13	researchers	researcher	NOUN
iajs-3400	164	14	.	.	PUNCT
iajs-3400	165	1	ethical	ethical	ADJ
iajs-3400	165	2	clearance	clearance	NOUN
iajs-3400	165	3	ethics	ethic	NOUN
iajs-3400	165	4	of	of	ADP
iajs-3400	165	5	scientific	scientific	ADJ
iajs-3400	165	6	research	research	NOUN
iajs-3400	165	7	were	be	AUX
iajs-3400	165	8	carried	carry	VERB
iajs-3400	165	9	out	out	ADP
iajs-3400	165	10	in	in	ADP
iajs-3400	165	11	accordance	accordance	NOUN
iajs-3400	165	12	with	with	ADP
iajs-3400	165	13	the	the	DET
iajs-3400	165	14	instructions	instruction	NOUN
iajs-3400	165	15	of	of	ADP
iajs-3400	165	16	the	the	DET
iajs-3400	165	17	iraqi	iraqi	ADJ
iajs-3400	165	18	ministry	ministry	PROPN
iajs-3400	165	19	of	of	ADP
iajs-3400	165	20	health	health	PROPN
iajs-3400	165	21	and	and	CCONJ
iajs-3400	165	22	environment	environment	NOUN
iajs-3400	165	23	.	.	PUNCT
iajs-3400	166	1	references	reference	NOUN
iajs-3400	166	2	1	1	NUM
iajs-3400	166	3	.	.	PUNCT
iajs-3400	167	1	singh	singh	PROPN
iajs-3400	167	2	,	,	PUNCT
iajs-3400	167	3	p.	p.	PROPN
iajs-3400	167	4	;	;	PUNCT
iajs-3400	167	5	harris	harris	PROPN
iajs-3400	167	6	,	,	PUNCT
iajs-3400	167	7	p.c	p.c	PROPN
iajs-3400	167	8	.	.	PROPN
iajs-3400	167	9	;	;	PUNCT
iajs-3400	167	10	sas	sas	PROPN
iajs-3400	167	11	,	,	PUNCT
iajs-3400	167	12	d.j	d.j	PROPN
iajs-3400	167	13	.	.	PROPN
iajs-3400	167	14	;	;	PUNCT
iajs-3400	167	15	lieske	lieske	PROPN
iajs-3400	167	16	,	,	PUNCT
iajs-3400	167	17	j.c	j.c	PROPN
iajs-3400	167	18	.	.	PROPN
iajs-3400	168	1	the	the	DET
iajs-3400	168	2	genetics	genetic	NOUN
iajs-3400	168	3	of	of	ADP
iajs-3400	168	4	kidney	kidney	NOUN
iajs-3400	168	5	stone	stone	NOUN
iajs-3400	168	6	disease	disease	NOUN
iajs-3400	168	7	and	and	CCONJ
iajs-3400	168	8	nephrocalcinosis	nephrocalcinosis	NOUN
iajs-3400	168	9	.	.	PUNCT
iajs-3400	169	1	nature	nature	NOUN
iajs-3400	169	2	reviews	review	VERB
iajs-3400	169	3	nephrology	nephrology	NOUN
iajs-3400	169	4	.	.	PUNCT
iajs-3400	170	1	2022	2022	NUM
iajs-3400	170	2	,	,	PUNCT
iajs-3400	170	3	18	18	NUM
iajs-3400	170	4	,	,	PUNCT
iajs-3400	170	5	224–240	224–240	NUM
iajs-3400	170	6	.	.	PUNCT
iajs-3400	171	1	doi	doi	NOUN
iajs-3400	171	2	:	:	PUNCT
iajs-3400	171	3	https://doi.org/10.3390/healthcare11030424	https://doi.org/10.3390/healthcare11030424	ADJ
iajs-3400	171	4	.	.	NOUN
iajs-3400	172	1	2	2	X
iajs-3400	172	2	.	.	X
iajs-3400	172	3	dobrek	dobrek	PROPN
iajs-3400	172	4	,	,	PUNCT
iajs-3400	172	5	ł	ł	PROPN
iajs-3400	172	6	.	.	PROPN
iajs-3400	172	7	kidney	kidney	PROPN
iajs-3400	172	8	stone	stone	NOUN
iajs-3400	172	9	disease	disease	NOUN
iajs-3400	172	10	with	with	ADP
iajs-3400	172	11	special	special	ADJ
iajs-3400	172	12	regard	regard	NOUN
iajs-3400	172	13	to	to	ADP
iajs-3400	172	14	drug	drug	NOUN
iajs-3400	172	15	-	-	PUNCT
iajs-3400	172	16	induced	induce	VERB
iajs-3400	172	17	kidney	kidney	NOUN
iajs-3400	172	18	stones	stone	NOUN
iajs-3400	172	19	–	–	PUNCT
iajs-3400	172	20	a	a	DET
iajs-3400	172	21	contemporary	contemporary	ADJ
iajs-3400	172	22	synopsis	synopsis	NOUN
iajs-3400	172	23	.	.	PUNCT
iajs-3400	173	1	wiadomości	wiadomości	NOUN
iajs-3400	173	2	lekarskie	lekarskie	PROPN
iajs-3400	173	3	.	.	PUNCT
iajs-3400	174	1	2020	2020	NUM
iajs-3400	174	2	,	,	PUNCT
iajs-3400	174	3	73	73	NUM
iajs-3400	174	4	,	,	PUNCT
iajs-3400	174	5	2031	2031	NUM
iajs-3400	174	6	-	-	SYM
iajs-3400	174	7	2039	2039	NUM
iajs-3400	174	8	.	.	PUNCT
iajs-3400	175	1	doi	doi	NOUN
iajs-3400	175	2	:	:	PUNCT
iajs-3400	175	3	https://doi.org/10.36740/wlek202009226	https://doi.org/10.36740/wlek202009226	PROPN
iajs-3400	175	4	.	.	PUNCT
iajs-3400	176	1	3	3	X
iajs-3400	176	2	.	.	X
iajs-3400	176	3	alelign	alelign	NOUN
iajs-3400	176	4	,	,	PUNCT
iajs-3400	176	5	t.	t.	PROPN
iajs-3400	176	6	;	;	PUNCT
iajs-3400	176	7	petros	petros	PROPN
iajs-3400	176	8	,	,	PUNCT
iajs-3400	176	9	b.	b.	PROPN
iajs-3400	176	10	kidney	kidney	PROPN
iajs-3400	176	11	stone	stone	NOUN
iajs-3400	176	12	disease	disease	NOUN
iajs-3400	176	13	:	:	PUNCT
iajs-3400	176	14	an	an	DET
iajs-3400	176	15	update	update	NOUN
iajs-3400	176	16	on	on	ADP
iajs-3400	176	17	current	current	ADJ
iajs-3400	176	18	concepts	concept	NOUN
iajs-3400	176	19	.	.	PUNCT
iajs-3400	177	1	advances	advance	NOUN
iajs-3400	177	2	in	in	ADP
iajs-3400	177	3	urology	urology	NOUN
iajs-3400	177	4	.	.	PUNCT
iajs-3400	178	1	2018	2018	NUM
iajs-3400	178	2	,	,	PUNCT
iajs-3400	178	3	1	1	NUM
iajs-3400	178	4	-	-	SYM
iajs-3400	178	5	12	12	NUM
iajs-3400	178	6	.	.	PUNCT
iajs-3400	179	1	doi	doi	NOUN
iajs-3400	179	2	:	:	PUNCT
iajs-3400	179	3	https://doi.org/10.1155/2018/3068365	https://doi.org/10.1155/2018/3068365	NOUN
iajs-3400	179	4	.	.	PROPN
iajs-3400	180	1	4	4	X
iajs-3400	180	2	.	.	X
iajs-3400	180	3	rukin	rukin	PROPN
iajs-3400	180	4	,	,	PUNCT
iajs-3400	180	5	n.j	n.j	PROPN
iajs-3400	180	6	.	.	PROPN
iajs-3400	180	7	;	;	PUNCT
iajs-3400	180	8	siddiqui	siddiqui	NOUN
iajs-3400	180	9	,	,	PUNCT
iajs-3400	180	10	z.a	z.a	PROPN
iajs-3400	180	11	.	.	PROPN
iajs-3400	180	12	;	;	PUNCT
iajs-3400	180	13	chedgy	chedgy	PROPN
iajs-3400	180	14	,	,	PUNCT
iajs-3400	180	15	e.c	e.c	PROPN
iajs-3400	180	16	.	.	PROPN
iajs-3400	180	17	;	;	PUNCT
iajs-3400	180	18	somani	somani	PROPN
iajs-3400	180	19	,	,	PUNCT
iajs-3400	180	20	b.k	b.k	PROPN
iajs-3400	180	21	.	.	NOUN
iajs-3400	180	22	trends	trend	NOUN
iajs-3400	180	23	in	in	ADP
iajs-3400	180	24	upper	upper	ADJ
iajs-3400	180	25	tract	tract	NOUN
iajs-3400	180	26	stone	stone	NOUN
iajs-3400	180	27	disease	disease	NOUN
iajs-3400	180	28	in	in	ADP
iajs-3400	180	29	england	england	PROPN
iajs-3400	180	30	:	:	PUNCT
iajs-3400	180	31	evidence	evidence	NOUN
iajs-3400	180	32	from	from	ADP
iajs-3400	180	33	the	the	DET
iajs-3400	180	34	hospital	hospital	NOUN
iajs-3400	180	35	episodes	episode	NOUN
iajs-3400	180	36	statistics	statistic	NOUN
iajs-3400	180	37	database	database	NOUN
iajs-3400	180	38	.	.	PUNCT
iajs-3400	181	1	urologia	urologia	PROPN
iajs-3400	181	2	internationalis	internationalis	PROPN
iajs-3400	181	3	.	.	PUNCT
iajs-3400	182	1	2017	2017	NUM
iajs-3400	182	2	,	,	PUNCT
iajs-3400	182	3	98	98	NUM
iajs-3400	182	4	,	,	PUNCT
iajs-3400	182	5	391	391	NUM
iajs-3400	182	6	-	-	SYM
iajs-3400	182	7	396	396	NUM
iajs-3400	182	8	.	.	PUNCT
iajs-3400	183	1	doi	doi	NOUN
iajs-3400	183	2	:	:	PUNCT
iajs-3400	183	3	https://doi.org/10.1159/000449510	https://doi.org/10.1159/000449510	NUM
iajs-3400	183	4	.	.	X
iajs-3400	184	1	5	5	NUM
iajs-3400	184	2	.	.	NUM
iajs-3400	184	3	moftakhar	moftakhar	PROPN
iajs-3400	184	4	,	,	PUNCT
iajs-3400	184	5	l.	l.	PROPN
iajs-3400	184	6	;	;	PUNCT
iajs-3400	184	7	jafari	jafari	PROPN
iajs-3400	184	8	,	,	PUNCT
iajs-3400	184	9	f.	f.	PROPN
iajs-3400	184	10	;	;	PUNCT
iajs-3400	184	11	ghoddusi	ghoddusi	NOUN
iajs-3400	184	12	johari	johari	PROPN
iajs-3400	184	13	,	,	PUNCT
iajs-3400	184	14	m.	m.	NOUN
iajs-3400	184	15	;	;	PUNCT
iajs-3400	184	16	rezaeianzadeh	rezaeianzadeh	PROPN
iajs-3400	184	17	,	,	PUNCT
iajs-3400	184	18	r.	r.	PROPN
iajs-3400	184	19	;	;	PUNCT
iajs-3400	184	20	hosseini	hosseini	PROPN
iajs-3400	184	21	,	,	PUNCT
iajs-3400	184	22	s.v	s.v	PROPN
iajs-3400	184	23	.	.	PROPN
iajs-3400	184	24	;	;	PUNCT
iajs-3400	185	1	rezaianzadeh	rezaianzadeh	NOUN
iajs-3400	185	2	,	,	PUNCT
iajs-3400	185	3	a.	a.	NOUN
iajs-3400	185	4	prevalence	prevalence	NOUN
iajs-3400	185	5	and	and	CCONJ
iajs-3400	185	6	risk	risk	NOUN
iajs-3400	185	7	factors	factor	NOUN
iajs-3400	185	8	of	of	ADP
iajs-3400	185	9	kidney	kidney	NOUN
iajs-3400	185	10	stone	stone	NOUN
iajs-3400	185	11	disease	disease	NOUN
iajs-3400	185	12	in	in	ADP
iajs-3400	185	13	population	population	NOUN
iajs-3400	185	14	aged	age	VERB
iajs-3400	185	15	40–70	40–70	NUM
iajs-3400	185	16	years	year	NOUN
iajs-3400	185	17	old	old	ADJ
iajs-3400	185	18	in	in	ADP
iajs-3400	185	19	kharameh	kharameh	PROPN
iajs-3400	185	20	cohort	cohort	PROPN
iajs-3400	185	21	study	study	PROPN
iajs-3400	185	22	:	:	PUNCT
iajs-3400	185	23	a	a	DET
iajs-3400	185	24	cross	cross	ADJ
iajs-3400	185	25	-	-	ADJ
iajs-3400	185	26	sectional	sectional	ADJ
iajs-3400	185	27	population	population	NOUN
iajs-3400	185	28	-	-	PUNCT
iajs-3400	185	29	based	base	VERB
iajs-3400	185	30	study	study	NOUN
iajs-3400	185	31	in	in	ADP
iajs-3400	185	32	southern	southern	ADJ
iajs-3400	185	33	iran	iran	PROPN
iajs-3400	185	34	.	.	PUNCT
iajs-3400	186	1	bmc	bmc	ADJ
iajs-3400	186	2	urology	urology	NOUN
iajs-3400	186	3	2022	2022	NUM
iajs-3400	186	4	,	,	PUNCT
iajs-3400	186	5	22	22	NUM
iajs-3400	186	6	,	,	PUNCT
iajs-3400	186	7	1	1	NUM
iajs-3400	186	8	-	-	SYM
iajs-3400	186	9	9	9	NUM
iajs-3400	186	10	.	.	PUNCT
iajs-3400	186	11	doi	doi	NOUN
iajs-3400	186	12	:	:	PUNCT
iajs-3400	186	13	https://doi.org/10.1186/s12894-022-01161-x	https://doi.org/10.1186/s12894-022-01161-x	NOUN
iajs-3400	186	14	.	.	PUNCT
iajs-3400	187	1	6	6	NUM
iajs-3400	187	2	.	.	PUNCT
iajs-3400	187	3	zahirian	zahirian	PROPN
iajs-3400	187	4	moghadam	moghadam	PROPN
iajs-3400	187	5	,	,	PUNCT
iajs-3400	187	6	t.	t.	PROPN
iajs-3400	187	7	;	;	PUNCT
iajs-3400	187	8	pourfarzi	pourfarzi	PROPN
iajs-3400	187	9	,	,	PUNCT
iajs-3400	187	10	f.	f.	PROPN
iajs-3400	187	11	;	;	PUNCT
iajs-3400	187	12	mohseni	mohseni	PROPN
iajs-3400	187	13	rad	rad	PROPN
iajs-3400	187	14	,	,	PUNCT
iajs-3400	187	15	h.	h.	PROPN
iajs-3400	187	16	;	;	PUNCT
iajs-3400	187	17	zandian	zandian	NOUN
iajs-3400	187	18	,	,	PUNCT
iajs-3400	187	19	h.	h.	PROPN
iajs-3400	187	20	kidney	kidney	PROPN
iajs-3400	187	21	stones	stone	NOUN
iajs-3400	187	22	among	among	ADP
iajs-3400	187	23	iranian	iranian	ADJ
iajs-3400	187	24	adults	adult	NOUN
iajs-3400	187	25	:	:	PUNCT
iajs-3400	187	26	prevalence	prevalence	NOUN
iajs-3400	187	27	and	and	CCONJ
iajs-3400	187	28	socioeconomic	socioeconomic	ADJ
iajs-3400	187	29	inequality	inequality	NOUN
iajs-3400	187	30	assessment	assessment	NOUN
iajs-3400	187	31	in	in	ADP
iajs-3400	187	32	a	a	DET
iajs-3400	187	33	cohort‐based	cohort‐based	ADJ
iajs-3400	187	34	cross‐sectional	cross‐sectional	ADJ
iajs-3400	187	35	study	study	NOUN
iajs-3400	187	36	.	.	PUNCT
iajs-3400	188	1	health	health	NOUN
iajs-3400	188	2	science	science	PROPN
iajs-3400	188	3	reports	report	VERB
iajs-3400	189	1	2022	2022	NUM
iajs-3400	189	2	,	,	PUNCT
iajs-3400	189	3	5	5	NUM
iajs-3400	189	4	,	,	PUNCT
iajs-3400	189	5	e877	e877	PROPN
iajs-3400	189	6	.	.	PUNCT
iajs-3400	189	7	doi	doi	PROPN
iajs-3400	189	8	:	:	PUNCT
iajs-3400	189	9	https://doi.org/10.1002/hsr2.877	https://doi.org/10.1002/hsr2.877	PROPN
iajs-3400	189	10	.	.	PROPN
iajs-3400	190	1	7	7	X
iajs-3400	190	2	.	.	X
iajs-3400	190	3	littlejohns	littlejohns	PROPN
iajs-3400	190	4	,	,	PUNCT
iajs-3400	190	5	t.	t.	PROPN
iajs-3400	190	6	j.	j.	PROPN
iajs-3400	190	7	;	;	PUNCT
iajs-3400	190	8	neal	neal	PROPN
iajs-3400	190	9	,	,	PUNCT
iajs-3400	190	10	n.	n.	PROPN
iajs-3400	190	11	l.	l.	PROPN
iajs-3400	190	12	;	;	PUNCT
iajs-3400	190	13	bradbury	bradbury	PROPN
iajs-3400	190	14	,	,	PUNCT
iajs-3400	190	15	k.	k.	PROPN
iajs-3400	190	16	e.	e.	PROPN
iajs-3400	190	17	;	;	PUNCT
iajs-3400	190	18	heers	heer	NOUN
iajs-3400	190	19	,	,	PUNCT
iajs-3400	190	20	h.	h.	PROPN
iajs-3400	190	21	;	;	PUNCT
iajs-3400	190	22	allen	allen	PROPN
iajs-3400	190	23	,	,	PUNCT
iajs-3400	190	24	n.	n.	PROPN
iajs-3400	190	25	e.	e.	PROPN
iajs-3400	190	26	;	;	PUNCT
iajs-3400	190	27	turney	turney	PROPN
iajs-3400	190	28	,	,	PUNCT
iajs-3400	190	29	b.	b.	PROPN
iajs-3400	190	30	w.	w.	PROPN
iajs-3400	190	31	fluid	fluid	PROPN
iajs-3400	190	32	intake	intake	NOUN
iajs-3400	190	33	and	and	CCONJ
iajs-3400	190	34	dietary	dietary	ADJ
iajs-3400	190	35	factors	factor	NOUN
iajs-3400	190	36	and	and	CCONJ
iajs-3400	190	37	the	the	DET
iajs-3400	190	38	risk	risk	NOUN
iajs-3400	190	39	of	of	ADP
iajs-3400	190	40	incident	incident	NOUN
iajs-3400	190	41	kidney	kidney	NOUN
iajs-3400	190	42	stones	stone	NOUN
iajs-3400	190	43	in	in	ADP
iajs-3400	190	44	uk	uk	PROPN
iajs-3400	190	45	biobank	biobank	NOUN
iajs-3400	190	46	:	:	PUNCT
iajs-3400	190	47	a	a	DET
iajs-3400	190	48	population	population	NOUN
iajs-3400	190	49	-	-	PUNCT
iajs-3400	190	50	based	base	VERB
iajs-3400	190	51	prospective	prospective	ADJ
iajs-3400	190	52	cohort	cohort	NOUN
iajs-3400	190	53	study	study	NOUN
iajs-3400	190	54	.	.	PUNCT
iajs-3400	191	1	european	european	ADJ
iajs-3400	191	2	urology	urology	NOUN
iajs-3400	191	3	focus	focus	VERB
iajs-3400	191	4	2022	2022	NUM
iajs-3400	191	5	,	,	PUNCT
iajs-3400	191	6	6	6	NUM
iajs-3400	191	7	,	,	PUNCT
iajs-3400	191	8	752	752	NUM
iajs-3400	191	9	-	-	SYM
iajs-3400	191	10	761	761	NUM
iajs-3400	191	11	.	.	PUNCT
iajs-3400	192	1	doi	doi	NOUN
iajs-3400	192	2	:	:	PUNCT
iajs-3400	192	3	https://doi.org/10.1016/j.euf.2019.05.002	https://doi.org/10.1016/j.euf.2019.05.002	NOUN
iajs-3400	192	4	.	.	PUNCT
iajs-3400	193	1	https://doi.org/10.3390/healthcare11030424	https://doi.org/10.3390/healthcare11030424	PROPN
iajs-3400	193	2	https://doi.org/10.36740/wlek202009226	https://doi.org/10.36740/wlek202009226	PROPN
iajs-3400	193	3	https://doi.org/10.1155/2018/3068365	https://doi.org/10.1155/2018/3068365	PROPN
iajs-3400	193	4	https://doi.org/10.1159/000449510	https://doi.org/10.1159/000449510	PROPN
iajs-3400	193	5	https://doi.org/10.1186/s12894-022-01161-x	https://doi.org/10.1186/s12894-022-01161-x	PROPN
iajs-3400	193	6	https://doi.org/10.1002/hsr2.877	https://doi.org/10.1002/hsr2.877	PROPN
iajs-3400	193	7	https://doi.org/10.1016/j.euf.2019.05.002	https://doi.org/10.1016/j.euf.2019.05.002	NOUN
iajs-3400	193	8	ihjpas	ihjpa	VERB
iajs-3400	193	9	.	.	PUNCT
iajs-3400	194	1	37	37	NUM
iajs-3400	194	2	(	(	PUNCT
iajs-3400	194	3	2	2	NUM
iajs-3400	194	4	)	)	PUNCT
iajs-3400	194	5	2024	2024	NUM
iajs-3400	194	6	165	165	NUM
iajs-3400	194	7	8	8	NUM
iajs-3400	194	8	.	.	PUNCT
iajs-3400	194	9	song	song	PROPN
iajs-3400	194	10	,	,	PUNCT
iajs-3400	194	11	s.	s.	PROPN
iajs-3400	194	12	;	;	PUNCT
iajs-3400	194	13	thomas	thomas	PROPN
iajs-3400	194	14	,	,	PUNCT
iajs-3400	194	15	i.c	i.c	PROPN
iajs-3400	194	16	.	.	PROPN
iajs-3400	194	17	;	;	PUNCT
iajs-3400	194	18	ganesan	ganesan	PROPN
iajs-3400	194	19	,	,	PUNCT
iajs-3400	194	20	c.	c.	PROPN
iajs-3400	194	21	;	;	PUNCT
iajs-3400	194	22	velaer	velaer	PROPN
iajs-3400	194	23	,	,	PUNCT
iajs-3400	194	24	k.n	k.n	PROPN
iajs-3400	194	25	.	.	PROPN
iajs-3400	194	26	;	;	PUNCT
iajs-3400	194	27	chertow	chertow	PROPN
iajs-3400	194	28	,	,	PUNCT
iajs-3400	194	29	g.m	g.m	PROPN
iajs-3400	194	30	.	.	PROPN
iajs-3400	194	31	,	,	PUNCT
iajs-3400	194	32	;	;	PUNCT
iajs-3400	194	33	pao	pao	PROPN
iajs-3400	194	34	,	,	PUNCT
iajs-3400	194	35	a.c	a.c	PROPN
iajs-3400	194	36	.	.	PROPN
iajs-3400	194	37	;	;	PUNCT
iajs-3400	194	38	leppert	leppert	PROPN
iajs-3400	194	39	,	,	PUNCT
iajs-3400	194	40	j.t	j.t	PROPN
iajs-3400	194	41	.	.	PROPN
iajs-3400	194	42	twentyfour	twentyfour	NOUN
iajs-3400	194	43	-	-	PUNCT
iajs-3400	194	44	hour	hour	NOUN
iajs-3400	194	45	urine	urine	NOUN
iajs-3400	194	46	testing	testing	NOUN
iajs-3400	194	47	and	and	CCONJ
iajs-3400	194	48	urinary	urinary	ADJ
iajs-3400	194	49	stone	stone	NOUN
iajs-3400	194	50	disease	disease	NOUN
iajs-3400	194	51	recurrence	recurrence	NOUN
iajs-3400	194	52	in	in	ADP
iajs-3400	194	53	veterans	veteran	NOUN
iajs-3400	194	54	.	.	PUNCT
iajs-3400	195	1	urology	urology	NOUN
iajs-3400	195	2	2022	2022	NUM
iajs-3400	195	3	,	,	PUNCT
iajs-3400	195	4	159	159	NUM
iajs-3400	195	5	,	,	PUNCT
iajs-3400	195	6	33	33	NUM
iajs-3400	195	7	-	-	SYM
iajs-3400	195	8	40	40	NUM
iajs-3400	195	9	.	.	PUNCT
iajs-3400	196	1	doi	doi	NOUN
iajs-3400	196	2	:	:	PUNCT
iajs-3400	196	3	https://doi.org/10.1016/j.urology.2021.10.005	https://doi.org/10.1016/j.urology.2021.10.005	NOUN
iajs-3400	196	4	.	.	PUNCT
iajs-3400	197	1	9	9	X
iajs-3400	197	2	.	.	X
iajs-3400	197	3	lin	lin	PROPN
iajs-3400	197	4	,	,	PUNCT
iajs-3400	197	5	b.b	b.b	PROPN
iajs-3400	197	6	.	.	PROPN
iajs-3400	197	7	;	;	PUNCT
iajs-3400	197	8	lin	lin	PROPN
iajs-3400	197	9	,	,	PUNCT
iajs-3400	197	10	m.e	m.e	PROPN
iajs-3400	197	11	.	.	PROPN
iajs-3400	197	12	;	;	PUNCT
iajs-3400	197	13	huang	huang	PROPN
iajs-3400	197	14	,	,	PUNCT
iajs-3400	197	15	r.h	r.h	PROPN
iajs-3400	197	16	.	.	PROPN
iajs-3400	197	17	;	;	PUNCT
iajs-3400	197	18	hong	hong	PROPN
iajs-3400	197	19	,	,	PUNCT
iajs-3400	197	20	y.k	y.k	PROPN
iajs-3400	197	21	.	.	PROPN
iajs-3400	197	22	;	;	PUNCT
iajs-3400	197	23	lin	lin	PROPN
iajs-3400	197	24	,	,	PUNCT
iajs-3400	197	25	b.l	b.l	PROPN
iajs-3400	197	26	.	.	PROPN
iajs-3400	197	27	;	;	PUNCT
iajs-3400	197	28	he	he	PRON
iajs-3400	197	29	,	,	PUNCT
iajs-3400	197	30	x.j	x.j	PROPN
iajs-3400	197	31	.	.	PUNCT
iajs-3400	197	32	dietary	dietary	ADJ
iajs-3400	197	33	and	and	CCONJ
iajs-3400	197	34	lifestyle	lifestyle	NOUN
iajs-3400	197	35	factors	factor	NOUN
iajs-3400	197	36	for	for	ADP
iajs-3400	197	37	primary	primary	ADJ
iajs-3400	197	38	prevention	prevention	NOUN
iajs-3400	197	39	of	of	ADP
iajs-3400	197	40	nephrolithiasis	nephrolithiasis	NOUN
iajs-3400	197	41	:	:	PUNCT
iajs-3400	197	42	a	a	DET
iajs-3400	197	43	systematic	systematic	ADJ
iajs-3400	197	44	review	review	NOUN
iajs-3400	197	45	and	and	CCONJ
iajs-3400	197	46	meta	meta	ADJ
iajs-3400	197	47	-	-	PUNCT
iajs-3400	197	48	analysis	analysis	NOUN
iajs-3400	197	49	.	.	PUNCT
iajs-3400	198	1	bmc	bmc	ADJ
iajs-3400	198	2	nephrology	nephrology	NOUN
iajs-3400	198	3	2022	2022	NUM
iajs-3400	198	4	,	,	PUNCT
iajs-3400	198	5	21	21	NUM
iajs-3400	198	6	,	,	PUNCT
iajs-3400	198	7	1	1	NUM
iajs-3400	198	8	-	-	SYM
iajs-3400	198	9	13	13	NUM
iajs-3400	198	10	.	.	PUNCT
iajs-3400	199	1	doi	doi	PROPN
iajs-3400	199	2	:	:	PUNCT
iajs-3400	199	3	https://doi.org/10.1186/s12882-020-01925-3	https://doi.org/10.1186/s12882-020-01925-3	PROPN
iajs-3400	199	4	.	.	PUNCT
iajs-3400	200	1	10	10	NUM
iajs-3400	200	2	.	.	PUNCT
iajs-3400	201	1	liu	liu	PROPN
iajs-3400	201	2	,	,	PUNCT
iajs-3400	201	3	y.	y.	PROPN
iajs-3400	201	4	;	;	PUNCT
iajs-3400	201	5	chen	chen	PROPN
iajs-3400	201	6	,	,	PUNCT
iajs-3400	201	7	y.	y.	PROPN
iajs-3400	201	8	;	;	PUNCT
iajs-3400	201	9	liao	liao	PROPN
iajs-3400	201	10	,	,	PUNCT
iajs-3400	201	11	b.	b.	PROPN
iajs-3400	201	12	;	;	PUNCT
iajs-3400	201	13	luo	luo	PROPN
iajs-3400	201	14	,	,	PUNCT
iajs-3400	201	15	d.	d.	PROPN
iajs-3400	201	16	;	;	PUNCT
iajs-3400	201	17	wang	wang	PROPN
iajs-3400	201	18	,	,	PUNCT
iajs-3400	201	19	k.	k.	PROPN
iajs-3400	201	20	;	;	PUNCT
iajs-3400	201	21	li	li	PROPN
iajs-3400	201	22	,	,	PUNCT
iajs-3400	201	23	h.	h.	PROPN
iajs-3400	201	24	;	;	PUNCT
iajs-3400	201	25	zeng	zeng	PROPN
iajs-3400	201	26	,	,	PUNCT
iajs-3400	201	27	g.	g.	PROPN
iajs-3400	201	28	epidemiology	epidemiology	NOUN
iajs-3400	201	29	of	of	ADP
iajs-3400	201	30	urolithiasis	urolithiasis	NOUN
iajs-3400	201	31	in	in	ADP
iajs-3400	201	32	asia	asia	PROPN
iajs-3400	201	33	.	.	PUNCT
iajs-3400	202	1	asian	asian	PROPN
iajs-3400	202	2	journal	journal	PROPN
iajs-3400	202	3	of	of	ADP
iajs-3400	202	4	urology	urology	NOUN
iajs-3400	202	5	2018	2018	NUM
iajs-3400	202	6	,	,	PUNCT
iajs-3400	202	7	5	5	NUM
iajs-3400	202	8	,	,	PUNCT
iajs-3400	202	9	205	205	NUM
iajs-3400	202	10	-	-	SYM
iajs-3400	202	11	214	214	NUM
iajs-3400	202	12	.	.	PUNCT
iajs-3400	203	1	doi	doi	NOUN
iajs-3400	203	2	:	:	PUNCT
iajs-3400	203	3	https://doi.org/10.1016/j.ajur.2018.08.007	https://doi.org/10.1016/j.ajur.2018.08.007	PROPN
iajs-3400	203	4	.	.	PUNCT
iajs-3400	204	1	11	11	NUM
iajs-3400	204	2	.	.	PUNCT
iajs-3400	205	1	wu	wu	PROPN
iajs-3400	205	2	,	,	PUNCT
iajs-3400	205	3	w.	w.	PROPN
iajs-3400	205	4	;	;	PUNCT
iajs-3400	205	5	yang	yang	PROPN
iajs-3400	205	6	,	,	PUNCT
iajs-3400	205	7	d.	d.	PROPN
iajs-3400	205	8	;	;	PUNCT
iajs-3400	205	9	tiselius	tiselius	NOUN
iajs-3400	205	10	,	,	PUNCT
iajs-3400	205	11	h.g	h.g	PROPN
iajs-3400	205	12	.	.	PROPN
iajs-3400	205	13	;	;	PUNCT
iajs-3400	205	14	ou	ou	PROPN
iajs-3400	205	15	,	,	PUNCT
iajs-3400	205	16	l.	l.	PROPN
iajs-3400	205	17	;	;	PUNCT
iajs-3400	205	18	liang	liang	PROPN
iajs-3400	205	19	,	,	PUNCT
iajs-3400	205	20	y.	y.	PROPN
iajs-3400	205	21	;	;	PUNCT
iajs-3400	205	22	zhu	zhu	PROPN
iajs-3400	205	23	,	,	PUNCT
iajs-3400	205	24	h.	h.	PROPN
iajs-3400	205	25	;	;	PUNCT
iajs-3400	205	26	li	li	PROPN
iajs-3400	205	27	,	,	PUNCT
iajs-3400	205	28	s.	s.	PROPN
iajs-3400	205	29	;	;	PUNCT
iajs-3400	205	30	zeng	zeng	PROPN
iajs-3400	205	31	,	,	PUNCT
iajs-3400	205	32	g.	g.	PROPN
iajs-3400	205	33	the	the	DET
iajs-3400	205	34	characteristics	characteristic	NOUN
iajs-3400	205	35	of	of	ADP
iajs-3400	205	36	the	the	DET
iajs-3400	205	37	stone	stone	NOUN
iajs-3400	205	38	and	and	CCONJ
iajs-3400	205	39	urine	urine	NOUN
iajs-3400	205	40	composition	composition	NOUN
iajs-3400	205	41	in	in	ADP
iajs-3400	205	42	chinese	chinese	ADJ
iajs-3400	205	43	stone	stone	NOUN
iajs-3400	205	44	formers	former	NOUN
iajs-3400	205	45	:	:	PUNCT
iajs-3400	205	46	primary	primary	ADJ
iajs-3400	205	47	report	report	NOUN
iajs-3400	205	48	of	of	ADP
iajs-3400	205	49	a	a	DET
iajs-3400	205	50	single	single	ADJ
iajs-3400	205	51	-	-	PUNCT
iajs-3400	205	52	center	center	NOUN
iajs-3400	205	53	results	result	NOUN
iajs-3400	205	54	.	.	PUNCT
iajs-3400	206	1	urology	urology	NOUN
iajs-3400	206	2	2014	2014	NUM
iajs-3400	206	3	,	,	PUNCT
iajs-3400	206	4	83	83	NUM
iajs-3400	206	5	,	,	PUNCT
iajs-3400	206	6	732	732	NUM
iajs-3400	206	7	-	-	SYM
iajs-3400	206	8	737	737	NUM
iajs-3400	206	9	.	.	PUNCT
iajs-3400	207	1	doi	doi	NOUN
iajs-3400	207	2	:	:	PUNCT
iajs-3400	207	3	https://doi.org/10.1016/j.urology.2013.11.012	https://doi.org/10.1016/j.urology.2013.11.012	NOUN
iajs-3400	207	4	.	.	PUNCT
iajs-3400	208	1	12	12	NUM
iajs-3400	208	2	.	.	PUNCT
iajs-3400	209	1	abood	abood	PROPN
iajs-3400	209	2	,	,	PUNCT
iajs-3400	209	3	s.j	s.j	PROPN
iajs-3400	209	4	.	.	PROPN
iajs-3400	209	5	;	;	PUNCT
iajs-3400	209	6	al	al	PROPN
iajs-3400	209	7	hayawi	hayawi	PROPN
iajs-3400	209	8	,	,	PUNCT
iajs-3400	209	9	a.y	a.y	PROPN
iajs-3400	209	10	.	.	PROPN
iajs-3400	209	11	detection	detection	NOUN
iajs-3400	209	12	of	of	ADP
iajs-3400	209	13	agtx	agtx	ADJ
iajs-3400	209	14	gene	gene	NOUN
iajs-3400	209	15	mutations	mutation	NOUN
iajs-3400	209	16	of	of	ADP
iajs-3400	209	17	kidney	kidney	NOUN
iajs-3400	209	18	stone	stone	NOUN
iajs-3400	209	19	patients	patient	NOUN
iajs-3400	209	20	in	in	ADP
iajs-3400	209	21	tikrit	tikrit	NOUN
iajs-3400	209	22	city	city	PROPN
iajs-3400	209	23	,	,	PUNCT
iajs-3400	209	24	iraq	iraq	PROPN
iajs-3400	209	25	.	.	PUNCT
iajs-3400	210	1	annals	annal	NOUN
iajs-3400	210	2	of	of	ADP
iajs-3400	210	3	tropical	tropical	ADJ
iajs-3400	210	4	medicine	medicine	NOUN
iajs-3400	210	5	and	and	CCONJ
iajs-3400	210	6	public	public	ADJ
iajs-3400	210	7	health	health	NOUN
iajs-3400	210	8	2019	2019	NUM
iajs-3400	210	9	,	,	PUNCT
iajs-3400	210	10	22	22	NUM
iajs-3400	210	11	.	.	PUNCT
iajs-3400	211	1	doi	doi	NOUN
iajs-3400	211	2	:	:	PUNCT
iajs-3400	211	3	http://doi.org/10.36295/asro.2019.22067	http://doi.org/10.36295/asro.2019.22067	PROPN
iajs-3400	211	4	.	.	PROPN
iajs-3400	211	5	13	13	NUM
iajs-3400	211	6	.	.	PUNCT
iajs-3400	212	1	esmail	esmail	PROPN
iajs-3400	212	2	,	,	PUNCT
iajs-3400	212	3	a.o	a.o	PROPN
iajs-3400	212	4	.	.	PROPN
iajs-3400	212	5	;	;	PUNCT
iajs-3400	212	6	qadir	qadir	PROPN
iajs-3400	212	7	,	,	PUNCT
iajs-3400	212	8	b.	b.	PROPN
iajs-3400	212	9	a.	a.	PROPN
iajs-3400	212	10	;	;	PUNCT
iajs-3400	213	1	hamad	hamad	PROPN
iajs-3400	213	2	,	,	PUNCT
iajs-3400	213	3	h.	h.	PROPN
iajs-3400	213	4	q.	q.	PROPN
iajs-3400	213	5	effect	effect	NOUN
iajs-3400	213	6	of	of	ADP
iajs-3400	213	7	drinking	drink	VERB
iajs-3400	213	8	water	water	NOUN
iajs-3400	213	9	hardness	hardness	ADV
iajs-3400	213	10	on	on	ADP
iajs-3400	213	11	kidney	kidney	NOUN
iajs-3400	213	12	stones	stone	NOUN
iajs-3400	213	13	formation	formation	NOUN
iajs-3400	213	14	in	in	ADP
iajs-3400	213	15	ranya	ranya	NOUN
iajs-3400	213	16	district	district	NOUN
iajs-3400	213	17	.	.	PUNCT
iajs-3400	214	1	cihan	cihan	VERB
iajs-3400	214	2	university	university	NOUN
iajs-3400	214	3	-	-	PUNCT
iajs-3400	214	4	erbil	erbil	PROPN
iajs-3400	214	5	scientific	scientific	ADJ
iajs-3400	214	6	journal	journal	NOUN
iajs-3400	214	7	2022	2022	NUM
iajs-3400	214	8	,	,	PUNCT
iajs-3400	214	9	4	4	NUM
iajs-3400	214	10	,	,	PUNCT
iajs-3400	214	11	1	1	NUM
iajs-3400	214	12	-	-	SYM
iajs-3400	214	13	6	6	NUM
iajs-3400	214	14	.	.	PUNCT
iajs-3400	215	1	doi	doi	NOUN
iajs-3400	215	2	:	:	PUNCT
iajs-3400	215	3	http://doi.org/10.24086/cuesj.v4n1y2020.pp1-6	http://doi.org/10.24086/cuesj.v4n1y2020.pp1-6	NOUN
iajs-3400	215	4	.	.	NOUN
iajs-3400	215	5	14	14	NUM
iajs-3400	215	6	.	.	PUNCT
iajs-3400	216	1	khalili	khalili	PROPN
iajs-3400	216	2	,	,	PUNCT
iajs-3400	216	3	p.	p.	PROPN
iajs-3400	216	4	;	;	PUNCT
iajs-3400	216	5	jamali	jamali	PROPN
iajs-3400	216	6	,	,	PUNCT
iajs-3400	216	7	z.	z.	PROPN
iajs-3400	216	8	;	;	PUNCT
iajs-3400	216	9	sadeghi	sadeghi	PROPN
iajs-3400	216	10	,	,	PUNCT
iajs-3400	216	11	t.	t.	PROPN
iajs-3400	216	12	;	;	PUNCT
iajs-3400	216	13	esmaeili	esmaeili	NOUN
iajs-3400	216	14	-	-	PUNCT
iajs-3400	216	15	nadimi	nadimi	PROPN
iajs-3400	216	16	,	,	PUNCT
iajs-3400	216	17	a.	a.	NOUN
iajs-3400	216	18	;	;	PUNCT
iajs-3400	216	19	mohamadi	mohamadi	NOUN
iajs-3400	216	20	,	,	PUNCT
iajs-3400	216	21	m.	m.	NOUN
iajs-3400	216	22	;	;	PUNCT
iajs-3400	216	23	moghadam	moghadam	PROPN
iajs-3400	216	24	-	-	PUNCT
iajs-3400	216	25	ahmadi	ahmadi	PROPN
iajs-3400	216	26	,	,	PUNCT
iajs-3400	216	27	a.	a.	NOUN
iajs-3400	216	28	;	;	PUNCT
iajs-3400	216	29	ayoobi	ayoobi	PROPN
iajs-3400	216	30	,	,	PUNCT
iajs-3400	216	31	f.	f.	PROPN
iajs-3400	216	32	;	;	PUNCT
iajs-3400	216	33	nazari	nazari	PROPN
iajs-3400	216	34	,	,	PUNCT
iajs-3400	216	35	a.	a.	NOUN
iajs-3400	216	36	risk	risk	NOUN
iajs-3400	216	37	factors	factor	NOUN
iajs-3400	216	38	of	of	ADP
iajs-3400	216	39	kidney	kidney	NOUN
iajs-3400	216	40	stone	stone	NOUN
iajs-3400	216	41	disease	disease	NOUN
iajs-3400	216	42	:	:	PUNCT
iajs-3400	216	43	a	a	DET
iajs-3400	216	44	cross	cross	ADJ
iajs-3400	216	45	-	-	ADJ
iajs-3400	216	46	sectional	sectional	ADJ
iajs-3400	216	47	study	study	NOUN
iajs-3400	216	48	in	in	ADP
iajs-3400	216	49	the	the	DET
iajs-3400	216	50	southeast	southeast	NOUN
iajs-3400	216	51	of	of	ADP
iajs-3400	216	52	iran	iran	PROPN
iajs-3400	216	53	.	.	PUNCT
iajs-3400	217	1	bmc	bmc	PROPN
iajs-3400	217	2	urology	urology	NOUN
iajs-3400	217	3	2021	2021	NUM
iajs-3400	217	4	,	,	PUNCT
iajs-3400	217	5	21	21	NUM
iajs-3400	217	6	,	,	PUNCT
iajs-3400	217	7	1	1	NUM
iajs-3400	217	8	-	-	SYM
iajs-3400	217	9	8	8	NUM
iajs-3400	217	10	.	.	PUNCT
iajs-3400	217	11	doi	doi	NOUN
iajs-3400	217	12	:	:	PUNCT
iajs-3400	217	13	https://doi.org/10.1186/s12894-021-00905-5	https://doi.org/10.1186/s12894-021-00905-5	NUM
iajs-3400	217	14	15	15	NUM
iajs-3400	217	15	.	.	PUNCT
iajs-3400	218	1	shahidi	shahidi	PROPN
iajs-3400	218	2	,	,	PUNCT
iajs-3400	218	3	s.	s.	PROPN
iajs-3400	218	4	;	;	PUNCT
iajs-3400	218	5	dolatkhah	dolatkhah	PROPN
iajs-3400	218	6	,	,	PUNCT
iajs-3400	218	7	s.	s.	PROPN
iajs-3400	218	8	;	;	PUNCT
iajs-3400	218	9	mortazavi	mortazavi	VERB
iajs-3400	218	10	,	,	PUNCT
iajs-3400	218	11	m.	m.	NOUN
iajs-3400	218	12	;	;	PUNCT
iajs-3400	218	13	atapour	atapour	PROPN
iajs-3400	218	14	,	,	PUNCT
iajs-3400	218	15	a.	a.	NOUN
iajs-3400	218	16	;	;	PUNCT
iajs-3400	218	17	aghaaliakbari	aghaaliakbari	PROPN
iajs-3400	218	18	,	,	PUNCT
iajs-3400	218	19	f.	f.	PROPN
iajs-3400	218	20	;	;	PUNCT
iajs-3400	218	21	meamar	meamar	PROPN
iajs-3400	218	22	,	,	PUNCT
iajs-3400	218	23	r.	r.	PROPN
iajs-3400	218	24	;	;	PUNCT
iajs-3400	218	25	badri	badri	PROPN
iajs-3400	218	26	,	,	PUNCT
iajs-3400	218	27	m.	m.	NOUN
iajs-3400	218	28	taheri	taheri	PROPN
iajs-3400	218	29	,	,	PUNCT
iajs-3400	218	30	d.	d.	PROPN
iajs-3400	218	31	an	an	DET
iajs-3400	218	32	epidemiological	epidemiological	ADJ
iajs-3400	218	33	survey	survey	NOUN
iajs-3400	218	34	on	on	ADP
iajs-3400	218	35	kidney	kidney	NOUN
iajs-3400	218	36	stones	stone	NOUN
iajs-3400	218	37	and	and	CCONJ
iajs-3400	218	38	related	relate	VERB
iajs-3400	218	39	risk	risk	NOUN
iajs-3400	218	40	factors	factor	NOUN
iajs-3400	218	41	in	in	ADP
iajs-3400	218	42	the	the	DET
iajs-3400	218	43	iranian	iranian	ADJ
iajs-3400	218	44	community	community	NOUN
iajs-3400	218	45	.	.	PUNCT
iajs-3400	219	1	acta	acta	PROPN
iajs-3400	219	2	medica	medica	PROPN
iajs-3400	219	3	iranica	iranica	PROPN
iajs-3400	219	4	2022	2022	NUM
iajs-3400	219	5	,	,	PUNCT
iajs-3400	219	6	60	60	NUM
iajs-3400	219	7	,	,	PUNCT
iajs-3400	219	8	307	307	NUM
iajs-3400	219	9	.	.	PUNCT
iajs-3400	220	1	doi	doi	NOUN
iajs-3400	220	2	:	:	PUNCT
iajs-3400	220	3	https://doi.org/10.18502/acta.v60i5.9558	https://doi.org/10.18502/acta.v60i5.9558	NUM
iajs-3400	220	4	.	.	PUNCT
iajs-3400	221	1	16	16	NUM
iajs-3400	221	2	.	.	PUNCT
iajs-3400	221	3	dibianco	dibianco	PROPN
iajs-3400	221	4	,	,	PUNCT
iajs-3400	221	5	j.	j.	PROPN
iajs-3400	221	6	m.	m.	PROPN
iajs-3400	221	7	;	;	PUNCT
iajs-3400	221	8	jarrett	jarrett	PROPN
iajs-3400	221	9	,	,	PUNCT
iajs-3400	221	10	t.	t.	PROPN
iajs-3400	221	11	w.	w.	PROPN
iajs-3400	221	12	;	;	PUNCT
iajs-3400	221	13	mufarrij	mufarrij	PROPN
iajs-3400	221	14	,	,	PUNCT
iajs-3400	221	15	p.	p.	NOUN
iajs-3400	221	16	metabolic	metabolic	NOUN
iajs-3400	221	17	syndrome	syndrome	PROPN
iajs-3400	221	18	and	and	CCONJ
iajs-3400	221	19	nephrolithiasis	nephrolithiasis	NOUN
iajs-3400	221	20	risk	risk	NOUN
iajs-3400	221	21	:	:	PUNCT
iajs-3400	221	22	should	should	AUX
iajs-3400	221	23	the	the	DET
iajs-3400	221	24	medical	medical	ADJ
iajs-3400	221	25	management	management	NOUN
iajs-3400	221	26	of	of	ADP
iajs-3400	221	27	nephrolithiasis	nephrolithiasis	NOUN
iajs-3400	221	28	include	include	VERB
iajs-3400	221	29	the	the	DET
iajs-3400	221	30	treatment	treatment	NOUN
iajs-3400	221	31	of	of	ADP
iajs-3400	221	32	metabolic	metabolic	NOUN
iajs-3400	221	33	syndrome	syndrome	NOUN
iajs-3400	221	34	?	?	PUNCT
iajs-3400	222	1	reviews	review	NOUN
iajs-3400	222	2	in	in	ADP
iajs-3400	222	3	urology	urology	NOUN
iajs-3400	222	4	2015	2015	NUM
iajs-3400	222	5	,	,	PUNCT
iajs-3400	222	6	17	17	NUM
iajs-3400	222	7	,	,	PUNCT
iajs-3400	222	8	117	117	NUM
iajs-3400	222	9	.	.	PUNCT
iajs-3400	223	1	doi	doi	NOUN
iajs-3400	223	2	:	:	PUNCT
iajs-3400	223	3	https://doi.org/10.3909/riu0650	https://doi.org/10.3909/riu0650	NOUN
iajs-3400	223	4	.	.	PUNCT
iajs-3400	224	1	17	17	NUM
iajs-3400	224	2	.	.	PUNCT
iajs-3400	225	1	baatiah	baatiah	PROPN
iajs-3400	225	2	,	,	PUNCT
iajs-3400	225	3	n.y	n.y	PROPN
iajs-3400	225	4	.	.	PROPN
iajs-3400	225	5	;	;	PUNCT
iajs-3400	225	6	alhazmi	alhazmi	PROPN
iajs-3400	225	7	,	,	PUNCT
iajs-3400	225	8	r.b	r.b	PROPN
iajs-3400	225	9	.	.	PROPN
iajs-3400	225	10	;	;	PUNCT
iajs-3400	225	11	albathi	albathi	ADV
iajs-3400	225	12	,	,	PUNCT
iajs-3400	225	13	f.a	f.a	PROPN
iajs-3400	225	14	.	.	PROPN
iajs-3400	225	15	;	;	PUNCT
iajs-3400	225	16	albogami	albogami	ADJ
iajs-3400	225	17	,	,	PUNCT
iajs-3400	225	18	e.g.	e.g.	ADV
iajs-3400	225	19	;	;	PUNCT
iajs-3400	225	20	mohammedkhalil	mohammedkhalil	NUM
iajs-3400	225	21	,	,	PUNCT
iajs-3400	225	22	a.k	a.k	PROPN
iajs-3400	225	23	.	.	PROPN
iajs-3400	225	24	;	;	PUNCT
iajs-3400	225	25	alsaywid	alsaywid	NOUN
iajs-3400	225	26	,	,	PUNCT
iajs-3400	226	1	b.s	b.s	PROPN
iajs-3400	226	2	.	.	PROPN
iajs-3400	226	3	urolithiasis	urolithiasis	NOUN
iajs-3400	226	4	:	:	PUNCT
iajs-3400	227	1	prevalence	prevalence	NOUN
iajs-3400	227	2	,	,	PUNCT
iajs-3400	227	3	risk	risk	NOUN
iajs-3400	227	4	factors	factor	NOUN
iajs-3400	227	5	,	,	PUNCT
iajs-3400	227	6	and	and	CCONJ
iajs-3400	227	7	public	public	ADJ
iajs-3400	227	8	awareness	awareness	NOUN
iajs-3400	227	9	regarding	regard	VERB
iajs-3400	227	10	dietary	dietary	ADJ
iajs-3400	227	11	and	and	CCONJ
iajs-3400	227	12	lifestyle	lifestyle	NOUN
iajs-3400	227	13	habits	habit	NOUN
iajs-3400	227	14	in	in	ADP
iajs-3400	227	15	jeddah	jeddah	PROPN
iajs-3400	227	16	,	,	PUNCT
iajs-3400	227	17	saudi	saudi	PROPN
iajs-3400	227	18	arabia	arabia	PROPN
iajs-3400	227	19	in	in	ADP
iajs-3400	227	20	2017	2017	NUM
iajs-3400	227	21	.	.	PUNCT
iajs-3400	228	1	urology	urology	NOUN
iajs-3400	228	2	annals	annal	NOUN
iajs-3400	228	3	2020	2020	NUM
iajs-3400	228	4	,	,	PUNCT
iajs-3400	228	5	12	12	NUM
iajs-3400	228	6	,	,	PUNCT
iajs-3400	228	7	57	57	NUM
iajs-3400	228	8	.	.	PUNCT
iajs-3400	229	1	doi	doi	NOUN
iajs-3400	229	2	:	:	PUNCT
iajs-3400	229	3	https://doi.org/10.4103/ua.ua_13_19	https://doi.org/10.4103/ua.ua_13_19	PROPN
iajs-3400	229	4	.	.	PROPN
iajs-3400	230	1	18	18	NUM
iajs-3400	230	2	.	.	X
iajs-3400	230	3	curhan	curhan	PROPN
iajs-3400	230	4	,	,	PUNCT
iajs-3400	230	5	g.	g.	PROPN
iajs-3400	230	6	c.	c.	PROPN
iajs-3400	230	7	epidemiology	epidemiology	PROPN
iajs-3400	230	8	of	of	ADP
iajs-3400	230	9	stone	stone	NOUN
iajs-3400	230	10	disease	disease	NOUN
iajs-3400	230	11	.	.	PUNCT
iajs-3400	231	1	urologic	urologic	ADJ
iajs-3400	231	2	clinics	clinic	NOUN
iajs-3400	231	3	of	of	ADP
iajs-3400	231	4	north	north	PROPN
iajs-3400	231	5	america	america	PROPN
iajs-3400	231	6	2007	2007	NUM
iajs-3400	231	7	,	,	PUNCT
iajs-3400	231	8	34	34	NUM
iajs-3400	231	9	,	,	PUNCT
iajs-3400	231	10	287	287	NUM
iajs-3400	231	11	-	-	SYM
iajs-3400	231	12	293	293	NUM
iajs-3400	231	13	.	.	PUNCT
iajs-3400	232	1	doi	doi	NOUN
iajs-3400	232	2	:	:	PUNCT
iajs-3400	232	3	https://doi.org/10.1016/j.ucl.2007.04.003	https://doi.org/10.1016/j.ucl.2007.04.003	NOUN
iajs-3400	232	4	.	.	PROPN
iajs-3400	232	5	19	19	NUM
iajs-3400	232	6	.	.	PUNCT
iajs-3400	233	1	mehrsai	mehrsai	PROPN
iajs-3400	233	2	,	,	PUNCT
iajs-3400	233	3	a.	a.	PROPN
iajs-3400	233	4	;	;	PUNCT
iajs-3400	233	5	naeini	naeini	PROPN
iajs-3400	233	6	,	,	PUNCT
iajs-3400	233	7	h.e	h.e	PROPN
iajs-3400	233	8	.	.	PROPN
iajs-3400	233	9	;	;	PUNCT
iajs-3400	233	10	tehrani	tehrani	PROPN
iajs-3400	233	11	,	,	PUNCT
iajs-3400	233	12	d.f	d.f	PROPN
iajs-3400	233	13	.	.	PROPN
iajs-3400	233	14	;	;	PUNCT
iajs-3400	233	15	jalayani	jalayani	PROPN
iajs-3400	233	16	,	,	PUNCT
iajs-3400	233	17	k.n	k.n	PROPN
iajs-3400	233	18	.	.	PROPN
iajs-3400	233	19	impact	impact	NOUN
iajs-3400	233	20	of	of	ADP
iajs-3400	233	21	bone	bone	NOUN
iajs-3400	233	22	mineral	mineral	NOUN
iajs-3400	233	23	density	density	NOUN
iajs-3400	233	24	on	on	ADP
iajs-3400	233	25	the	the	DET
iajs-3400	233	26	recurrent	recurrent	ADJ
iajs-3400	233	27	urolithiasis	urolithiasis	NOUN
iajs-3400	233	28	.	.	PUNCT
iajs-3400	234	1	translational	translational	ADJ
iajs-3400	234	2	research	research	NOUN
iajs-3400	234	3	in	in	ADP
iajs-3400	234	4	urology	urology	NOUN
iajs-3400	234	5	.	.	PUNCT
iajs-3400	235	1	2019	2019	NUM
iajs-3400	235	2	,	,	PUNCT
iajs-3400	235	3	12–16	12–16	NUM
iajs-3400	235	4	.	.	PUNCT
iajs-3400	235	5	doi	doi	NOUN
iajs-3400	235	6	:	:	PUNCT
iajs-3400	235	7	https://doi.org/10.22034/au.2020.227228.1014	https://doi.org/10.22034/au.2020.227228.1014	PROPN
iajs-3400	235	8	.	.	PROPN
iajs-3400	235	9	20	20	NUM
iajs-3400	235	10	.	.	PUNCT
iajs-3400	236	1	espinosa	espinosa	PROPN
iajs-3400	236	2	-	-	PUNCT
iajs-3400	236	3	ortiz	ortiz	PROPN
iajs-3400	236	4	,	,	PUNCT
iajs-3400	236	5	e.j	e.j	PROPN
iajs-3400	236	6	.	.	PROPN
iajs-3400	236	7	;	;	PUNCT
iajs-3400	236	8	eisner	eisner	PROPN
iajs-3400	236	9	,	,	PUNCT
iajs-3400	236	10	b.	b.	PROPN
iajs-3400	236	11	;	;	PUNCT
iajs-3400	236	12	h.	h.	PROPN
iajs-3400	236	13	;	;	PUNCT
iajs-3400	236	14	lange	lange	PROPN
iajs-3400	236	15	,	,	PUNCT
iajs-3400	236	16	d.	d.	PROPN
iajs-3400	236	17	;	;	PUNCT
iajs-3400	236	18	gerlach	gerlach	PROPN
iajs-3400	236	19	,	,	PUNCT
iajs-3400	236	20	r.	r.	PROPN
iajs-3400	236	21	current	current	ADJ
iajs-3400	236	22	insights	insight	NOUN
iajs-3400	236	23	into	into	ADP
iajs-3400	236	24	the	the	DET
iajs-3400	236	25	mechanisms	mechanism	NOUN
iajs-3400	236	26	and	and	CCONJ
iajs-3400	236	27	management	management	NOUN
iajs-3400	236	28	of	of	ADP
iajs-3400	236	29	infection	infection	NOUN
iajs-3400	236	30	stones	stone	NOUN
iajs-3400	236	31	.	.	PUNCT
iajs-3400	237	1	nature	nature	NOUN
iajs-3400	237	2	reviews	review	VERB
iajs-3400	237	3	urology	urology	NOUN
iajs-3400	237	4	2019	2019	NUM
iajs-3400	237	5	,	,	PUNCT
iajs-3400	237	6	16	16	NUM
iajs-3400	237	7	,	,	PUNCT
iajs-3400	237	8	35	35	NUM
iajs-3400	237	9	-	-	SYM
iajs-3400	237	10	53	53	NUM
iajs-3400	237	11	.	.	PUNCT
iajs-3400	238	1	doi	doi	NOUN
iajs-3400	238	2	:	:	PUNCT
iajs-3400	239	1	https://doi.org/10.1038/s41585-018-0120-z	https://doi.org/10.1038/s41585-018-0120-z	PROPN
iajs-3400	239	2	.	.	PROPN
iajs-3400	239	3	21	21	NUM
iajs-3400	239	4	.	.	PUNCT
iajs-3400	240	1	daudon	daudon	NOUN
iajs-3400	240	2	,	,	PUNCT
iajs-3400	240	3	m.	m.	NOUN
iajs-3400	240	4	;	;	PUNCT
iajs-3400	240	5	petay	petay	NOUN
iajs-3400	240	6	,	,	PUNCT
iajs-3400	240	7	m.	m.	NOUN
iajs-3400	240	8	;	;	PUNCT
iajs-3400	240	9	vimont	vimont	NOUN
iajs-3400	240	10	,	,	PUNCT
iajs-3400	240	11	s.	s.	PROPN
iajs-3400	240	12	;	;	PUNCT
iajs-3400	240	13	deniset	deniset	VERB
iajs-3400	240	14	,	,	PUNCT
iajs-3400	240	15	a.	a.	NOUN
iajs-3400	240	16	;	;	PUNCT
iajs-3400	240	17	tielens	tielens	PROPN
iajs-3400	240	18	,	,	PUNCT
iajs-3400	240	19	f.	f.	PROPN
iajs-3400	240	20	;	;	PUNCT
iajs-3400	240	21	haymann	haymann	PROPN
iajs-3400	240	22	,	,	PUNCT
iajs-3400	240	23	j.p	j.p	PROPN
iajs-3400	240	24	.	.	PROPN
iajs-3400	240	25	;	;	PUNCT
iajs-3400	240	26	letavernier	letavernier	PROPN
iajs-3400	240	27	,	,	PUNCT
iajs-3400	240	28	e.	e.	PROPN
iajs-3400	240	29	;	;	PUNCT
iajs-3400	240	30	frochot	frochot	PROPN
iajs-3400	240	31	,	,	PUNCT
iajs-3400	240	32	v.	v.	PROPN
iajs-3400	240	33	;	;	PUNCT
iajs-3400	240	34	bazin	bazin	PROPN
iajs-3400	240	35	,	,	PUNCT
iajs-3400	240	36	d.	d.	PROPN
iajs-3400	240	37	urinary	urinary	ADJ
iajs-3400	240	38	tract	tract	NOUN
iajs-3400	240	39	infection	infection	NOUN
iajs-3400	240	40	inducing	induce	VERB
iajs-3400	240	41	stones	stone	NOUN
iajs-3400	240	42	:	:	PUNCT
iajs-3400	240	43	some	some	DET
iajs-3400	240	44	clinical	clinical	ADJ
iajs-3400	240	45	and	and	CCONJ
iajs-3400	240	46	chemical	chemical	NOUN
iajs-3400	240	47	data	datum	NOUN
iajs-3400	240	48	.	.	PUNCT
iajs-3400	241	1	comptes	compte	VERB
iajs-3400	241	2	rendus	rendus	PROPN
iajs-3400	241	3	.	.	PUNCT
iajs-3400	241	4	chimie	chimie	PROPN
iajs-3400	241	5	,	,	PUNCT
iajs-3400	241	6	2022	2022	NUM
iajs-3400	241	7	,	,	PUNCT
iajs-3400	241	8	25	25	NUM
iajs-3400	241	9	,	,	PUNCT
iajs-3400	241	10	315	315	NUM
iajs-3400	241	11	-	-	SYM
iajs-3400	241	12	334	334	NUM
iajs-3400	241	13	.	.	PUNCT
iajs-3400	242	1	doi	doi	NOUN
iajs-3400	242	2	:	:	PUNCT
iajs-3400	242	3	https://doi.org/10.5802/crchim.159	https://doi.org/10.5802/crchim.159	PROPN
iajs-3400	242	4	.	.	PUNCT
iajs-3400	243	1	22	22	NUM
iajs-3400	243	2	.	.	PUNCT
iajs-3400	244	1	al	al	PROPN
iajs-3400	244	2	-	-	PUNCT
iajs-3400	244	3	khamesi	khamesi	PROPN
iajs-3400	244	4	,	,	PUNCT
iajs-3400	244	5	m.b	m.b	PROPN
iajs-3400	244	6	.	.	PROPN
iajs-3400	244	7	;	;	PUNCT
iajs-3400	244	8	al	al	PROPN
iajs-3400	244	9	-	-	PUNCT
iajs-3400	244	10	sibahi	sibahi	PROPN
iajs-3400	244	11	,	,	PUNCT
iajs-3400	244	12	z.n	z.n	PROPN
iajs-3400	244	13	.	.	PROPN
iajs-3400	244	14	;	;	PUNCT
iajs-3400	244	15	al	al	PROPN
iajs-3400	244	16	-	-	PUNCT
iajs-3400	244	17	obaidy	obaidy	VERB
iajs-3400	244	18	,	,	PUNCT
iajs-3400	244	19	l.	l.	PROPN
iajs-3400	244	20	h.a	h.a	PROPN
iajs-3400	244	21	.	.	PROPN
iajs-3400	244	22	;	;	PUNCT
iajs-3400	244	23	hilal	hilal	PROPN
iajs-3400	244	24	,	,	PUNCT
iajs-3400	244	25	a.h	a.h	PROPN
iajs-3400	244	26	.	.	PROPN
iajs-3400	244	27	studying	study	VERB
iajs-3400	244	28	of	of	ADP
iajs-3400	244	29	kidney	kidney	NOUN
iajs-3400	244	30	,	,	PUNCT
iajs-3400	244	31	liver	liver	NOUN
iajs-3400	244	32	functions	function	NOUN
iajs-3400	244	33	and	and	CCONJ
iajs-3400	244	34	some	some	DET
iajs-3400	244	35	blood	blood	NOUN
iajs-3400	244	36	ions	ion	NOUN
iajs-3400	244	37	in	in	ADP
iajs-3400	244	38	toxoplasmosis	toxoplasmosis	NOUN
iajs-3400	244	39	patients	patient	NOUN
iajs-3400	244	40	.	.	PUNCT
iajs-3400	245	1	al	al	PROPN
iajs-3400	245	2	-	-	PUNCT
iajs-3400	245	3	mustansiriyah	mustansiriyah	PROPN
iajs-3400	245	4	journal	journal	NOUN
iajs-3400	245	5	of	of	ADP
iajs-3400	245	6	science	science	NOUN
iajs-3400	245	7	2016	2016	NUM
iajs-3400	245	8	,	,	PUNCT
iajs-3400	245	9	27(1	27(1	NUM
iajs-3400	245	10	)	)	PUNCT
iajs-3400	245	11	,	,	PUNCT
iajs-3400	245	12	43	43	NUM
iajs-3400	245	13	-	-	SYM
iajs-3400	245	14	46	46	NUM
iajs-3400	245	15	.	.	PUNCT
iajs-3400	245	16	23	23	NUM
iajs-3400	245	17	.	.	X
iajs-3400	246	1	tanikawa	tanikawa	PROPN
iajs-3400	246	2	,	,	PUNCT
iajs-3400	246	3	c.	c.	PROPN
iajs-3400	246	4	;	;	PUNCT
iajs-3400	246	5	kamatani	kamatani	PROPN
iajs-3400	246	6	,	,	PUNCT
iajs-3400	246	7	y.	y.	PROPN
iajs-3400	246	8	;	;	PUNCT
iajs-3400	246	9	terao	terao	PROPN
iajs-3400	246	10	,	,	PUNCT
iajs-3400	246	11	c.	c.	PROPN
iajs-3400	246	12	;	;	PUNCT
iajs-3400	246	13	usami	usami	ADJ
iajs-3400	246	14	,	,	PUNCT
iajs-3400	246	15	m.	m.	NOUN
iajs-3400	246	16	;	;	PUNCT
iajs-3400	246	17	takahashi	takahashi	PROPN
iajs-3400	246	18	,	,	PUNCT
iajs-3400	246	19	a.	a.	PROPN
iajs-3400	246	20	;	;	PUNCT
iajs-3400	246	21	momozawa	momozawa	PROPN
iajs-3400	246	22	,	,	PUNCT
iajs-3400	246	23	y.	y.	PROPN
iajs-3400	246	24	;	;	PUNCT
iajs-3400	246	25	suzuki	suzuki	PROPN
iajs-3400	246	26	,	,	PUNCT
iajs-3400	246	27	k.	k.	PROPN
iajs-3400	246	28	;	;	PUNCT
iajs-3400	246	29	ogishima	ogishima	PROPN
iajs-3400	246	30	,	,	PUNCT
iajs-3400	246	31	s.	s.	PROPN
iajs-3400	246	32	;	;	PUNCT
iajs-3400	246	33	shimizu	shimizu	PROPN
iajs-3400	246	34	,	,	PUNCT
iajs-3400	246	35	a.	a.	NOUN
iajs-3400	246	36	;	;	PUNCT
iajs-3400	246	37	satoh	satoh	NOUN
iajs-3400	246	38	,	,	PUNCT
iajs-3400	246	39	m.	m.	NOUN
iajs-3400	246	40	;	;	PUNCT
iajs-3400	246	41	matsuda	matsuda	PROPN
iajs-3400	246	42	,	,	PUNCT
iajs-3400	246	43	k.	k.	PROPN
iajs-3400	246	44	novel	novel	PROPN
iajs-3400	246	45	risk	risk	NOUN
iajs-3400	246	46	loci	locus	NOUN
iajs-3400	246	47	identified	identify	VERB
iajs-3400	246	48	in	in	ADP
iajs-3400	246	49	a	a	DET
iajs-3400	246	50	genome	genome	NOUN
iajs-3400	246	51	-	-	PUNCT
iajs-3400	246	52	wide	wide	ADJ
iajs-3400	246	53	association	association	NOUN
iajs-3400	246	54	study	study	NOUN
iajs-3400	246	55	of	of	ADP
iajs-3400	246	56	urolithiasis	urolithiasis	NOUN
iajs-3400	246	57	in	in	ADP
iajs-3400	246	58	a	a	DET
iajs-3400	246	59	japanese	japanese	ADJ
iajs-3400	246	60	population	population	NOUN
iajs-3400	246	61	.	.	PUNCT
iajs-3400	247	1	journal	journal	PROPN
iajs-3400	247	2	of	of	ADP
iajs-3400	247	3	the	the	DET
iajs-3400	247	4	american	american	ADJ
iajs-3400	247	5	society	society	NOUN
iajs-3400	247	6	of	of	ADP
iajs-3400	247	7	nephrology	nephrology	NOUN
iajs-3400	247	8	2019	2019	NUM
iajs-3400	247	9	,	,	PUNCT
iajs-3400	247	10	30	30	NUM
iajs-3400	247	11	,	,	PUNCT
iajs-3400	247	12	855	855	NUM
iajs-3400	247	13	-	-	SYM
iajs-3400	247	14	864	864	NUM
iajs-3400	247	15	.	.	PUNCT
iajs-3400	248	1	doi	doi	NOUN
iajs-3400	248	2	:	:	PUNCT
iajs-3400	248	3	https://doi.org/10.1681/asn.2018090942	https://doi.org/10.1681/asn.2018090942	ADJ
iajs-3400	248	4	.	.	PUNCT
iajs-3400	249	1	https://doi.org/10.1016/j.urology.2021.10.005	https://doi.org/10.1016/j.urology.2021.10.005	PROPN
iajs-3400	249	2	https://doi.org/10.1186/s12882-020-01925-3	https://doi.org/10.1186/s12882-020-01925-3	PROPN
iajs-3400	249	3	https://doi.org/10.1016/j.ajur.2018.08.007	https://doi.org/10.1016/j.ajur.2018.08.007	VERB
iajs-3400	249	4	https://doi.org/10.1016/j.urology.2013.11.012	https://doi.org/10.1016/j.urology.2013.11.012	NOUN
iajs-3400	249	5	http://doi.org/10.36295/asro.2019.22067	http://doi.org/10.36295/asro.2019.22067	PROPN
iajs-3400	249	6	http://doi.org/10.24086/cuesj.v4n1y2020.pp1-6	http://doi.org/10.24086/cuesj.v4n1y2020.pp1-6	NOUN
iajs-3400	249	7	https://doi.org/10.1186/s12894-021-00905-5	https://doi.org/10.1186/s12894-021-00905-5	NUM
iajs-3400	249	8	https://doi.org/10.18502/acta.v60i5.9558	https://doi.org/10.18502/acta.v60i5.9558	X
iajs-3400	249	9	https://doi.org/10.3909/riu0650	https://doi.org/10.3909/riu0650	NOUN
iajs-3400	249	10	https://doi.org/10.3909/riu0650	https://doi.org/10.3909/riu0650	NOUN
iajs-3400	249	11	https://doi.org/10.4103/ua.ua_13_19	https://doi.org/10.4103/ua.ua_13_19	X
iajs-3400	249	12	https://doi.org/10.1016/j.ucl.2007.04.003	https://doi.org/10.1016/j.ucl.2007.04.003	NOUN
iajs-3400	249	13	https://doi.org/10.22034/au.2020.227228.1014	https://doi.org/10.22034/au.2020.227228.1014	PROPN
iajs-3400	249	14	https://doi.org/10.1038/s41585-018-0120-z	https://doi.org/10.1038/s41585-018-0120-z	NOUN
iajs-3400	249	15	https://doi.org/10.5802/crchim.159	https://doi.org/10.5802/crchim.159	VERB
iajs-3400	249	16	https://doi.org/10.1681/asn.2018090942	https://doi.org/10.1681/asn.2018090942	ADJ
iajs-3400	249	17	ihjpas	ihjpa	NOUN
iajs-3400	249	18	.	.	PUNCT
iajs-3400	250	1	37	37	NUM
iajs-3400	250	2	(	(	PUNCT
iajs-3400	250	3	2	2	NUM
iajs-3400	250	4	)	)	PUNCT
iajs-3400	250	5	2024	2024	NUM
iajs-3400	250	6	166	166	NUM
iajs-3400	250	7	24	24	NUM
iajs-3400	250	8	.	.	PUNCT
iajs-3400	251	1	shah	shah	PROPN
iajs-3400	251	2	,	,	PUNCT
iajs-3400	251	3	r.j	r.j	PROPN
iajs-3400	251	4	.	.	PROPN
iajs-3400	251	5	;	;	PUNCT
iajs-3400	251	6	vaughan	vaughan	PROPN
iajs-3400	251	7	,	,	PUNCT
iajs-3400	251	8	l.e	l.e	PROPN
iajs-3400	251	9	.	.	PROPN
iajs-3400	251	10	;	;	PUNCT
iajs-3400	251	11	enders	ender	NOUN
iajs-3400	251	12	,	,	PUNCT
iajs-3400	251	13	f.t	f.t	PROPN
iajs-3400	251	14	.	.	PUNCT
iajs-3400	251	15	;	;	PUNCT
iajs-3400	251	16	milliner	milliner	PROPN
iajs-3400	251	17	,	,	PUNCT
iajs-3400	251	18	d.s	d.s	PROPN
iajs-3400	251	19	.	.	PROPN
iajs-3400	251	20	;	;	PUNCT
iajs-3400	251	21	lieske	lieske	PROPN
iajs-3400	251	22	,	,	PUNCT
iajs-3400	251	23	j.c	j.c	PROPN
iajs-3400	251	24	.	.	PROPN
iajs-3400	251	25	plasma	plasma	PROPN
iajs-3400	251	26	oxalate	oxalate	NOUN
iajs-3400	251	27	as	as	ADP
iajs-3400	251	28	a	a	DET
iajs-3400	251	29	predictor	predictor	NOUN
iajs-3400	251	30	of	of	ADP
iajs-3400	251	31	kidney	kidney	NOUN
iajs-3400	251	32	function	function	NOUN
iajs-3400	251	33	decline	decline	NOUN
iajs-3400	251	34	in	in	ADP
iajs-3400	251	35	a	a	DET
iajs-3400	251	36	primary	primary	ADJ
iajs-3400	251	37	hyperoxaluria	hyperoxaluria	NOUN
iajs-3400	251	38	cohort	cohort	NOUN
iajs-3400	251	39	.	.	PUNCT
iajs-3400	252	1	international	international	ADJ
iajs-3400	252	2	journal	journal	NOUN
iajs-3400	252	3	of	of	ADP
iajs-3400	252	4	molecular	molecular	ADJ
iajs-3400	252	5	sciences	science	NOUN
iajs-3400	252	6	2020	2020	NUM
iajs-3400	252	7	,	,	PUNCT
iajs-3400	252	8	21	21	NUM
iajs-3400	252	9	,	,	PUNCT
iajs-3400	252	10	3608	3608	NUM
iajs-3400	252	11	.	.	PUNCT
iajs-3400	253	1	doi	doi	NOUN
iajs-3400	253	2	:	:	PUNCT
iajs-3400	253	3	https://doi.org/10.3390/ijms21103608	https://doi.org/10.3390/ijms21103608	NOUN
iajs-3400	253	4	.	.	PUNCT
iajs-3400	254	1	25	25	NUM
iajs-3400	254	2	.	.	PUNCT
iajs-3400	254	3	harambat	harambat	PROPN
iajs-3400	254	4	,	,	PUNCT
iajs-3400	254	5	j.	j.	PROPN
iajs-3400	254	6	;	;	PUNCT
iajs-3400	254	7	fargue	fargue	PROPN
iajs-3400	254	8	,	,	PUNCT
iajs-3400	254	9	s.	s.	PROPN
iajs-3400	254	10	;	;	PUNCT
iajs-3400	254	11	bacchetta	bacchetta	NOUN
iajs-3400	254	12	,	,	PUNCT
iajs-3400	254	13	j.	j.	PROPN
iajs-3400	254	14	;	;	PUNCT
iajs-3400	254	15	acquaviva	acquaviva	PROPN
iajs-3400	254	16	,	,	PUNCT
iajs-3400	254	17	c.	c.	PROPN
iajs-3400	254	18	;	;	PUNCT
iajs-3400	254	19	cochat	cochat	ADP
iajs-3400	254	20	,	,	PUNCT
iajs-3400	254	21	p.	p.	PROPN
iajs-3400	254	22	primary	primary	ADJ
iajs-3400	254	23	hyperoxaluria	hyperoxaluria	NOUN
iajs-3400	254	24	.	.	PUNCT
iajs-3400	255	1	international	international	ADJ
iajs-3400	255	2	journal	journal	PROPN
iajs-3400	255	3	of	of	ADP
iajs-3400	255	4	nephrology	nephrology	NOUN
iajs-3400	255	5	2011	2011	NUM
iajs-3400	255	6	,	,	PUNCT
iajs-3400	255	7	2011	2011	NUM
iajs-3400	255	8	.	.	PUNCT
iajs-3400	256	1	doi	doi	NOUN
iajs-3400	256	2	:	:	PUNCT
iajs-3400	256	3	https://doi.org/10.4061/2011/864580	https://doi.org/10.4061/2011/864580	PROPN
iajs-3400	256	4	.	.	PROPN
iajs-3400	257	1	26	26	NUM
iajs-3400	257	2	.	.	PUNCT
iajs-3400	258	1	takayama	takayama	PROPN
iajs-3400	258	2	,	,	PUNCT
iajs-3400	258	3	t.	t.	PROPN
iajs-3400	258	4	;	;	PUNCT
iajs-3400	258	5	nagata	nagata	PROPN
iajs-3400	258	6	,	,	PUNCT
iajs-3400	258	7	m.	m.	NOUN
iajs-3400	258	8	;	;	PUNCT
iajs-3400	258	9	ozono	ozono	PROPN
iajs-3400	258	10	,	,	PUNCT
iajs-3400	258	11	s.	s.	PROPN
iajs-3400	258	12	;	;	PUNCT
iajs-3400	258	13	nonomura	nonomura	PROPN
iajs-3400	258	14	,	,	PUNCT
iajs-3400	258	15	k.	k.	PROPN
iajs-3400	258	16	;	;	PUNCT
iajs-3400	258	17	cramer	cramer	PROPN
iajs-3400	258	18	,	,	PUNCT
iajs-3400	258	19	s.	s.	PROPN
iajs-3400	258	20	d.	d.	PROPN
iajs-3400	258	21	a	a	DET
iajs-3400	258	22	novel	novel	ADJ
iajs-3400	258	23	mutation	mutation	NOUN
iajs-3400	258	24	in	in	ADP
iajs-3400	258	25	the	the	DET
iajs-3400	258	26	grhpr	grhpr	ADJ
iajs-3400	258	27	gene	gene	NOUN
iajs-3400	258	28	in	in	ADP
iajs-3400	258	29	a	a	DET
iajs-3400	258	30	japanese	japanese	ADJ
iajs-3400	258	31	patient	patient	NOUN
iajs-3400	258	32	with	with	ADP
iajs-3400	258	33	primary	primary	ADJ
iajs-3400	258	34	hyperoxaluria	hyperoxaluria	NOUN
iajs-3400	258	35	type	type	NOUN
iajs-3400	258	36	2	2	NUM
iajs-3400	258	37	.	.	PUNCT
iajs-3400	258	38	nephrology	nephrology	NOUN
iajs-3400	258	39	dialysis	dialysis	NOUN
iajs-3400	258	40	transplantation	transplantation	NOUN
iajs-3400	258	41	2007	2007	NUM
iajs-3400	258	42	,	,	PUNCT
iajs-3400	258	43	22	22	NUM
iajs-3400	258	44	,	,	PUNCT
iajs-3400	258	45	2371	2371	NUM
iajs-3400	258	46	-	-	SYM
iajs-3400	258	47	2374	2374	NUM
iajs-3400	258	48	.	.	PUNCT
iajs-3400	259	1	doi	doi	NOUN
iajs-3400	259	2	:	:	PUNCT
iajs-3400	259	3	https://doi.org/10.1093/ndt/gfm271	https://doi.org/10.1093/ndt/gfm271	NOUN
iajs-3400	259	4	.	.	PUNCT
iajs-3400	260	1	27	27	NUM
iajs-3400	260	2	.	.	PUNCT
iajs-3400	261	1	rumsby	rumsby	PROPN
iajs-3400	261	2	,	,	PUNCT
iajs-3400	261	3	g.	g.	PROPN
iajs-3400	261	4	;	;	PUNCT
iajs-3400	261	5	cregeen	cregeen	PROPN
iajs-3400	261	6	,	,	PUNCT
iajs-3400	261	7	d.p	d.p	PROPN
iajs-3400	261	8	.	.	PROPN
iajs-3400	261	9	identification	identification	NOUN
iajs-3400	261	10	and	and	CCONJ
iajs-3400	261	11	expression	expression	NOUN
iajs-3400	261	12	of	of	ADP
iajs-3400	261	13	a	a	DET
iajs-3400	261	14	cdna	cdna	PROPN
iajs-3400	261	15	for	for	ADP
iajs-3400	261	16	human	human	ADJ
iajs-3400	261	17	hydroxypyruvate	hydroxypyruvate	NOUN
iajs-3400	261	18	/	/	SYM
iajs-3400	261	19	glyoxylate	glyoxylate	NOUN
iajs-3400	261	20	reductase	reductase	NOUN
iajs-3400	261	21	.	.	PUNCT
iajs-3400	262	1	biochimica	biochimica	PROPN
iajs-3400	262	2	et	et	PROPN
iajs-3400	262	3	biophysica	biophysica	PROPN
iajs-3400	262	4	acta	acta	PROPN
iajs-3400	262	5	(	(	PUNCT
iajs-3400	262	6	bba)-gene	bba)-gene	ADJ
iajs-3400	262	7	structure	structure	NOUN
iajs-3400	262	8	and	and	CCONJ
iajs-3400	262	9	expression	expression	NOUN
iajs-3400	262	10	1999	1999	NUM
iajs-3400	262	11	,	,	PUNCT
iajs-3400	262	12	1446	1446	NUM
iajs-3400	262	13	,	,	PUNCT
iajs-3400	262	14	383	383	NUM
iajs-3400	262	15	-	-	SYM
iajs-3400	262	16	388	388	NUM
iajs-3400	262	17	.	.	PUNCT
iajs-3400	263	1	doi	doi	NOUN
iajs-3400	263	2	:	:	PUNCT
iajs-3400	263	3	https://doi.org/10.1016/s0167-4781(99)00105-0	https://doi.org/10.1016/s0167-4781(99)00105-0	PROPN
iajs-3400	263	4	.	.	PUNCT
iajs-3400	264	1	28	28	NUM
iajs-3400	264	2	.	.	PUNCT
iajs-3400	265	1	garrelfs	garrelfs	PROPN
iajs-3400	265	2	,	,	PUNCT
iajs-3400	265	3	s.f	s.f	PROPN
iajs-3400	265	4	.	.	PROPN
iajs-3400	265	5	;	;	PUNCT
iajs-3400	265	6	rumsby	rumsby	VERB
iajs-3400	265	7	,	,	PUNCT
iajs-3400	265	8	g.	g.	PROPN
iajs-3400	265	9	;	;	PUNCT
iajs-3400	265	10	peters	peters	PROPN
iajs-3400	265	11	-	-	PUNCT
iajs-3400	265	12	sengers	senger	NOUN
iajs-3400	265	13	,	,	PUNCT
iajs-3400	265	14	h.	h.	PROPN
iajs-3400	265	15	;	;	PUNCT
iajs-3400	265	16	erger	erger	PROPN
iajs-3400	265	17	,	,	PUNCT
iajs-3400	265	18	f.	f.	PROPN
iajs-3400	265	19	;	;	PUNCT
iajs-3400	265	20	groothoff	groothoff	PROPN
iajs-3400	265	21	,	,	PUNCT
iajs-3400	265	22	j.w	j.w	PROPN
iajs-3400	265	23	.	.	PROPN
iajs-3400	265	24	;	;	PUNCT
iajs-3400	265	25	beck	beck	PROPN
iajs-3400	265	26	,	,	PUNCT
iajs-3400	265	27	b.b	b.b	PROPN
iajs-3400	265	28	.	.	PROPN
iajs-3400	265	29	;	;	PUNCT
iajs-3400	265	30	oosterveld	oosterveld	ADJ
iajs-3400	265	31	,	,	PUNCT
iajs-3400	265	32	m.j	m.j	PROPN
iajs-3400	265	33	.	.	PROPN
iajs-3400	265	34	;	;	PUNCT
iajs-3400	265	35	pelle	pelle	PROPN
iajs-3400	265	36	,	,	PUNCT
iajs-3400	265	37	a.	a.	NOUN
iajs-3400	265	38	;	;	PUNCT
iajs-3400	265	39	neuhaus	neuhaus	PROPN
iajs-3400	265	40	,	,	PUNCT
iajs-3400	265	41	t.	t.	PROPN
iajs-3400	265	42	;	;	PUNCT
iajs-3400	265	43	adams	adams	PROPN
iajs-3400	265	44	,	,	PUNCT
iajs-3400	265	45	b.	b.	PROPN
iajs-3400	265	46	;	;	PUNCT
iajs-3400	265	47	cochat	cochat	PROPN
iajs-3400	265	48	,	,	PUNCT
iajs-3400	265	49	p.	p.	NOUN
iajs-3400	265	50	patients	patient	NOUN
iajs-3400	265	51	with	with	ADP
iajs-3400	265	52	primary	primary	ADJ
iajs-3400	265	53	hyperoxaluria	hyperoxaluria	NOUN
iajs-3400	265	54	type	type	NOUN
iajs-3400	265	55	2	2	NUM
iajs-3400	265	56	have	have	VERB
iajs-3400	265	57	significant	significant	ADJ
iajs-3400	265	58	morbidity	morbidity	NOUN
iajs-3400	265	59	and	and	CCONJ
iajs-3400	265	60	require	require	VERB
iajs-3400	265	61	careful	careful	ADJ
iajs-3400	265	62	follow	follow	NOUN
iajs-3400	265	63	-	-	PUNCT
iajs-3400	265	64	up	up	NOUN
iajs-3400	265	65	.	.	PUNCT
iajs-3400	266	1	kidney	kidney	NOUN
iajs-3400	266	2	international	international	ADJ
iajs-3400	266	3	2019	2019	NUM
iajs-3400	266	4	,	,	PUNCT
iajs-3400	266	5	96(6	96(6	NOUN
iajs-3400	266	6	)	)	PUNCT
iajs-3400	266	7	,	,	PUNCT
iajs-3400	266	8	1389	1389	NUM
iajs-3400	266	9	-	-	SYM
iajs-3400	266	10	1399	1399	NUM
iajs-3400	266	11	.	.	PUNCT
iajs-3400	267	1	doi	doi	NOUN
iajs-3400	267	2	:	:	PUNCT
iajs-3400	267	3	https://doi.org/10.1016/j.kint.2019.08.018	https://doi.org/10.1016/j.kint.2019.08.018	NOUN
iajs-3400	267	4	.	.	PUNCT
iajs-3400	268	1	29	29	NUM
iajs-3400	268	2	.	.	X
iajs-3400	269	1	forbes	forbes	PROPN
iajs-3400	269	2	,	,	PUNCT
iajs-3400	269	3	t.a	t.a	PROPN
iajs-3400	269	4	.	.	PROPN
iajs-3400	269	5	;	;	PUNCT
iajs-3400	269	6	brown	brown	PROPN
iajs-3400	269	7	,	,	PUNCT
iajs-3400	269	8	b.d	b.d	PROPN
iajs-3400	269	9	.	.	PROPN
iajs-3400	269	10	;	;	PUNCT
iajs-3400	270	1	lai	lai	PROPN
iajs-3400	270	2	,	,	PUNCT
iajs-3400	270	3	c.	c.	PROPN
iajs-3400	270	4	,	,	PUNCT
iajs-3400	270	5	therapeutic	therapeutic	ADJ
iajs-3400	270	6	rna	rna	NOUN
iajs-3400	270	7	interference	interference	NOUN
iajs-3400	270	8	:	:	PUNCT
iajs-3400	270	9	a	a	DET
iajs-3400	270	10	novel	novel	ADJ
iajs-3400	270	11	approach	approach	NOUN
iajs-3400	270	12	to	to	ADP
iajs-3400	270	13	the	the	DET
iajs-3400	270	14	treatment	treatment	NOUN
iajs-3400	270	15	of	of	ADP
iajs-3400	270	16	primary	primary	ADJ
iajs-3400	270	17	hyperoxaluria	hyperoxaluria	NOUN
iajs-3400	270	18	.	.	PUNCT
iajs-3400	271	1	british	british	ADJ
iajs-3400	271	2	journal	journal	PROPN
iajs-3400	271	3	of	of	ADP
iajs-3400	271	4	clinical	clinical	ADJ
iajs-3400	271	5	pharmacology	pharmacology	NOUN
iajs-3400	271	6	2022	2022	NUM
iajs-3400	271	7	,	,	PUNCT
iajs-3400	271	8	88(6	88(6	NUM
iajs-3400	271	9	)	)	PUNCT
iajs-3400	271	10	,	,	PUNCT
iajs-3400	271	11	2525	2525	NUM
iajs-3400	271	12	-	-	SYM
iajs-3400	271	13	2538	2538	NUM
iajs-3400	271	14	.	.	PUNCT
iajs-3400	272	1	doi	doi	NOUN
iajs-3400	272	2	:	:	PUNCT
iajs-3400	272	3	https://doi.org/10.1111/bcp.14925	https://doi.org/10.1111/bcp.14925	PROPN
iajs-3400	272	4	.	.	PUNCT
iajs-3400	273	1	30	30	NUM
iajs-3400	273	2	.	.	PUNCT
iajs-3400	274	1	wang	wang	PROPN
iajs-3400	274	2	,	,	PUNCT
iajs-3400	274	3	j.	j.	PROPN
iajs-3400	274	4	;	;	PUNCT
iajs-3400	274	5	wang	wang	PROPN
iajs-3400	274	6	,	,	PUNCT
iajs-3400	274	7	y.	y.	PROPN
iajs-3400	274	8	;	;	PUNCT
iajs-3400	274	9	xing	xing	PROPN
iajs-3400	274	10	,	,	PUNCT
iajs-3400	274	11	p.	p.	PROPN
iajs-3400	274	12	;	;	PUNCT
iajs-3400	274	13	liu	liu	PROPN
iajs-3400	274	14	,	,	PUNCT
iajs-3400	274	15	q.	q.	PROPN
iajs-3400	274	16	;	;	PUNCT
iajs-3400	274	17	zhang	zhang	PROPN
iajs-3400	274	18	,	,	PUNCT
iajs-3400	274	19	c.	c.	PROPN
iajs-3400	274	20	;	;	PUNCT
iajs-3400	274	21	sui	sui	PROPN
iajs-3400	274	22	,	,	PUNCT
iajs-3400	274	23	y.	y.	PROPN
iajs-3400	274	24	;	;	PUNCT
iajs-3400	274	25	wu	wu	PROPN
iajs-3400	274	26	,	,	PUNCT
iajs-3400	274	27	c.	c.	PROPN
iajs-3400	274	28	development	development	PROPN
iajs-3400	274	29	and	and	CCONJ
iajs-3400	274	30	validation	validation	NOUN
iajs-3400	274	31	of	of	ADP
iajs-3400	274	32	a	a	DET
iajs-3400	274	33	hypoxia‑related	hypoxia‑relate	VERB
iajs-3400	274	34	prognostic	prognostic	ADJ
iajs-3400	274	35	signature	signature	NOUN
iajs-3400	274	36	for	for	ADP
iajs-3400	274	37	breast	breast	NOUN
iajs-3400	274	38	cancer	cancer	NOUN
iajs-3400	274	39	.	.	PUNCT
iajs-3400	275	1	oncology	oncology	NOUN
iajs-3400	275	2	letters	letter	NOUN
iajs-3400	275	3	2020	2020	NUM
iajs-3400	275	4	,	,	PUNCT
iajs-3400	275	5	20	20	NUM
iajs-3400	275	6	,	,	PUNCT
iajs-3400	275	7	1906	1906	NUM
iajs-3400	275	8	-	-	SYM
iajs-3400	275	9	1914	1914	NUM
iajs-3400	275	10	.	.	PUNCT
iajs-3400	276	1	doi	doi	NOUN
iajs-3400	276	2	:	:	PUNCT
iajs-3400	276	3	https://doi.org/10.3892/ol.2020.11733	https://doi.org/10.3892/ol.2020.11733	PROPN
iajs-3400	276	4	.	.	PUNCT
iajs-3400	277	1	31	31	NUM
iajs-3400	277	2	.	.	X
iajs-3400	278	1	yang	yang	PROPN
iajs-3400	278	2	,	,	PUNCT
iajs-3400	278	3	s.	s.	PROPN
iajs-3400	278	4	;	;	PUNCT
iajs-3400	278	5	liu	liu	PROPN
iajs-3400	278	6	,	,	PUNCT
iajs-3400	278	7	y.	y.	PROPN
iajs-3400	278	8	;	;	PUNCT
iajs-3400	278	9	zhang	zhang	PROPN
iajs-3400	278	10	,	,	PUNCT
iajs-3400	278	11	b.	b.	PROPN
iajs-3400	278	12	;	;	PUNCT
iajs-3400	278	13	li	li	PROPN
iajs-3400	278	14	,	,	PUNCT
iajs-3400	278	15	j.	j.	PROPN
iajs-3400	278	16	;	;	PUNCT
iajs-3400	278	17	xu	xu	PROPN
iajs-3400	278	18	,	,	PUNCT
iajs-3400	278	19	f.	f.	PROPN
iajs-3400	278	20	;	;	PUNCT
iajs-3400	278	21	yu	yu	PROPN
iajs-3400	278	22	,	,	PUNCT
iajs-3400	278	23	m.	m.	NOUN
iajs-3400	278	24	;	;	PUNCT
iajs-3400	278	25	chen	chen	PROPN
iajs-3400	278	26	,	,	PUNCT
iajs-3400	278	27	y.	y.	PROPN
iajs-3400	278	28	li	li	PROPN
iajs-3400	278	29	,	,	PUNCT
iajs-3400	278	30	c.	c.	PROPN
iajs-3400	278	31	liu	liu	PROPN
iajs-3400	278	32	,	,	PUNCT
iajs-3400	278	33	t.	t.	PROPN
iajs-3400	278	34	zhang	zhang	PROPN
iajs-3400	278	35	,	,	PUNCT
iajs-3400	278	36	j.	j.	PROPN
iajs-3400	278	37	grhpr	grhpr	PROPN
iajs-3400	278	38	,	,	PUNCT
iajs-3400	278	39	targeted	target	VERB
iajs-3400	278	40	by	by	ADP
iajs-3400	278	41	mir-138	mir-138	PROPN
iajs-3400	278	42	-	-	PUNCT
iajs-3400	278	43	5p	5p	NUM
iajs-3400	278	44	,	,	PUNCT
iajs-3400	278	45	inhibits	inhibit	VERB
iajs-3400	278	46	the	the	DET
iajs-3400	278	47	proliferation	proliferation	NOUN
iajs-3400	278	48	and	and	CCONJ
iajs-3400	278	49	metastasis	metastasis	NOUN
iajs-3400	278	50	of	of	ADP
iajs-3400	278	51	hepatocellular	hepatocellular	ADJ
iajs-3400	278	52	carcinoma	carcinoma	NOUN
iajs-3400	278	53	through	through	ADP
iajs-3400	278	54	pi3k	pi3k	PROPN
iajs-3400	278	55	/	/	SYM
iajs-3400	278	56	akt	akt	PROPN
iajs-3400	278	57	signaling	signal	VERB
iajs-3400	278	58	pathway	pathway	NOUN
iajs-3400	278	59	.	.	PUNCT
iajs-3400	279	1	2022	2022	NUM
iajs-3400	279	2	.	.	PUNCT
iajs-3400	280	1	doi	doi	NOUN
iajs-3400	280	2	:	:	PUNCT
iajs-3400	280	3	https://doi.org/10.21203/rs.3.rs-2015954/v1	https://doi.org/10.21203/rs.3.rs-2015954/v1	PROPN
iajs-3400	280	4	.	.	PUNCT
iajs-3400	281	1	32	32	NUM
iajs-3400	281	2	.	.	X
iajs-3400	282	1	inserra	inserra	PROPN
iajs-3400	282	2	,	,	PUNCT
iajs-3400	282	3	a.	a.	NOUN
iajs-3400	282	4	;	;	PUNCT
iajs-3400	282	5	campanale	campanale	NOUN
iajs-3400	282	6	,	,	PUNCT
iajs-3400	282	7	a.	a.	NOUN
iajs-3400	282	8	;	;	PUNCT
iajs-3400	282	9	cheishvili	cheishvili	NOUN
iajs-3400	282	10	,	,	PUNCT
iajs-3400	282	11	d.	d.	PROPN
iajs-3400	282	12	;	;	PUNCT
iajs-3400	282	13	dymov	dymov	PROPN
iajs-3400	282	14	,	,	PUNCT
iajs-3400	282	15	s.	s.	PROPN
iajs-3400	282	16	;	;	PUNCT
iajs-3400	282	17	wong	wong	PROPN
iajs-3400	282	18	,	,	PUNCT
iajs-3400	282	19	a.	a.	NOUN
iajs-3400	282	20	;	;	PUNCT
iajs-3400	282	21	marcal	marcal	ADJ
iajs-3400	282	22	,	,	PUNCT
iajs-3400	282	23	n.	n.	NOUN
iajs-3400	282	24	;	;	PUNCT
iajs-3400	282	25	gobbi	gobbi	PROPN
iajs-3400	282	26	,	,	PUNCT
iajs-3400	282	27	g.	g.	PROPN
iajs-3400	282	28	;	;	PUNCT
iajs-3400	282	29	syme	syme	PROPN
iajs-3400	282	30	,	,	PUNCT
iajs-3400	282	31	r.a	r.a	PROPN
iajs-3400	282	32	.	.	PROPN
iajs-3400	282	33	;	;	PUNCT
iajs-3400	282	34	taylor	taylor	PROPN
iajs-3400	282	35	,	,	PUNCT
iajs-3400	282	36	l.	l.	PROPN
iajs-3400	282	37	;	;	PUNCT
iajs-3400	282	38	de	de	PROPN
iajs-3400	282	39	gregorio	gregorio	PROPN
iajs-3400	282	40	,	,	PUNCT
iajs-3400	282	41	d.	d.	PROPN
iajs-3400	282	42	;	;	PUNCT
iajs-3400	282	43	kennedy	kennedy	PROPN
iajs-3400	282	44	,	,	PUNCT
iajs-3400	282	45	t.e	t.e	PROPN
iajs-3400	282	46	.	.	PROPN
iajs-3400	282	47	;	;	PUNCT
iajs-3400	282	48	szyf	szyf	PROPN
iajs-3400	282	49	,	,	PUNCT
iajs-3400	282	50	m.	m.	NOUN
iajs-3400	282	51	modulation	modulation	NOUN
iajs-3400	282	52	of	of	ADP
iajs-3400	282	53	dna	dna	PROPN
iajs-3400	282	54	methylation	methylation	NOUN
iajs-3400	282	55	and	and	CCONJ
iajs-3400	282	56	protein	protein	NOUN
iajs-3400	282	57	expression	expression	NOUN
iajs-3400	282	58	in	in	ADP
iajs-3400	282	59	the	the	DET
iajs-3400	282	60	prefrontal	prefrontal	ADJ
iajs-3400	282	61	cortex	cortex	NOUN
iajs-3400	282	62	by	by	ADP
iajs-3400	282	63	repeated	repeat	VERB
iajs-3400	282	64	administration	administration	NOUN
iajs-3400	282	65	of	of	ADP
iajs-3400	282	66	d	d	PROPN
iajs-3400	282	67	-	-	ADJ
iajs-3400	282	68	lysergic	lysergic	ADJ
iajs-3400	282	69	acid	acid	NOUN
iajs-3400	282	70	diethylamide	diethylamide	NOUN
iajs-3400	282	71	(	(	PUNCT
iajs-3400	282	72	lsd	lsd	NOUN
iajs-3400	282	73	):	):	PUNCT
iajs-3400	282	74	impact	impact	NOUN
iajs-3400	282	75	on	on	ADP
iajs-3400	282	76	neurotropic	neurotropic	NOUN
iajs-3400	282	77	,	,	PUNCT
iajs-3400	282	78	neurotrophic	neurotrophic	NOUN
iajs-3400	282	79	,	,	PUNCT
iajs-3400	282	80	and	and	CCONJ
iajs-3400	282	81	neuroplasticity	neuroplasticity	NOUN
iajs-3400	282	82	signaling	signal	VERB
iajs-3400	282	83	.	.	PUNCT
iajs-3400	283	1	progress	progress	NOUN
iajs-3400	283	2	in	in	ADP
iajs-3400	283	3	neuropsychopharmacology	neuropsychopharmacology	NOUN
iajs-3400	283	4	and	and	CCONJ
iajs-3400	283	5	biological	biological	ADJ
iajs-3400	283	6	psychiatry	psychiatry	NOUN
iajs-3400	283	7	2022	2022	NUM
iajs-3400	283	8	,	,	PUNCT
iajs-3400	283	9	119	119	NUM
iajs-3400	283	10	,	,	PUNCT
iajs-3400	283	11	110594	110594	NUM
iajs-3400	283	12	.	.	PUNCT
iajs-3400	284	1	doi	doi	NOUN
iajs-3400	284	2	:	:	PUNCT
iajs-3400	284	3	https://doi.org/10.1016/j.pnpbp.2022.110594	https://doi.org/10.1016/j.pnpbp.2022.110594	NOUN
iajs-3400	284	4	.	.	PUNCT
iajs-3400	285	1	33	33	NUM
iajs-3400	285	2	.	.	PUNCT
iajs-3400	286	1	elshal	elshal	VERB
iajs-3400	286	2	,	,	PUNCT
iajs-3400	286	3	a.m.	a.m.	ADV
iajs-3400	286	4	;	;	PUNCT
iajs-3400	286	5	shamshoun	shamshoun	ADV
iajs-3400	286	6	,	,	PUNCT
iajs-3400	286	7	h.	h.	PROPN
iajs-3400	286	8	;	;	PUNCT
iajs-3400	286	9	awadalla	awadalla	PROPN
iajs-3400	286	10	,	,	PUNCT
iajs-3400	286	11	a.	a.	NOUN
iajs-3400	286	12	;	;	PUNCT
iajs-3400	286	13	elbaz	elbaz	PROPN
iajs-3400	286	14	,	,	PUNCT
iajs-3400	286	15	r.	r.	PROPN
iajs-3400	286	16	;	;	PUNCT
iajs-3400	286	17	ahmed	ahmed	PROPN
iajs-3400	286	18	,	,	PUNCT
iajs-3400	286	19	a.e	a.e	PROPN
iajs-3400	286	20	.	.	PROPN
iajs-3400	286	21	;	;	PUNCT
iajs-3400	287	1	el	el	PROPN
iajs-3400	287	2	-	-	PUNCT
iajs-3400	287	3	khawaga	khawaga	PROPN
iajs-3400	287	4	,	,	PUNCT
iajs-3400	287	5	o.y	o.y	PROPN
iajs-3400	287	6	.	.	PROPN
iajs-3400	287	7	;	;	PUNCT
iajs-3400	287	8	shokeir	shokeir	PROPN
iajs-3400	287	9	,	,	PUNCT
iajs-3400	287	10	a.a	a.a	PROPN
iajs-3400	287	11	.	.	PROPN
iajs-3400	287	12	hormonal	hormonal	ADJ
iajs-3400	287	13	and	and	CCONJ
iajs-3400	287	14	molecular	molecular	ADJ
iajs-3400	287	15	characterization	characterization	NOUN
iajs-3400	287	16	of	of	ADP
iajs-3400	287	17	calcium	calcium	NOUN
iajs-3400	287	18	oxalate	oxalate	NOUN
iajs-3400	287	19	stone	stone	NOUN
iajs-3400	287	20	formers	former	NOUN
iajs-3400	287	21	predicting	predict	VERB
iajs-3400	287	22	occurrence	occurrence	NOUN
iajs-3400	287	23	and	and	CCONJ
iajs-3400	287	24	recurrence	recurrence	NOUN
iajs-3400	287	25	.	.	PUNCT
iajs-3400	288	1	urolithiasis	urolithiasis	NOUN
iajs-3400	288	2	.	.	PUNCT
iajs-3400	289	1	2023	2023	NUM
iajs-3400	289	2	,	,	PUNCT
iajs-3400	289	3	51(1	51(1	NUM
iajs-3400	289	4	)	)	PUNCT
iajs-3400	289	5	,	,	PUNCT
iajs-3400	289	6	76	76	NUM
iajs-3400	289	7	.	.	PUNCT
iajs-3400	289	8	doi	doi	NOUN
iajs-3400	289	9	:	:	PUNCT
iajs-3400	289	10	https://doi.org/10.1007/s00240-023-01440-8	https://doi.org/10.1007/s00240-023-01440-8	NUM
iajs-3400	289	11	.	.	PUNCT
iajs-3400	290	1	34	34	NUM
iajs-3400	290	2	.	.	X
iajs-3400	290	3	moftakhar	moftakhar	PROPN
iajs-3400	290	4	,	,	PUNCT
iajs-3400	290	5	l.	l.	PROPN
iajs-3400	290	6	;	;	PUNCT
iajs-3400	290	7	jafari	jafari	PROPN
iajs-3400	290	8	,	,	PUNCT
iajs-3400	290	9	f.	f.	PROPN
iajs-3400	290	10	;	;	PUNCT
iajs-3400	290	11	ghoddusi	ghoddusi	NOUN
iajs-3400	290	12	johari	johari	PROPN
iajs-3400	290	13	,	,	PUNCT
iajs-3400	290	14	m.	m.	NOUN
iajs-3400	290	15	;	;	PUNCT
iajs-3400	290	16	rezaeianzadeh	rezaeianzadeh	PROPN
iajs-3400	290	17	,	,	PUNCT
iajs-3400	290	18	r.	r.	PROPN
iajs-3400	290	19	;	;	PUNCT
iajs-3400	290	20	hosseini	hosseini	PROPN
iajs-3400	290	21	,	,	PUNCT
iajs-3400	290	22	s.	s.	PROPN
iajs-3400	290	23	v.	v.	PROPN
iajs-3400	290	24	;	;	PUNCT
iajs-3400	290	25	rezaianzadeh	rezaianzadeh	NOUN
iajs-3400	290	26	,	,	PUNCT
iajs-3400	290	27	a.	a.	NOUN
iajs-3400	290	28	prevalence	prevalence	NOUN
iajs-3400	290	29	and	and	CCONJ
iajs-3400	290	30	risk	risk	NOUN
iajs-3400	290	31	factors	factor	NOUN
iajs-3400	290	32	of	of	ADP
iajs-3400	290	33	kidney	kidney	NOUN
iajs-3400	290	34	stone	stone	NOUN
iajs-3400	290	35	disease	disease	NOUN
iajs-3400	290	36	in	in	ADP
iajs-3400	290	37	population	population	NOUN
iajs-3400	290	38	aged	age	VERB
iajs-3400	290	39	40–70	40–70	NUM
iajs-3400	290	40	years	year	NOUN
iajs-3400	290	41	old	old	ADJ
iajs-3400	290	42	in	in	ADP
iajs-3400	290	43	kharameh	kharameh	PROPN
iajs-3400	290	44	cohort	cohort	PROPN
iajs-3400	290	45	study	study	PROPN
iajs-3400	290	46	:	:	PUNCT
iajs-3400	290	47	a	a	DET
iajs-3400	290	48	cross	cross	ADJ
iajs-3400	290	49	-	-	ADJ
iajs-3400	290	50	sectional	sectional	ADJ
iajs-3400	290	51	population	population	NOUN
iajs-3400	290	52	-	-	PUNCT
iajs-3400	290	53	based	base	VERB
iajs-3400	290	54	study	study	NOUN
iajs-3400	290	55	in	in	ADP
iajs-3400	290	56	southern	southern	ADJ
iajs-3400	290	57	iran	iran	PROPN
iajs-3400	290	58	.	.	PUNCT
iajs-3400	291	1	bmc	bmc	ADJ
iajs-3400	291	2	urology	urology	NOUN
iajs-3400	291	3	2022	2022	NUM
iajs-3400	291	4	,	,	PUNCT
iajs-3400	291	5	22	22	NUM
iajs-3400	291	6	,	,	PUNCT
iajs-3400	291	7	1	1	NUM
iajs-3400	291	8	-	-	SYM
iajs-3400	291	9	9	9	NUM
iajs-3400	291	10	.	.	PUNCT
iajs-3400	291	11	doi	doi	NOUN
iajs-3400	291	12	:	:	PUNCT
iajs-3400	291	13	https://doi.org/10.1186/s12894-022-01161-x	https://doi.org/10.1186/s12894-022-01161-x	NOUN
iajs-3400	291	14	.	.	PROPN
iajs-3400	292	1	35	35	NUM
iajs-3400	292	2	.	.	PUNCT
iajs-3400	293	1	fadhil	fadhil	PROPN
iajs-3400	293	2	,	,	PUNCT
iajs-3400	293	3	y.s	y.s	PROPN
iajs-3400	293	4	.	.	PROPN
iajs-3400	294	1	a	a	DET
iajs-3400	294	2	study	study	NOUN
iajs-3400	294	3	on	on	ADP
iajs-3400	294	4	renal	renal	ADJ
iajs-3400	294	5	stones	stone	NOUN
iajs-3400	294	6	incidence	incidence	NOUN
iajs-3400	294	7	with	with	ADP
iajs-3400	294	8	regard	regard	NOUN
iajs-3400	294	9	to	to	ADP
iajs-3400	294	10	age	age	NOUN
iajs-3400	294	11	,	,	PUNCT
iajs-3400	294	12	gender	gender	NOUN
iajs-3400	294	13	and	and	CCONJ
iajs-3400	294	14	chemical	chemical	NOUN
iajs-3400	294	15	composition	composition	NOUN
iajs-3400	294	16	of	of	ADP
iajs-3400	294	17	stones	stone	NOUN
iajs-3400	294	18	in	in	ADP
iajs-3400	294	19	western	western	ADJ
iajs-3400	294	20	iraq	iraq	PROPN
iajs-3400	294	21	.	.	PUNCT
iajs-3400	294	22	"	"	PUNCT
iajs-3400	295	1	international	international	ADJ
iajs-3400	295	2	journal	journal	PROPN
iajs-3400	295	3	of	of	ADP
iajs-3400	295	4	health	health	PROPN
iajs-3400	295	5	sciences	science	NOUN
iajs-3400	295	6	2022	2022	NUM
iajs-3400	295	7	,	,	PUNCT
iajs-3400	295	8	9814	9814	NUM
iajs-3400	295	9	-	-	SYM
iajs-3400	295	10	9818	9818	NUM
iajs-3400	295	11	.	.	PUNCT
iajs-3400	296	1	doi	doi	NOUN
iajs-3400	296	2	:	:	PUNCT
iajs-3400	296	3	https://dx.doi.org/10.53730/ijhs.v6ns1.7291	https://dx.doi.org/10.53730/ijhs.v6ns1.7291	PROPN
iajs-3400	296	4	.	.	PUNCT
iajs-3400	297	1	36	36	NUM
iajs-3400	297	2	.	.	PUNCT
iajs-3400	298	1	jaff	jaff	PROPN
iajs-3400	298	2	,	,	PUNCT
iajs-3400	298	3	m.s	m.s	PROPN
iajs-3400	298	4	.	.	PROPN
iajs-3400	298	5	abo	abo	PROPN
iajs-3400	298	6	and	and	CCONJ
iajs-3400	298	7	rhesus	rhesus	NOUN
iajs-3400	298	8	blood	blood	NOUN
iajs-3400	298	9	group	group	NOUN
iajs-3400	298	10	distribution	distribution	NOUN
iajs-3400	298	11	in	in	ADP
iajs-3400	298	12	kurds	kurds	PROPN
iajs-3400	298	13	.	.	PUNCT
iajs-3400	299	1	journal	journal	PROPN
iajs-3400	299	2	of	of	ADP
iajs-3400	299	3	blood	blood	NOUN
iajs-3400	299	4	medicine	medicine	NOUN
iajs-3400	299	5	2010	2010	NUM
iajs-3400	299	6	,	,	PUNCT
iajs-3400	299	7	143146	143146	NUM
iajs-3400	299	8	.	.	PUNCT
iajs-3400	300	1	doi	doi	NOUN
iajs-3400	300	2	:	:	PUNCT
iajs-3400	300	3	https://doi.org/10.2147%2fjbm.s12262	https://doi.org/10.2147%2fjbm.s12262	PROPN
iajs-3400	300	4	.	.	PROPN
iajs-3400	300	5	37	37	NUM
iajs-3400	300	6	.	.	PUNCT
iajs-3400	301	1	baatiah	baatiah	PROPN
iajs-3400	301	2	,	,	PUNCT
iajs-3400	301	3	n.y	n.y	PROPN
iajs-3400	301	4	.	.	PROPN
iajs-3400	301	5	;	;	PUNCT
iajs-3400	301	6	alhazmi	alhazmi	PROPN
iajs-3400	301	7	,	,	PUNCT
iajs-3400	301	8	r.b	r.b	PROPN
iajs-3400	301	9	.	.	PROPN
iajs-3400	301	10	;	;	PUNCT
iajs-3400	301	11	albathi	albathi	ADV
iajs-3400	301	12	,	,	PUNCT
iajs-3400	301	13	f.a	f.a	PROPN
iajs-3400	301	14	.	.	PROPN
iajs-3400	301	15	;	;	PUNCT
iajs-3400	301	16	albogami	albogami	ADJ
iajs-3400	301	17	,	,	PUNCT
iajs-3400	301	18	e.g.	e.g.	ADV
iajs-3400	301	19	;	;	PUNCT
iajs-3400	301	20	mohammedkhalil	mohammedkhalil	NUM
iajs-3400	301	21	,	,	PUNCT
iajs-3400	301	22	a.k	a.k	PROPN
iajs-3400	301	23	.	.	PROPN
iajs-3400	301	24	;	;	PUNCT
iajs-3400	301	25	alsaywid	alsaywid	NOUN
iajs-3400	301	26	,	,	PUNCT
iajs-3400	301	27	b.s	b.s	PROPN
iajs-3400	301	28	.	.	PROPN
iajs-3400	301	29	urolithiasis	urolithiasis	NOUN
iajs-3400	301	30	:	:	PUNCT
iajs-3400	302	1	prevalence	prevalence	NOUN
iajs-3400	302	2	,	,	PUNCT
iajs-3400	302	3	risk	risk	NOUN
iajs-3400	302	4	factors	factor	NOUN
iajs-3400	302	5	,	,	PUNCT
iajs-3400	302	6	and	and	CCONJ
iajs-3400	302	7	public	public	ADJ
iajs-3400	302	8	awareness	awareness	NOUN
iajs-3400	302	9	regarding	regard	VERB
iajs-3400	302	10	dietary	dietary	ADJ
iajs-3400	302	11	and	and	CCONJ
iajs-3400	302	12	lifestyle	lifestyle	NOUN
iajs-3400	302	13	habits	habit	NOUN
iajs-3400	302	14	in	in	ADP
iajs-3400	302	15	jeddah	jeddah	PROPN
iajs-3400	302	16	,	,	PUNCT
iajs-3400	302	17	saudi	saudi	PROPN
iajs-3400	302	18	arabia	arabia	PROPN
iajs-3400	302	19	in	in	ADP
iajs-3400	302	20	2017	2017	NUM
iajs-3400	302	21	.	.	PUNCT
iajs-3400	303	1	urology	urology	NOUN
iajs-3400	303	2	annals	annal	NOUN
iajs-3400	303	3	2020	2020	NUM
iajs-3400	303	4	;	;	PUNCT
iajs-3400	303	5	12(1	12(1	NUM
iajs-3400	303	6	)	)	PUNCT
iajs-3400	303	7	,	,	PUNCT
iajs-3400	303	8	57	57	NUM
iajs-3400	303	9	.	.	PUNCT
iajs-3400	304	1	doi	doi	NOUN
iajs-3400	304	2	:	:	PUNCT
iajs-3400	304	3	https://doi.org/10.4103/ua.ua_13_19	https://doi.org/10.4103/ua.ua_13_19	X
iajs-3400	304	4	.	.	PUNCT
iajs-3400	305	1	38	38	NUM
iajs-3400	305	2	.	.	PUNCT
iajs-3400	305	3	dawson	dawson	PROPN
iajs-3400	305	4	,	,	PUNCT
iajs-3400	305	5	c.	c.	PROPN
iajs-3400	305	6	h.	h.	PROPN
iajs-3400	305	7	;	;	PUNCT
iajs-3400	305	8	tomson	tomson	PROPN
iajs-3400	305	9	,	,	PUNCT
iajs-3400	305	10	c.	c.	PROPN
iajs-3400	305	11	r.	r.	PROPN
iajs-3400	305	12	kidney	kidney	PROPN
iajs-3400	305	13	stone	stone	NOUN
iajs-3400	305	14	disease	disease	NOUN
iajs-3400	305	15	:	:	PUNCT
iajs-3400	305	16	pathophysiology	pathophysiology	NOUN
iajs-3400	305	17	,	,	PUNCT
iajs-3400	305	18	investigation	investigation	NOUN
iajs-3400	305	19	and	and	CCONJ
iajs-3400	305	20	medical	medical	ADJ
iajs-3400	305	21	treatment	treatment	NOUN
iajs-3400	305	22	.	.	PUNCT
iajs-3400	306	1	clinical	clinical	ADJ
iajs-3400	306	2	medicine	medicine	NOUN
iajs-3400	306	3	2012	2012	NUM
iajs-3400	306	4	,	,	PUNCT
iajs-3400	306	5	12	12	NUM
iajs-3400	306	6	,	,	PUNCT
iajs-3400	306	7	467	467	NUM
iajs-3400	306	8	.	.	PUNCT
iajs-3400	306	9	doi	doi	PROPN
iajs-3400	306	10	:	:	PUNCT
iajs-3400	306	11	https://doi.org/10.7861/clinmedicine.12-5-467	https://doi.org/10.7861/clinmedicine.12-5-467	PROPN
iajs-3400	306	12	.	.	PUNCT
iajs-3400	307	1	https://doi.org/10.3390/ijms21103608	https://doi.org/10.3390/ijms21103608	NOUN
iajs-3400	307	2	https://doi.org/10.4061/2011/864580	https://doi.org/10.4061/2011/864580	PROPN
iajs-3400	307	3	https://doi.org/10.1093/ndt/gfm271	https://doi.org/10.1093/ndt/gfm271	NOUN
iajs-3400	307	4	https://doi.org/10.1016/s0167-4781(99)00105-0	https://doi.org/10.1016/s0167-4781(99)00105-0	VERB
iajs-3400	307	5	https://doi.org/10.1016/j.kint.2019.08.018	https://doi.org/10.1016/j.kint.2019.08.018	PROPN
iajs-3400	307	6	https://doi.org/10.1111/bcp.14925	https://doi.org/10.1111/bcp.14925	PROPN
iajs-3400	307	7	https://doi.org/10.3892/ol.2020.11733	https://doi.org/10.3892/ol.2020.11733	NOUN
iajs-3400	307	8	https://doi.org/10.21203/rs.3.rs-2015954/v1	https://doi.org/10.21203/rs.3.rs-2015954/v1	CCONJ
iajs-3400	307	9	https://doi.org/10.1016/j.pnpbp.2022.110594	https://doi.org/10.1016/j.pnpbp.2022.110594	PROPN
iajs-3400	307	10	https://doi.org/10.1007/s00240-023-01440-8	https://doi.org/10.1007/s00240-023-01440-8	NUM
iajs-3400	307	11	https://doi.org/10.1186/s12894-022-01161-x	https://doi.org/10.1186/s12894-022-01161-x	PROPN
iajs-3400	307	12	https://dx.doi.org/10.53730/ijhs.v6ns1.7291	https://dx.doi.org/10.53730/ijhs.v6ns1.7291	PROPN
iajs-3400	307	13	https://doi.org/10.2147%2fjbm.s12262	https://doi.org/10.2147%2fjbm.s12262	PROPN
iajs-3400	307	14	https://doi.org/10.4103/ua.ua_13_19	https://doi.org/10.4103/ua.ua_13_19	PROPN
iajs-3400	307	15	https://doi.org/10.7861/clinmedicine.12-5-467	https://doi.org/10.7861/clinmedicine.12-5-467	NOUN
iajs-3400	307	16	ihjpas	ihjpas	PROPN
iajs-3400	307	17	.	.	PUNCT
iajs-3400	308	1	37	37	NUM
iajs-3400	308	2	(	(	PUNCT
iajs-3400	308	3	2	2	NUM
iajs-3400	308	4	)	)	PUNCT
iajs-3400	308	5	2024	2024	NUM
iajs-3400	308	6	167	167	NUM
iajs-3400	308	7	39	39	NUM
iajs-3400	308	8	.	.	PUNCT
iajs-3400	309	1	al	al	PROPN
iajs-3400	309	2	-	-	PUNCT
iajs-3400	309	3	taiee	taiee	PROPN
iajs-3400	309	4	,	,	PUNCT
iajs-3400	309	5	t.a.k	t.a.k	NOUN
iajs-3400	309	6	.	.	PUNCT
iajs-3400	309	7	;	;	PUNCT
iajs-3400	310	1	al	al	PROPN
iajs-3400	310	2	-	-	PUNCT
iajs-3400	310	3	shammaa	shammaa	ADJ
iajs-3400	310	4	,	,	PUNCT
iajs-3400	310	5	n.m	n.m	PROPN
iajs-3400	310	6	.	.	PROPN
iajs-3400	310	7	effect	effect	NOUN
iajs-3400	310	8	of	of	ADP
iajs-3400	310	9	anti	anti	X
iajs-3400	310	10	diuretic	diuretic	ADJ
iajs-3400	310	11	hormon	hormon	NOUN
iajs-3400	310	12	(	(	PUNCT
iajs-3400	310	13	adh	adh	PROPN
iajs-3400	310	14	)	)	PUNCT
iajs-3400	310	15	in	in	ADP
iajs-3400	310	16	kidney	kidney	NOUN
iajs-3400	310	17	function	function	NOUN
iajs-3400	310	18	on	on	ADP
iajs-3400	310	19	post	post	NOUN
iajs-3400	310	20	hemodialysis	hemodialysis	NOUN
iajs-3400	310	21	end	end	NOUN
iajs-3400	310	22	stage	stage	NOUN
iajs-3400	310	23	renal	renal	ADJ
iajs-3400	310	24	failure	failure	NOUN
iajs-3400	310	25	disease	disease	NOUN
iajs-3400	310	26	(	(	PUNCT
iajs-3400	310	27	esrd	esrd	PROPN
iajs-3400	310	28	)	)	PUNCT
iajs-3400	310	29	iraqi	iraqi	ADJ
iajs-3400	310	30	patients	patient	NOUN
iajs-3400	310	31	.	.	PUNCT
iajs-3400	311	1	iraqi	iraqi	ADJ
iajs-3400	311	2	journal	journal	PROPN
iajs-3400	311	3	of	of	ADP
iajs-3400	311	4	science	science	NOUN
iajs-3400	311	5	2018	2018	NUM
iajs-3400	311	6	,	,	PUNCT
iajs-3400	311	7	1372	1372	NUM
iajs-3400	311	8	-	-	SYM
iajs-3400	311	9	1377	1377	NUM
iajs-3400	311	10	.	.	PUNCT
iajs-3400	312	1	doi	doi	NOUN
iajs-3400	312	2	:	:	PUNCT
iajs-3400	312	3	https://doi.org/10.24996/ijs.2018.59.3b.4	https://doi.org/10.24996/ijs.2018.59.3b.4	NOUN
iajs-3400	312	4	.	.	PROPN
iajs-3400	313	1	40	40	NUM
iajs-3400	313	2	.	.	PUNCT
iajs-3400	314	1	salih	salih	PROPN
iajs-3400	314	2	,	,	PUNCT
iajs-3400	314	3	s.	s.	PROPN
iajs-3400	314	4	s.	s.	PROPN
iajs-3400	314	5	;	;	PUNCT
iajs-3400	314	6	yenzeel	yenzeel	PROPN
iajs-3400	314	7	,	,	PUNCT
iajs-3400	314	8	j.	j.	PROPN
iajs-3400	314	9	h.	h.	PROPN
iajs-3400	314	10	evaluation	evaluation	PROPN
iajs-3400	314	11	of	of	ADP
iajs-3400	314	12	thyroid	thyroid	NOUN
iajs-3400	314	13	hormones	hormone	NOUN
iajs-3400	314	14	and	and	CCONJ
iajs-3400	314	15	some	some	DET
iajs-3400	314	16	biochemical	biochemical	ADJ
iajs-3400	314	17	variables	variable	NOUN
iajs-3400	314	18	in	in	ADP
iajs-3400	314	19	patients	patient	NOUN
iajs-3400	314	20	with	with	ADP
iajs-3400	314	21	chronic	chronic	ADJ
iajs-3400	314	22	kidney	kidney	NOUN
iajs-3400	314	23	disease	disease	NOUN
iajs-3400	314	24	.	.	PUNCT
iajs-3400	315	1	iraqi	iraqi	ADJ
iajs-3400	315	2	journal	journal	PROPN
iajs-3400	315	3	of	of	ADP
iajs-3400	315	4	science	science	NOUN
iajs-3400	315	5	2020	2020	NUM
iajs-3400	315	6	,	,	PUNCT
iajs-3400	315	7	985	985	NUM
iajs-3400	315	8	-	-	SYM
iajs-3400	315	9	992	992	NUM
iajs-3400	315	10	.	.	PUNCT
iajs-3400	316	1	doi	doi	NOUN
iajs-3400	316	2	:	:	PUNCT
iajs-3400	316	3	https://doi.org/10.24996/ijs.2020.61.5.6	https://doi.org/10.24996/ijs.2020.61.5.6	PROPN
iajs-3400	316	4	.	.	PROPN
iajs-3400	316	5	41	41	NUM
iajs-3400	316	6	.	.	PUNCT
iajs-3400	317	1	asif	asif	NOUN
iajs-3400	317	2	,	,	PUNCT
iajs-3400	317	3	a.	a.	NOUN
iajs-3400	317	4	a.	a.	NOUN
iajs-3400	317	5	;	;	PUNCT
iajs-3400	317	6	hussain	hussain	PROPN
iajs-3400	317	7	,	,	PUNCT
iajs-3400	317	8	h.	h.	PROPN
iajs-3400	317	9	;	;	PUNCT
iajs-3400	317	10	chatterjee	chatterjee	PROPN
iajs-3400	317	11	,	,	PUNCT
iajs-3400	317	12	t.	t.	PROPN
iajs-3400	317	13	extraordinary	extraordinary	ADJ
iajs-3400	317	14	creatinine	creatinine	NOUN
iajs-3400	317	15	level	level	NOUN
iajs-3400	317	16	:	:	PUNCT
iajs-3400	317	17	a	a	DET
iajs-3400	317	18	case	case	NOUN
iajs-3400	317	19	report	report	NOUN
iajs-3400	317	20	.	.	PUNCT
iajs-3400	318	1	cureus	cureus	NOUN
iajs-3400	318	2	2020	2020	NUM
iajs-3400	318	3	,	,	PUNCT
iajs-3400	318	4	12	12	NUM
iajs-3400	318	5	.	.	PUNCT
iajs-3400	319	1	doi	doi	NOUN
iajs-3400	319	2	:	:	PUNCT
iajs-3400	319	3	https://doi.org/10.7759/cureus.9076	https://doi.org/10.7759/cureus.9076	ADJ
iajs-3400	319	4	.	.	PUNCT
iajs-3400	320	1	42	42	NUM
iajs-3400	320	2	.	.	PUNCT
iajs-3400	321	1	chatterjee	chatterjee	PROPN
iajs-3400	321	2	,	,	PUNCT
iajs-3400	321	3	a.	a.	PROPN
iajs-3400	321	4	;	;	PUNCT
iajs-3400	321	5	sarkar	sarkar	PROPN
iajs-3400	321	6	,	,	PUNCT
iajs-3400	321	7	k.	k.	PROPN
iajs-3400	321	8	;	;	PUNCT
iajs-3400	321	9	bank	bank	PROPN
iajs-3400	321	10	,	,	PUNCT
iajs-3400	321	11	s.	s.	PROPN
iajs-3400	321	12	;	;	PUNCT
iajs-3400	321	13	ghosh	ghosh	PROPN
iajs-3400	321	14	,	,	PUNCT
iajs-3400	321	15	s.	s.	PROPN
iajs-3400	321	16	;	;	PUNCT
iajs-3400	321	17	pal	pal	NOUN
iajs-3400	321	18	,	,	PUNCT
iajs-3400	321	19	d.	d.	PROPN
iajs-3400	321	20	k.	k.	PROPN
iajs-3400	321	21	;	;	PUNCT
iajs-3400	321	22	saraf	saraf	PROPN
iajs-3400	321	23	,	,	PUNCT
iajs-3400	321	24	s.	s.	PROPN
iajs-3400	321	25	;	;	PUNCT
iajs-3400	321	26	wakle	wakle	VERB
iajs-3400	321	27	,	,	PUNCT
iajs-3400	321	28	d.	d.	PROPN
iajs-3400	321	29	;	;	PUNCT
iajs-3400	321	30	roy	roy	PROPN
iajs-3400	321	31	,	,	PUNCT
iajs-3400	321	32	b.	b.	PROPN
iajs-3400	321	33	;	;	PUNCT
iajs-3400	321	34	chakraborty	chakraborty	PROPN
iajs-3400	321	35	,	,	PUNCT
iajs-3400	321	36	s.	s.	PROPN
iajs-3400	321	37	;	;	PUNCT
iajs-3400	321	38	bankura	bankura	PROPN
iajs-3400	321	39	,	,	PUNCT
iajs-3400	321	40	b.	b.	PROPN
iajs-3400	321	41	;	;	PUNCT
iajs-3400	321	42	chattopadhyay	chattopadhyay	PROPN
iajs-3400	321	43	,	,	PUNCT
iajs-3400	321	44	d.	d.	PROPN
iajs-3400	321	45	homozygous	homozygous	PROPN
iajs-3400	321	46	grhpr	grhpr	PROPN
iajs-3400	321	47	c.	c.	PROPN
iajs-3400	321	48	494	494	NUM
iajs-3400	321	49	g	g	NOUN
iajs-3400	321	50	>	>	X
iajs-3400	321	51	a	a	DET
iajs-3400	321	52	mutation	mutation	NOUN
iajs-3400	321	53	is	be	AUX
iajs-3400	321	54	deleterious	deleterious	ADJ
iajs-3400	321	55	that	that	SCONJ
iajs-3400	321	56	causes	cause	VERB
iajs-3400	321	57	early	early	ADJ
iajs-3400	321	58	onset	onset	NOUN
iajs-3400	321	59	of	of	ADP
iajs-3400	321	60	nephrolithiasis	nephrolithiasis	NOUN
iajs-3400	321	61	in	in	ADP
iajs-3400	321	62	west	west	PROPN
iajs-3400	321	63	bengal	bengal	PROPN
iajs-3400	321	64	,	,	PUNCT
iajs-3400	321	65	india	india	PROPN
iajs-3400	321	66	.	.	PUNCT
iajs-3400	322	1	frontiers	frontier	NOUN
iajs-3400	322	2	in	in	ADP
iajs-3400	322	3	molecular	molecular	ADJ
iajs-3400	322	4	biosciences	bioscience	NOUN
iajs-3400	322	5	.	.	PUNCT
iajs-3400	322	6	2022	2022	NUM
iajs-3400	322	7	,	,	PUNCT
iajs-3400	322	8	9	9	NUM
iajs-3400	322	9	.	.	X
iajs-3400	322	10	doi	doi	NOUN
iajs-3400	322	11	:	:	PUNCT
iajs-3400	322	12	https://doi.org/10.3389/fmolb.2022.1049620	https://doi.org/10.3389/fmolb.2022.1049620	PROPN
iajs-3400	322	13	.	.	PUNCT
iajs-3400	323	1	43	43	NUM
iajs-3400	323	2	.	.	PUNCT
iajs-3400	324	1	haley	haley	NOUN
iajs-3400	324	2	,	,	PUNCT
iajs-3400	324	3	w.	w.	PROPN
iajs-3400	324	4	e.	e.	PROPN
iajs-3400	324	5	;	;	PUNCT
iajs-3400	324	6	enders	ender	NOUN
iajs-3400	324	7	,	,	PUNCT
iajs-3400	324	8	f.	f.	PROPN
iajs-3400	324	9	t.	t.	PROPN
iajs-3400	324	10	;	;	PUNCT
iajs-3400	324	11	vaughan	vaughan	PROPN
iajs-3400	324	12	,	,	PUNCT
iajs-3400	324	13	l.	l.	PROPN
iajs-3400	324	14	e.	e.	PROPN
iajs-3400	324	15	;	;	PUNCT
iajs-3400	324	16	mehta	mehta	PROPN
iajs-3400	324	17	,	,	PUNCT
iajs-3400	324	18	r.	r.	PROPN
iajs-3400	324	19	a.	a.	PROPN
iajs-3400	324	20	;	;	PUNCT
iajs-3400	324	21	thoman	thoman	NOUN
iajs-3400	324	22	,	,	PUNCT
iajs-3400	324	23	m.	m.	PROPN
iajs-3400	324	24	e.	e.	PROPN
iajs-3400	324	25	;	;	PUNCT
iajs-3400	324	26	vrtiska	vrtiska	PROPN
iajs-3400	324	27	,	,	PUNCT
iajs-3400	324	28	t.	t.	PROPN
iajs-3400	324	29	j.	j.	PROPN
iajs-3400	324	30	;	;	PUNCT
iajs-3400	324	31	krambeck	krambeck	PROPN
iajs-3400	324	32	,	,	PUNCT
iajs-3400	324	33	a.e	a.e	PROPN
iajs-3400	324	34	.	.	PROPN
iajs-3400	324	35	;	;	PUNCT
iajs-3400	324	36	lieske	lieske	PROPN
iajs-3400	324	37	,	,	PUNCT
iajs-3400	324	38	j.	j.	PROPN
iajs-3400	324	39	c.	c.	PROPN
iajs-3400	324	40	;	;	PUNCT
iajs-3400	324	41	rule	rule	NOUN
iajs-3400	324	42	,	,	PUNCT
iajs-3400	324	43	a.	a.	PROPN
iajs-3400	324	44	d.	d.	PROPN
iajs-3400	324	45	kidney	kidney	PROPN
iajs-3400	324	46	function	function	NOUN
iajs-3400	324	47	after	after	ADP
iajs-3400	324	48	the	the	DET
iajs-3400	324	49	first	first	ADJ
iajs-3400	324	50	kidney	kidney	NOUN
iajs-3400	324	51	stone	stone	NOUN
iajs-3400	324	52	event	event	NOUN
iajs-3400	324	53	.	.	PUNCT
iajs-3400	325	1	in	in	ADP
iajs-3400	325	2	mayo	mayo	NOUN
iajs-3400	325	3	clinic	clinic	NOUN
iajs-3400	325	4	proceedings	proceeding	NOUN
iajs-3400	325	5	2016	2016	NUM
iajs-3400	325	6	,	,	PUNCT
iajs-3400	325	7	91(12	91(12	NUM
iajs-3400	325	8	)	)	PUNCT
iajs-3400	325	9	,	,	PUNCT
iajs-3400	325	10	1744	1744	NUM
iajs-3400	325	11	-	-	SYM
iajs-3400	325	12	1752	1752	NUM
iajs-3400	325	13	.	.	PUNCT
iajs-3400	326	1	doi	doi	NOUN
iajs-3400	326	2	:	:	PUNCT
iajs-3400	326	3	https://doi.org/10.1016/j.mayocp.2016.08.014	https://doi.org/10.1016/j.mayocp.2016.08.014	PROPN
iajs-3400	326	4	.	.	PROPN
iajs-3400	327	1	44	44	NUM
iajs-3400	327	2	.	.	PUNCT
iajs-3400	328	1	geraghty	geraghty	PROPN
iajs-3400	328	2	,	,	PUNCT
iajs-3400	328	3	r.	r.	PROPN
iajs-3400	328	4	;	;	PUNCT
iajs-3400	328	5	abdi	abdi	PROPN
iajs-3400	328	6	,	,	PUNCT
iajs-3400	328	7	a.	a.	NOUN
iajs-3400	328	8	;	;	PUNCT
iajs-3400	328	9	somani	somani	PROPN
iajs-3400	328	10	,	,	PUNCT
iajs-3400	328	11	b.	b.	PROPN
iajs-3400	328	12	;	;	PUNCT
iajs-3400	328	13	cook	cook	VERB
iajs-3400	328	14	,	,	PUNCT
iajs-3400	328	15	p.	p.	NOUN
iajs-3400	328	16	;	;	PUNCT
iajs-3400	328	17	roderick	roderick	PROPN
iajs-3400	328	18	,	,	PUNCT
iajs-3400	328	19	p.	p.	PROPN
iajs-3400	328	20	does	do	AUX
iajs-3400	328	21	chronic	chronic	ADJ
iajs-3400	328	22	hyperglycaemia	hyperglycaemia	NOUN
iajs-3400	328	23	increase	increase	VERB
iajs-3400	328	24	the	the	DET
iajs-3400	328	25	risk	risk	NOUN
iajs-3400	328	26	of	of	ADP
iajs-3400	328	27	kidney	kidney	NOUN
iajs-3400	328	28	stone	stone	NOUN
iajs-3400	328	29	disease	disease	NOUN
iajs-3400	328	30	?	?	PUNCT
iajs-3400	329	1	results	result	NOUN
iajs-3400	329	2	from	from	ADP
iajs-3400	329	3	a	a	DET
iajs-3400	329	4	systematic	systematic	ADJ
iajs-3400	329	5	review	review	NOUN
iajs-3400	329	6	and	and	CCONJ
iajs-3400	329	7	meta	meta	ADJ
iajs-3400	329	8	-	-	PUNCT
iajs-3400	329	9	analysis	analysis	NOUN
iajs-3400	329	10	.	.	PUNCT
iajs-3400	330	1	bmj	bmj	PROPN
iajs-3400	330	2	open	open	VERB
iajs-3400	330	3	2020	2020	NUM
iajs-3400	330	4	,	,	PUNCT
iajs-3400	330	5	10	10	NUM
iajs-3400	330	6	,	,	PUNCT
iajs-3400	330	7	e032094	e032094	PROPN
iajs-3400	330	8	.	.	PUNCT
iajs-3400	331	1	doi	doi	NOUN
iajs-3400	331	2	:	:	PUNCT
iajs-3400	332	1	https://doi.org/10.1136/bmjopen-2019-032094	https://doi.org/10.1136/bmjopen-2019-032094	VERB
iajs-3400	332	2	.	.	PUNCT
iajs-3400	333	1	45	45	NUM
iajs-3400	333	2	.	.	X
iajs-3400	334	1	zeng	zeng	PROPN
iajs-3400	334	2	,	,	PUNCT
iajs-3400	334	3	g.	g.	PROPN
iajs-3400	334	4	;	;	PUNCT
iajs-3400	334	5	mai	mai	PROPN
iajs-3400	334	6	,	,	PUNCT
iajs-3400	334	7	z.	z.	PROPN
iajs-3400	334	8	;	;	PUNCT
iajs-3400	334	9	xia	xia	PROPN
iajs-3400	334	10	,	,	PUNCT
iajs-3400	334	11	s.	s.	PROPN
iajs-3400	334	12	;	;	PUNCT
iajs-3400	334	13	wang	wang	PROPN
iajs-3400	334	14	,	,	PUNCT
iajs-3400	334	15	z.	z.	PROPN
iajs-3400	334	16	;	;	PUNCT
iajs-3400	334	17	zhang	zhang	PROPN
iajs-3400	334	18	,	,	PUNCT
iajs-3400	334	19	k.	k.	PROPN
iajs-3400	334	20	;	;	PUNCT
iajs-3400	334	21	wang	wang	PROPN
iajs-3400	334	22	,	,	PUNCT
iajs-3400	334	23	l	l	NOUN
iajs-3400	334	24	;	;	PUNCT
iajs-3400	334	25	long	long	ADV
iajs-3400	334	26	,	,	PUNCT
iajs-3400	334	27	y.	y.	PROPN
iajs-3400	334	28	;	;	PUNCT
iajs-3400	334	29	ma	ma	PROPN
iajs-3400	334	30	,	,	PUNCT
iajs-3400	334	31	j.	j.	PROPN
iajs-3400	334	32	;	;	PUNCT
iajs-3400	334	33	li	li	PROPN
iajs-3400	334	34	,	,	PUNCT
iajs-3400	334	35	y.	y.	PROPN
iajs-3400	334	36	;	;	PUNCT
iajs-3400	334	37	wan	wan	PROPN
iajs-3400	334	38	,	,	PUNCT
iajs-3400	334	39	s.	s.	PROPN
iajs-3400	334	40	p.	p.	PROPN
iajs-3400	334	41	;	;	PUNCT
iajs-3400	334	42	wu	wu	PROPN
iajs-3400	334	43	,	,	PUNCT
iajs-3400	334	44	w.	w.	PROPN
iajs-3400	334	45	prevalence	prevalence	NOUN
iajs-3400	334	46	of	of	ADP
iajs-3400	334	47	kidney	kidney	NOUN
iajs-3400	334	48	stones	stone	NOUN
iajs-3400	334	49	in	in	ADP
iajs-3400	334	50	china	china	PROPN
iajs-3400	334	51	:	:	PUNCT
iajs-3400	334	52	an	an	DET
iajs-3400	334	53	ultrasonography	ultrasonography	NOUN
iajs-3400	334	54	based	base	VERB
iajs-3400	334	55	cross‐sectional	cross‐sectional	ADJ
iajs-3400	334	56	study	study	NOUN
iajs-3400	334	57	.	.	PUNCT
iajs-3400	335	1	bju	bju	PROPN
iajs-3400	335	2	international	international	PROPN
iajs-3400	335	3	.	.	PUNCT
iajs-3400	336	1	2017	2017	NUM
iajs-3400	336	2	,	,	PUNCT
iajs-3400	336	3	120	120	NUM
iajs-3400	336	4	,	,	PUNCT
iajs-3400	336	5	109	109	NUM
iajs-3400	336	6	-	-	SYM
iajs-3400	336	7	16	16	NUM
iajs-3400	336	8	.	.	PUNCT
iajs-3400	337	1	doi	doi	NOUN
iajs-3400	337	2	:	:	PUNCT
iajs-3400	337	3	https://doi.org/10.1111/bju.13828	https://doi.org/10.1111/bju.13828	PROPN
iajs-3400	337	4	.	.	PUNCT
iajs-3400	338	1	46	46	NUM
iajs-3400	338	2	.	.	PUNCT
iajs-3400	339	1	markovič	markovič	PROPN
iajs-3400	339	2	,	,	PUNCT
iajs-3400	339	3	r.	r.	PROPN
iajs-3400	339	4	;	;	PUNCT
iajs-3400	339	5	grubelnik	grubelnik	NOUN
iajs-3400	339	6	,	,	PUNCT
iajs-3400	339	7	v.	v.	PROPN
iajs-3400	339	8	;	;	PUNCT
iajs-3400	339	9	vošner	vošner	NOUN
iajs-3400	339	10	,	,	PUNCT
iajs-3400	339	11	h.	h.	PROPN
iajs-3400	339	12	b.	b.	PROPN
iajs-3400	339	13	kokol	kokol	PROPN
iajs-3400	339	14	,	,	PUNCT
iajs-3400	339	15	p.	p.	PROPN
iajs-3400	339	16	;	;	PUNCT
iajs-3400	339	17	završnik	završnik	X
iajs-3400	339	18	,	,	PUNCT
iajs-3400	339	19	m.	m.	NOUN
iajs-3400	339	20	;	;	PUNCT
iajs-3400	339	21	janša	janša	PROPN
iajs-3400	339	22	,	,	PUNCT
iajs-3400	339	23	k.	k.	PROPN
iajs-3400	339	24	;	;	PUNCT
iajs-3400	339	25	zupet	zupet	PROPN
iajs-3400	339	26	,	,	PUNCT
iajs-3400	339	27	m.	m.	NOUN
iajs-3400	339	28	;	;	PUNCT
iajs-3400	339	29	završnik	završnik	X
iajs-3400	339	30	,	,	PUNCT
iajs-3400	339	31	j.	j.	PROPN
iajs-3400	339	32	;	;	PUNCT
iajs-3400	339	33	marhl	marhl	NOUN
iajs-3400	339	34	,	,	PUNCT
iajs-3400	339	35	m.	m.	NOUN
iajs-3400	339	36	age	age	NOUN
iajs-3400	339	37	-	-	PUNCT
iajs-3400	339	38	related	relate	VERB
iajs-3400	339	39	changes	change	NOUN
iajs-3400	339	40	in	in	ADP
iajs-3400	339	41	lipid	lipid	NOUN
iajs-3400	339	42	and	and	CCONJ
iajs-3400	339	43	glucose	glucose	NOUN
iajs-3400	339	44	levels	level	NOUN
iajs-3400	339	45	associated	associate	VERB
iajs-3400	339	46	with	with	ADP
iajs-3400	339	47	drug	drug	NOUN
iajs-3400	339	48	use	use	NOUN
iajs-3400	339	49	and	and	CCONJ
iajs-3400	339	50	mortality	mortality	NOUN
iajs-3400	339	51	:	:	PUNCT
iajs-3400	339	52	an	an	DET
iajs-3400	339	53	observational	observational	ADJ
iajs-3400	339	54	study	study	NOUN
iajs-3400	339	55	.	.	PUNCT
iajs-3400	340	1	journal	journal	NOUN
iajs-3400	340	2	of	of	ADP
iajs-3400	340	3	personalized	personalized	ADJ
iajs-3400	340	4	medicine	medicine	NOUN
iajs-3400	340	5	.	.	PUNCT
iajs-3400	341	1	2022	2022	NUM
iajs-3400	341	2	,	,	PUNCT
iajs-3400	341	3	12	12	NUM
iajs-3400	341	4	,	,	PUNCT
iajs-3400	341	5	280	280	NUM
iajs-3400	341	6	.	.	PUNCT
iajs-3400	341	7	doi	doi	NOUN
iajs-3400	341	8	:	:	PUNCT
iajs-3400	341	9	https://doi.org/10.3390/jpm12020280	https://doi.org/10.3390/jpm12020280	NOUN
iajs-3400	341	10	.	.	PUNCT
iajs-3400	342	1	47	47	NUM
iajs-3400	342	2	.	.	PUNCT
iajs-3400	343	1	alzubaidy	alzubaidy	ADJ
iajs-3400	343	2	,	,	PUNCT
iajs-3400	343	3	d.a.a.m	d.a.a.m	PROPN
iajs-3400	343	4	.	.	PROPN
iajs-3400	343	5	and	and	CCONJ
iajs-3400	343	6	al	al	PROPN
iajs-3400	343	7	obaidy	obaidy	VERB
iajs-3400	343	8	,	,	PUNCT
iajs-3400	343	9	l.h.a	l.h.a	ADJ
iajs-3400	343	10	.	.	PUNCT
iajs-3400	343	11	2024	2024	NUM
iajs-3400	343	12	.	.	PUNCT
iajs-3400	344	1	grhpr	grhpr	ADJ
iajs-3400	344	2	gene	gene	NOUN
iajs-3400	344	3	variations	variation	NOUN
iajs-3400	344	4	in	in	ADP
iajs-3400	344	5	iraqi	iraqi	ADJ
iajs-3400	344	6	patients	patient	NOUN
iajs-3400	344	7	infected	infect	VERB
iajs-3400	344	8	with	with	ADP
iajs-3400	344	9	calcium	calcium	NOUN
iajs-3400	344	10	oxalate	oxalate	NOUN
iajs-3400	344	11	kidney	kidney	NOUN
iajs-3400	344	12	stones	stone	NOUN
iajs-3400	344	13	.	.	PUNCT
iajs-3400	345	1	baghdad	baghdad	PROPN
iajs-3400	345	2	science	science	PROPN
iajs-3400	345	3	journal	journal	PROPN
iajs-3400	345	4	.	.	PUNCT
iajs-3400	346	1	online	online	ADJ
iajs-3400	346	2	first	first	ADV
iajs-3400	346	3	,	,	PUNCT
iajs-3400	346	4	doi	doi	INTJ
iajs-3400	346	5	:	:	PUNCT
iajs-3400	346	6	https://doi.org/10.21123/bsj.2024.9066	https://doi.org/10.21123/bsj.2024.9066	ADJ
iajs-3400	346	7	.	.	PUNCT
iajs-3400	347	1	48	48	NUM
iajs-3400	347	2	.	.	PUNCT
iajs-3400	348	1	lai	lai	PROPN
iajs-3400	348	2	,	,	PUNCT
iajs-3400	348	3	c.	c.	PROPN
iajs-3400	348	4	;	;	PUNCT
iajs-3400	348	5	pursell	pursell	PROPN
iajs-3400	348	6	,	,	PUNCT
iajs-3400	348	7	n.	n.	NOUN
iajs-3400	348	8	;	;	PUNCT
iajs-3400	348	9	gierut	gierut	PROPN
iajs-3400	348	10	,	,	PUNCT
iajs-3400	348	11	j.	j.	PROPN
iajs-3400	348	12	;	;	PUNCT
iajs-3400	348	13	saxena	saxena	PROPN
iajs-3400	348	14	,	,	PUNCT
iajs-3400	348	15	u.	u.	PROPN
iajs-3400	348	16	;	;	PUNCT
iajs-3400	348	17	zhou	zhou	PROPN
iajs-3400	348	18	,	,	PUNCT
iajs-3400	348	19	w.	w.	PROPN
iajs-3400	348	20	;	;	PUNCT
iajs-3400	348	21	dills	dill	NOUN
iajs-3400	348	22	,	,	PUNCT
iajs-3400	348	23	m.	m.	NOUN
iajs-3400	348	24	;	;	PUNCT
iajs-3400	348	25	diwanji	diwanji	PROPN
iajs-3400	348	26	,	,	PUNCT
iajs-3400	348	27	r.	r.	PROPN
iajs-3400	348	28	;	;	PUNCT
iajs-3400	348	29	dutta	dutta	PROPN
iajs-3400	348	30	,	,	PUNCT
iajs-3400	348	31	c.	c.	PROPN
iajs-3400	348	32	;	;	PUNCT
iajs-3400	348	33	koser	koser	NOUN
iajs-3400	348	34	,	,	PUNCT
iajs-3400	348	35	m.	m.	NOUN
iajs-3400	348	36	;	;	PUNCT
iajs-3400	348	37	nazef	nazef	PROPN
iajs-3400	348	38	,	,	PUNCT
iajs-3400	348	39	n.	n.	PROPN
iajs-3400	348	40	;	;	PUNCT
iajs-3400	348	41	storr	storr	PROPN
iajs-3400	348	42	,	,	PUNCT
iajs-3400	348	43	r.	r.	PROPN
iajs-3400	348	44	,	,	PUNCT
iajs-3400	348	45	2018	2018	NUM
iajs-3400	348	46	.	.	PUNCT
iajs-3400	349	1	specific	specific	ADJ
iajs-3400	349	2	inhibition	inhibition	NOUN
iajs-3400	349	3	of	of	ADP
iajs-3400	349	4	hepatic	hepatic	ADJ
iajs-3400	349	5	lactate	lactate	NOUN
iajs-3400	349	6	dehydrogenase	dehydrogenase	NOUN
iajs-3400	349	7	reduces	reduce	VERB
iajs-3400	349	8	oxalate	oxalate	NOUN
iajs-3400	349	9	production	production	NOUN
iajs-3400	349	10	in	in	ADP
iajs-3400	349	11	mouse	mouse	NOUN
iajs-3400	349	12	models	model	NOUN
iajs-3400	349	13	of	of	ADP
iajs-3400	349	14	primary	primary	ADJ
iajs-3400	349	15	hyperoxaluria	hyperoxaluria	NOUN
iajs-3400	349	16	.	.	PUNCT
iajs-3400	350	1	molecular	molecular	ADJ
iajs-3400	350	2	therapy	therapy	NOUN
iajs-3400	350	3	2018	2018	NUM
iajs-3400	350	4	,	,	PUNCT
iajs-3400	350	5	26(8	26(8	NUM
iajs-3400	350	6	)	)	PUNCT
iajs-3400	350	7	,	,	PUNCT
iajs-3400	350	8	1983	1983	NUM
iajs-3400	350	9	-	-	SYM
iajs-3400	350	10	1995	1995	NUM
iajs-3400	350	11	.	.	PUNCT
iajs-3400	351	1	doi	doi	NOUN
iajs-3400	351	2	:	:	PUNCT
iajs-3400	351	3	https://doi.org/10.1016/j.ymthe.2018.05.016	https://doi.org/10.1016/j.ymthe.2018.05.016	PROPN
iajs-3400	351	4	.	.	PUNCT
iajs-3400	351	5	https://doi.org/10.24996/ijs.2018.59.3b.4	https://doi.org/10.24996/ijs.2018.59.3b.4	NOUN
iajs-3400	352	1	https://doi.org/10.24996/ijs.2020.61.5.6	https://doi.org/10.24996/ijs.2020.61.5.6	ADJ
iajs-3400	352	2	https://doi.org/10.7759/cureus.9076	https://doi.org/10.7759/cureus.9076	ADJ
iajs-3400	352	3	https://doi.org/10.3389/fmolb.2022.1049620	https://doi.org/10.3389/fmolb.2022.1049620	PROPN
iajs-3400	352	4	https://doi.org/10.1016/j.mayocp.2016.08.014	https://doi.org/10.1016/j.mayocp.2016.08.014	NOUN
iajs-3400	352	5	https://doi.org/10.1136/bmjopen-2019-032094	https://doi.org/10.1136/bmjopen-2019-032094	PROPN
iajs-3400	352	6	https://doi.org/10.1111/bju.13828	https://doi.org/10.1111/bju.13828	PROPN
iajs-3400	352	7	https://doi.org/10.3390/jpm12020280	https://doi.org/10.3390/jpm12020280	VERB
iajs-3400	352	8	https://doi.org/10.21123/bsj.2024.9066	https://doi.org/10.21123/bsj.2024.9066	ADJ
iajs-3400	352	9	https://doi.org/10.1016/j.ymthe.2018.05.016	https://doi.org/10.1016/j.ymthe.2018.05.016	PROPN